
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152544938AF30823054493001B6BEF1F.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="stemcellres">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Stem Cell Research &amp; Therapy">
<meta name="citation_title" content="Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside">
<meta name="citation_author" content="Jiatong Zhao">
<meta name="citation_author_institution" content="Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Shuzi Xin">
<meta name="citation_author_institution" content="Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Xiaohui Liu">
<meta name="citation_author_institution" content="Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Weikai Shi">
<meta name="citation_author_institution" content="Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Boya Wang">
<meta name="citation_author_institution" content="Key laboratory of Carcinogenesis and Translational Research Ministry of Education, Beijing, China">
<meta name="citation_author_institution" content="Department of Gastrointestinal Oncology, Peking University Cancer Hospital &amp; Institute, Beijing, 100142 China">
<meta name="citation_author" content="Hongli Wang">
<meta name="citation_author_institution" content="Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Yi Wang">
<meta name="citation_author_institution" content="Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Rongxuan Hua">
<meta name="citation_author_institution" content="Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Yize Li">
<meta name="citation_author_institution" content="Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Lei Gao">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, School of Biomedical Engineering, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Xin Lu">
<meta name="citation_author_institution" content="Experimental Center for Morphological Research Platform, Capital Medical University, Beijing, 100069 China">
<meta name="citation_author" content="Jingdong Xu">
<meta name="citation_author_institution" content="Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="16">
<meta name="citation_firstpage" content="444">
<meta name="citation_doi" content="10.1186/s13287-025-04549-2">
<meta name="citation_pmid" content="40830985">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/pdf/13287_2025_Article_4549.pdf">
<meta name="description" content="Adipose-derived stem cells (ADSCs) are a specific type of mesenchymal stem cells (MSCs) obtained easily from adipose tissue (AT). Compared with MSCs, ADSCs are easier to obtain, have fewer ethical issues, and have a higher proliferative capacity, ...">
<meta name="og:title" content="Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Adipose-derived stem cells (ADSCs) are a specific type of mesenchymal stem cells (MSCs) obtained easily from adipose tissue (AT). Compared with MSCs, ADSCs are easier to obtain, have fewer ethical issues, and have a higher proliferative capacity, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366020">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13287-025-04549-2"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13287_2025_Article_4549.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366020%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366020/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366020/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-stemcellres.png" alt="Stem Cell Research &amp; Therapy logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Stem Cell Research &amp; Therapy" title="Link to Stem Cell Research &amp; Therapy" shape="default" href="https://stemcellres.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Stem Cell Res Ther</button></div>. 2025 Aug 20;16:444. doi: <a href="https://doi.org/10.1186/s13287-025-04549-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13287-025-04549-2</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Stem%20Cell%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stem%20Cell%20Res%20Ther%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Stem%20Cell%20Res%20Ther%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Stem%20Cell%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jiatong Zhao</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jiatong Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiatong Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xin%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Shuzi Xin</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Shuzi Xin</span></h3>
<div class="p">
<sup>2</sup>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xin%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuzi Xin</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xiaohui Liu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xiaohui Liu</span></h3>
<div class="p">
<sup>2</sup>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaohui Liu</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Weikai Shi</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Weikai Shi</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weikai Shi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Boya Wang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Boya Wang</span></h3>
<div class="p">
<sup>3</sup>Key laboratory of Carcinogenesis and Translational Research Ministry of Education, Beijing, China </div>
<div class="p">
<sup>4</sup>Department of Gastrointestinal Oncology, Peking University Cancer Hospital &amp; Institute, Beijing, 100142 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Boya Wang</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hongli Wang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hongli Wang</span></h3>
<div class="p">
<sup>2</sup>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hongli Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yi Wang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yi Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hua%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Rongxuan Hua</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Rongxuan Hua</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hua%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rongxuan Hua</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yize Li</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yize Li</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yize Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Lei Gao</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Lei Gao</span></h3>
<div class="p">
<sup>5</sup>Department of Biomedical Informatics, School of Biomedical Engineering, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lei Gao</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Xin Lu</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Xin Lu</span></h3>
<div class="p">
<sup>6</sup>Experimental Center for Morphological Research Platform, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xin Lu</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Jingdong Xu</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Jingdong Xu</span></h3>
<div class="p">
<sup>2</sup>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jingdong Xu</span></a>
</div>
</div>
<sup>2,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div id="Aff2">
<sup>2</sup>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China </div>
<div id="Aff3">
<sup>3</sup>Key laboratory of Carcinogenesis and Translational Research Ministry of Education, Beijing, China </div>
<div id="Aff4">
<sup>4</sup>Department of Gastrointestinal Oncology, Peking University Cancer Hospital &amp; Institute, Beijing, 100142 China </div>
<div id="Aff5">
<sup>5</sup>Department of Biomedical Informatics, School of Biomedical Engineering, Capital Medical University, Beijing, 100069 China </div>
<div id="Aff6">
<sup>6</sup>Experimental Center for Morphological Research Platform, Capital Medical University, Beijing, 100069 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 15; Accepted 2025 Jul 18; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366020Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830985/" class="usa-link">40830985</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><hr class="headless">
<p id="Par1">Adipose-derived stem cells (ADSCs) are a specific type of mesenchymal stem cells (MSCs) obtained easily from adipose tissue (AT). Compared with MSCs, ADSCs are easier to obtain, have fewer ethical issues, and have a higher proliferative capacity, which makes them a promising type of stem cell in regenerative medicine. ADSCs possess impressive capabilities in cell regeneration as well as differentiation, making them promising candidates for injury repair, tissue regeneration and alleviation of inflamed tissues. At present, most clinical studies on ADSCs focus on the treatment of wounds, multiple sclerosis, soft tissue trauma, aging, diabetes, Parkinsonâ€™s disease, bone and cartilage regeneration, stroke, and spinal cord injury, while its clinical applications in the gastrointestinal tract are relatively few. Therefore, this review summarizes the findings of preclinical experiments, clinical trials, and areas that may require further development of ADSCs in the treatment of digestive disorders, including inflammatory bowel disease (IBD), colorectal cancer (CRC), colorectal fibrosis, hepatocellular carcinoma, hepatic fibrosis, gastric cancer (GC), gastrostomy closure and radiation-induced proctitis. The review is concluded by discussing the goals for improvement and future directions for ADSCs before large-scale clinical application.</p>
<section id="sec1"><h3 class="pmc_sec_title">Graphical Abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/ba49518c7f59/13287_2025_4549_Figa_HTML.jpg" loading="lazy" id="d33e268" height="762" width="762" alt="graphic file with name 13287_2025_4549_Figa_HTML.jpg"></a></p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Adipose-derived stem cells, Mesenchymal stem cells, Inflammatory bowel disease, Immunoregulatory effects, Anti-inflammation, Fibrosis</p></section></section><section class="abstract" id="Abs2"><h2>Highlights</h2>
<p id="Par3">ADSCs are simple to isolate and access, and they have few ethical issues for their application.</p>
<p id="Par4">ADSCs can differentiate into various cell types, supporting their use in regenerative medicine.</p>
<p id="Par5">ADSCs hold great promise for treating gastrointestinal diseases through modulation of immune response, anti-inflammation and tissue repair.</p>
<p id="Par6">ADSCs effectively treat gastrointestinal diseases like IBD and colorectal cancer, and show potential for liver fibrosis and gastric cancer.</p>
<p id="Par7">ADSC-derived extracellular vesicles (EVs) mimic parental cellsâ€™ bioactivity and mitigate safety issues of live stem cell delivery, crucial for their application.</p></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par8">Mesenchymal stem cells (MSCs) are pluripotent stem cells with the ability to self-renew and differentiate into multiple cell types, which play a key role in tissue healing and regenerative medicine. MSCs are adult stem cells residing in diverse tissues, including bone marrow, muscle, skin, adipose tissue (AT), and umbilical cord. They are termed according to their tissue sources: bone marrow stem cells (BMSCs), umbilical cord-mesenchymal stem cells (UC-MSCs), and adipose-derived stem cells (ADSCs). Although early MSC research predominantly focused on BMSCs, ADSCs have recently gained prominence in clinical applications due to their favorable ethical profile. The terminology for ADSCs has varied in different studies, including adipose mesenchymal stem cells, adipose-derived mesenchymal stem cells, ADSCs. In the following context, we will consistently use the term ADSCs as recommended by the International Federation of Adipose Therapeutics (IFATS).</p>
<p id="Par9">Studies have demonstrated that ADSCs possess adipogenic, osteogenic, chondrogenic, myogenic, and cardiogenic differentiation potential. Moreover, ADSCs also exhibit low immunogenicity and have the capacity for self-renewal. They can migrate to damaged areas and function through autocrine and paracrine signaling pathways, which are key mechanisms in cell repair and regeneration. These cells have raised significant interest in therapeutic applications particularly in treating a wide range of conditions, including autoimmune and neurodegenerative diseases, hematologic disorders, graft-versus-host disease (GVHD), bone/cartilage repair, as well as cardiovascular and muscle diseases [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>].</p></section><section id="Sec2"><h2 class="pmc_sec_title">General biological peculiarity of the ADSCs</h2>
<p id="Par10">ADSCs exhibit several fundamental characteristics shared by all MSCs, including multipotency, immunomodulatory capacity, and typical surface marker expression. However, ADSCs demonstrate superior advantages over BMSCs and UC-MSCs in several critical aspects: tissue accessibility, proliferative potential, viability maintenance, and clinical applicability. Collecting BMSCs is painful and challenging procedure due to their scarcity, comprising only 0.002% of total stromal cells [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], and the results are greatly influenced by the patientâ€™s age, status, and other factors. BMSCs stop growing at the 11-12th generation of expansion culture and strongly express the senescence-associated proteins p53, p21, and p16 [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Compared to BMSCs, UC-MSCs are present at lower frequencies, but their pluripotency is maintained for a longer period, as evidenced by the significantly reduced expression of the senescence markers p53, p21, and p16 in UC-MSCs [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. In addition, UC-MSCs show slightly positive for the embryonic stem cell markers Oct4, Nanog, Sox2 and KLF4, suggesting that they are more primitive than adult stem cells [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. In contrast, ADSCs can be quickly obtained in large quantities and exhibit high cellular activity, with a content of nearly 2% in the stromal vascular fraction [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. The viability of BMSCs decrease with age, but the ability to differentiate ADSCs from aged donors can be maintained [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. TableÂ <a href="#Tab1" class="usa-link">1</a>; Fig.Â <a href="#Fig1" class="usa-link">1</a> illustrate both the similarities and differences between ADSCs and other MSCs (BMSCs and UC-MSCs) concerning their sources and application.</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Similarities and differences between ADSCs and other MSCs</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Condition</th>
<th align="left" colspan="1" rowspan="1">ADSCs</th>
<th align="left" colspan="1" rowspan="1">BMSCs, UC-MSCs</th>
<th align="left" colspan="1" rowspan="1">Refs</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Sources &amp; Acquisition</td>
<td align="left" colspan="1" rowspan="1">Easily obtained from AT via liposuction with minimal donor damage.</td>
<td align="left" colspan="1" rowspan="1">Usually obtained from bone marrow and umbilical cord, a complex and invasive process.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Proliferative &amp; regeneration ability</td>
<td align="left" colspan="1" rowspan="1">Strong proliferation ability under higher culture algebra.</td>
<td align="left" colspan="1" rowspan="1">Proliferation ability gradually declined with increasing culture algebra.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Immunomodulatory capacity</td>
<td align="left" colspan="1" rowspan="1">Weaker than MSCs, inhibiting inflammatory cell activation and migration by secreting IL-10 and TGF-Î².</td>
<td align="left" colspan="1" rowspan="1">A strong immunomodulatory capacity suppresses inflammation and coordinates immune functions.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical application</td>
<td align="left" colspan="1" rowspan="1">A variety of applications including autoimmune disorders, cardiovascular conditions, neurological illnesses, and liver ailments.</td>
<td align="left" colspan="1" rowspan="1">Primarily utilized in regenerative medicine for skin regeneration, soft tissue repair, bone defect repair.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Both belong to adult stem cells</td>
<td align="left" colspan="2" rowspan="1">Undifferentiated cells with self-renewal capacity and tissue-specific differentiation potential.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Role in regenerative medicine</td>
<td align="left" colspan="2" rowspan="1">Widely used in regenerative medicine, promoting tissue repair and offering new treatment options for diseases.</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/d70d85e43a6d/13287_2025_4549_Fig1_HTML.jpg" loading="lazy" id="d33e443" height="332" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Differences between ADSCs and other MSCs. MSCs derived from bone marrow, umbilical cord and AT are called BMSCs, UC-MSCs and ADSCs, respectively. ADSCs and other MSCs have different roles in proliferation ability, immunomodulatory function and clinical application</p></figcaption></figure><section id="Sec3"><h3 class="pmc_sec_title">Phenotypic characteristics of ADSCs</h3>
<p id="Par13">As a subtype of MSCs, ADSCs must fulfill the established criteria for MSC identification. One of the key criteria is the expression of specific surface antigens, including markers such as CD44, CD105, and CD90 expressed by MSCs [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Previous reviews reveal that human ADSCs share several common markers with other types of MSCs include CD13, CD29, CD34, CD44, CD54, CD58, CD71, CD90, CD105/SH2, CD166/SH3, Stro âˆ’â€‰1 [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. It is worth mentioning that ADSCs express the marker CD49d but do not express CD106, typically present in BMSCs [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. In particular, the expression levels of certain markers vary between ADSCs and other MSCs. For instance, high levels of CD54 are observed in ADSCs compared to lower levels in BMSCs. Conversely, BMSCs exhibit higher levels of expression for CD34 than ADSCs [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. TableÂ <a href="#Tab2" class="usa-link">2</a> compares the surface marker of ADSCs and BMSCs and outlines their functional implications.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Expression of CD markers in stem cells and their potential features</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">CD Marker</th>
<th align="left" colspan="1" rowspan="1">Expression</th>
<th align="left" colspan="1" rowspan="1">Function</th>
<th align="left" colspan="1" rowspan="1">Refs</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD13</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Playing a role in antigen processing, cell trafficking and processing of inflammatory mediators.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD29</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Also known as integrin Î²1, involved in promoting cell spreading and migration, facilitating extracellular matrix (ECM) assembly, and activating multiple signal transduction pathways, governing proliferation, survival, and gene expression.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD34</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Involved in cell adhesion and/or HSC differentiation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD44</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">As a hyaluronic acid/fibronectin receptor, implicated in hematopoietic stem cell adhesion, proliferation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD49d</strong>
</td>
<td align="left" colspan="1" rowspan="1">ADSCs</td>
<td align="left" colspan="1" rowspan="1">Also known as integrin VLA-4, having a key role in hematopoiesis, cell adhesion, peripheral tissue cell migration, and inflammation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD54</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Also known as intercellular Adhesion Molecule-1 (ICAM-1), mediating cell-cell interactions and immune responses by binding to its ligands.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD58</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Also known as lymphocyte functional antigen-3 (LFA-3), binding to its ligand CD2 to induce the activation and proliferation of T/NK cells, triggering a series of intracellular signals in T/NK cells and target cells, respectively.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD71</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">As an important regulator in the proliferation and activation of T cells, which may be related to immune regulation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD90</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Known as thymus cell antigen 1 (Thy-1), promoting osteogenic differentiation and inhibiting adipogenic differentiation and restricting AT accumulation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD105/ SH2</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Playing a vital role in cell migration, tissue-specific homing of leukocytes and trafficking of hematopoietic precursors into or through tissue.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD106</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs</td>
<td align="left" colspan="1" rowspan="1">Known as vascular cell adhesion molecule-1 (VCAM-1), belonging to the cell adhesion molecule (CAM) of the immunoglobulin superfamily, mediating the strong adhesion of leukocytes to endothelial cells in a variety of acute and chronic diseases.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>CD166/ SH3</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Recognizing an epitope present on CD73 (ecto-5â€²-nucleotidase) and involving in cellâ€“cell interactions.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Stro âˆ’â€‰1</strong>
</td>
<td align="left" colspan="1" rowspan="1">BMSCs, ADSCs</td>
<td align="left" colspan="1" rowspan="1">Binding to bone marrow stromal elements and metastasizing the hematopoietic microenvironment in vitro.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec4"><h3 class="pmc_sec_title">Isolation and acquisition of ADSCs</h3>
<p id="Par15">ADSCs are notable among stem cells due to their easy acquisition and minimal ethical issues [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. In 2001, <em>Zuk</em> and his team introduced the concept of differentiation plasticity in preadipocytes. They successfully obtained human AT by liposuction (suction-assisted lipectomy) and processed it to yield a fibroblast-like cells population known as processed lipoaspirate (PLA) [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Researchers digest lipoaspirate with collagenase to obtain the stromal vascular fraction (SVF), which contains immune cells, ADSCs, endothelial progenitor cells, and other cell types. ADSCs can be purified from the SVF by culturing the adherent proliferating cells and discarding the non-adherent ones. The pioneering study conducted by <em>Zuk et al.</em>. has laid an immense foundation for future investigations on ADSCs. Since then, several techniques for isolating ADSCs have emerged, including magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting, both of which offering unique advantages. Notably, MACS provides benefits over traditional adherent culture purification due to its shorter processing time, which eliminates the need for extensive cell expansion while allowing rapid generation of specific cell population suitable for patient treatment within hours [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p>
<p id="Par16">The general standard procedure for isolating ADSCs involves the following steps. First, AT is collected from the abdomen, waist, and inner thighs [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Second, the collected AT is centrifuged and washed thoroughly with phosphate-buffered saline (PBS). The fat aspirate is then digested with 0.075% collagenase and incubated for 30Â min at 37Â Â°C [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Ultimately, the isolated and purified cells were cultured and subsequently passaged to obtain ADSCs for application. The procedure for isolating ADSCs, along with the expression of surface markers, is illustrated in Fig.Â <a href="#Fig2" class="usa-link">2</a>A.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/5b2e115a4096/13287_2025_4549_Fig2_HTML.jpg" loading="lazy" id="d33e1024" height="756" width="756" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schema diagrams of isolation, acquisition, culture steps as well as differentiation of ADSCs. (<strong>A</strong>) The ADSC isolation protocol includes four main steps: harvesting, digestion, purification, and cell culture. (<strong>B</strong>) ADSCs can differentiate into several cell types including osteoblasts, adipocytes, chondrocytes, cardiomyocytes, endothelial cells, and neurons, via multiple signaling pathways</p></figcaption></figure><p id="Par17">Of concern is the absence of extensive guidelines for the standardization of ADSCs isolation and culture, which hampers their clinical utilization. Due to differences in cell sources, culture conditions, acquisition methods, and the number of cell passages, the viability and content of the obtained ADSCs were also different. For example, research indicates that human platelet lysate, serves as an effective supplement for in vitro cell expansion, enhancing the adhesion and proliferation rates of ADSCs while effectively promoting cell development [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. In summary, the development of ADSCs in regenerative medicine is impeded by the lack of consistency between experimental results from fat transplantation and clinical outcomes, which can be attributed to the heterogeneity of ADSC collection techniques, donor locations, the initial health conditions of patients, and the absence of standardized methods for evaluate clinical outcomes [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Multilateral mechanisms involved in the development of ADSCs</h3>
<p id="Par18">ADSCs can develop into several cell types, including osteoblasts, adipocytes, chondrocytes, cardiomyocytes, endothelial cells, and neuro-like cells [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Investigating signaling pathways and associated proteins can lay the groundwork for clinical research and disease treatment.</p>
<p id="Par19">Osteogenic differentiation of ADSCs can be mediated through the BMP, Hedgehog, Wnt, Notch and FGF signaling pathways, all of which are also crucial for skeletal development and maturation, and they significantly influence the differentiation of ADSCs into osteoblasts [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. In addition, Notch and MAPK pathways are also signaling pathways involved in osteogenesis in ADSCs, with Notch acting both independently and through interaction with BMP [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>].</p>
<p id="Par20">Lipogenic differentiation of ADSCs involves the VRAC, Wnt/Î²-catenin, and PI3K/AKT signaling pathways. Key proteins in the VRAC signaling pathway include peroxisome proliferator-activated receptor gamma (PPARÎ³) and CCAAT/enhancer-binding proteins, which are also major regulators of adipogenesis. The main regulatory mechanism involves recruited transcription factors activating CCAAT/enhancer binding proteins and PPARÎ³, leading to conformational changes in the active sites of the target proteins, stimulating the lipogenesis of adipose stem cells [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. The Wnt/Î²-catenin signaling pathway, on the other hand, is primarily a key pathway regulating the maturation of adipocytes and may play a role in inhibiting adipocyte proliferation. In addition, the PI3K/AKT signaling pathway also plays a vital role in adipogenic differentiation of ADSCs [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<p id="Par21">In terms of chondrogenic differentiation of stem cells, a large body of literature have depicted the signaling pathways involved in chondrogenesis, including Notch, Wnt/Î²-catenin, Hedgehog, FGF, BMP, and TGF-Î² signaling pathway [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. In the cardiomyogenic differentiation of ADSCs, in addition to the traditional Wnt/Î²-catenin, TGF-Î² signaling pathway, which is recognized as a key pathway for cardiomyogenesis, the ROCK pathway is also involved in the differentiation process to cardiomyocytes. ROCKs are one of the key downstream effectors of Rho GTPase that regulate stress fiber contraction. It has been also documented that differentiation of ADSCs to cardiomyocytes involves changes in stress fibers [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par22">It was shown that ADSCs could successfully differentiate into endothelial cells under specific induction conditions, and that ADSCs exhibited a faster rate and greater proliferation capacity when differentiating into endothelial cells compared to BMSCs [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. This ability to differentiate into endothelial cells is regulated through VEGF and Notch signaling. VEGFA is a crucial protein within VEGF signaling pathway, significantly influencing proliferation, migration, survival of endothelial cells, in addition to regulating vascular permeability [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Notch signaling pathway directly induce arterial endothelial differentiation along with negatively regulate VEGF-induced angiogenesis and inhibit the occurrence of abnormal vascular branching [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>].</p>
<p id="Par23">One bright spot deserves attention is that the differentiation of ADSCs into neurons involves Wnt and Notch signaling pathways. In the nervous system, the Wnt signaling cascade is crucial for the self-renewal, maintenance, and differentiation of neural progenitor cells. The Wnt/Î²-catenin signaling pathway significantly contributes to the proliferation of neural progenitor cells [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Furthermore, the Notch pathway is essential for cell fate decisions in the CNS and plays a significant role in various critical events in glial cell development, such as maintaining NG2 cells in an undifferentiated state [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>].</p>
<p id="Par24">The signaling pathways mentioned above are involved in the differentiation of ADSCs into various cell types. FigureÂ <a href="#Fig2" class="usa-link">2</a>B provides a general summary of the signaling pathways involved in the differentiation of ADSCs into different types of tissues. TableÂ <a href="#Tab3" class="usa-link">3</a> provides a comprehensive overview of the various signaling pathway along with the principal proteins that play a significant role in each pathway.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Signaling pathways and their key proteins involved in the development of ADSCs</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Differentiation</th>
<th align="left" colspan="1" rowspan="1">Signaling pathways</th>
<th align="left" colspan="1" rowspan="1">Key proteins in signaling pathways</th>
<th align="left" colspan="1" rowspan="1">Refs</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="5" colspan="1">Osteogenic differentiation</td>
<td align="left" colspan="1" rowspan="1">BMP signaling pathway</td>
<td align="left" colspan="1" rowspan="1">BMP, BMPR, Smad4, Runx2, Osterix, ERK1/2, p38, JNK</td>
<td align="left" rowspan="5" colspan="1"> [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hedgehog signaling pathway</td>
<td align="left" colspan="1" rowspan="1">SHH, Ptch-1 receptor, SMO, Gli A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Wnt signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Wnt-5a, Wnt-16, FZD, LRP5/6, ROR1/ROR2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Notch signaling pathway</td>
<td align="left" colspan="1" rowspan="1">NICD, Runx2, Notch-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MAPK signaling pathway</td>
<td align="left" colspan="1" rowspan="1">p38MAPK, ERK1/2, MKP1</td>
</tr>
<tr>
<td align="left" rowspan="3" colspan="1">Adipogenic differentiation</td>
<td align="left" colspan="1" rowspan="1">VRAC signaling pathway</td>
<td align="left" colspan="1" rowspan="1">target CCAAT/enhancer-binding proteins, PPARÎ³, C/EBPÎ²</td>
<td align="left" rowspan="3" colspan="1"> [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Wnt/Î²-catenin signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Wnt-10b, Wnt-5a, Î²-catenin, CREB binding protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PI3K/AKT signaling pathway</td>
<td align="left" colspan="1" rowspan="1">p-PI3K, PI3K, p-AKT, AKT, PPARÎ³</td>
</tr>
<tr>
<td align="left" rowspan="6" colspan="1">Chondrogenic differentiation</td>
<td align="left" colspan="1" rowspan="1">Notch signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Hes/Hey, NICD, Runx2, Notch</td>
<td align="left" rowspan="6" colspan="1"> [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Wnt/Î²-catenin signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Wnt4, Wnt9a, Î²-catenin, Proteoglycan 4(Prg4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hedgehog signaling pathway</td>
<td align="left" colspan="1" rowspan="1">IHH, PTHrP, Ptch-1 receptor, Gli1, Gli3, SMO</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FGF signaling pathway</td>
<td align="left" colspan="1" rowspan="1">FGF18, FGFR3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BMP signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Smad1, 5 and 8, Bmp2 and Bmp4, GDF5, noggin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TGF-Î² signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Tgfbr2, TGF-Î², Smad4</td>
</tr>
<tr>
<td align="left" rowspan="3" colspan="1">Myocardial differentiation</td>
<td align="left" colspan="1" rowspan="1">Wnt/Î²-catenin signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Î²-catenin, GPCR, Wnt2, Wnt5A/5B, Wnt11, FZD, LRP5/6</td>
<td align="left" rowspan="3" colspan="1"> [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TGF-Î² signaling pathway</td>
<td align="left" colspan="1" rowspan="1">TGF-Î², TÎ²RI/ALK-5, TÎ²RII, ALK-1, Smad, BMPRII, ActRII</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Rho/ROCK signaling pathway</td>
<td align="left" colspan="1" rowspan="1">ROCK, RhoA, MLCK, p-MLC</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Endothelial differentiation</td>
<td align="left" colspan="1" rowspan="1">Notch signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Delta-like1, Jagged1-2, Notch1-4, RBP-JÎº, ADAM/TACE</td>
<td align="left" rowspan="2" colspan="1"> [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VEGF signaling pathway</td>
<td align="left" colspan="1" rowspan="1">VEGFA, Flt1/VEGFR, Neuropillin-1, Neuropillin-2</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Neuronal differentiation</td>
<td align="left" colspan="1" rowspan="1">Wnt/Î²-catenin signaling pathway</td>
<td align="left" colspan="1" rowspan="1">FZD, Î²-catenin, LRP5 ROR, receptor-like tyrosine kinase Ryk</td>
<td align="left" rowspan="2" colspan="1"> [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Notch signaling pathway</td>
<td align="left" colspan="1" rowspan="1">Notch1-4, Jagged1-2, Delta-like (DLL1/3/4)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="Sec6"><h2 class="pmc_sec_title">Diverse and functional ADSCs in gastrointestinal field</h2>
<p id="Par27">The primary roles of ADSCs encompass immunomodulatory and anti-inflammatory effects that interact with immune cells, as well as their regenerative capabilities stemming from their stem cell characteristics. Owing to their distinctive capacity to modulate the immune system and promote regeneration, ADSCs show great potential for addressing gastrointestinal issues.</p>
<section id="Sec7"><h3 class="pmc_sec_title">Immunoregulatory effects</h3>
<p id="Par28">ADSCs have immunomodulatory properties in the gut, especially in the context of intestinal inflammation. A large body of research indicates that MSCs can express immunomodulatory capabilities through cell contact and paracrine effects. MSCs, especially ADSCs, interact with innate and adaptive immune responses to inhibit T helper cells proliferation and upregulate regulatory T cells [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>].</p>
<section id="Sec8"><h4 class="pmc_sec_title">Insight into the immune system and immune cells in the gut</h4>
<p id="Par29">The intestinal mucosa serves as a vital immune barrier of the intestine, made up of epithelial cells, stromal cells, and immune cells. Epithelial cells, including goblet cells and Paneth cells, function as protective barriers by producing mucus and antimicrobial peptides [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. They also interact with both intestinal microbiota and the immune system, contributing to their role in establishment of immune barrier function. Stromal cells located in the lamina propria beneath the epithelium are crucial for processes like intestinal fibrosis and wound healing [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. When it comes to gut immunity, itâ€™s primarily the immune cells present in the lamina propria that carry out essential functions.</p>
<p id="Par30">The immune system can be categorized into innate immunity and adaptive immunity. Innate immunity consists of innate immune cells (IICs), including neutrophils, monocytes, macrophages MÏ†s), and dendritic cells (DCs) [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. These IICs possess pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), enabling them to discriminate between pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. The innate immune response is non-specific, wherein IICs contribute to host defense and inflammation by generating cytokines and chemokines, initiating complement cascades, as well as engaging in phagocytosis. Adaptive immunity, in contrast to innate immunity, is highly specific and adaptive due to its reliance on complex maturation processes of immune cells [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. The most notably component of adaptive immunity is T cells. In the intestinal tract, these two systems work together effectively to prevent pathogen invasion and support normal physiological functions.</p></section><section id="Sec9"><h4 class="pmc_sec_title">ADSCs involving in adaptive immunity</h4>
<p id="Par31">Among T cell subsets, T helper (Th) cells and regulatory T cells (Tregs) play crucial roles in the adaptive immune response.</p>
<p id="Par32">Th cells mainly include Th1, Th2 and Th17 cells, which are activated and differentiated from Th0 cells [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. Th1 cells produce IFN-Î³, which is essential for eliminating intracellular pathogens [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Meanwhile, IL-4/5, and IL-13 secreted by Th2 cells confer antiparasitic effect and mediate allergic responses [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Additionally, IL-17, IL-17Â F, and IL-22 produced by Th17 cells may contribute to the elimination of extracellular bacteria and fungi while also playing a pivotal role in chronic inflammatory and autoimmune diseases [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. These Th cells guide innate immune responses by directing neutrophils to sites of inflammation where they produce pro-inflammatory cytokines that initiate immune reactions [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>].</p>
<p id="Par33">Tregs express Foxp3 and can suppress Th0 cell proliferation [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. They play a vital role in inhibiting inappropriate immune responses to antigens while maintaining intestinal mucosal homeostasis. Specifically, they exert their functions through secretion of anti-inflammatory cytokines IL-10 and TGF-Î² while also preventing activation in other potentially harmful T cell populations [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. TGF-Î² inhibits Th2 cell proliferation by reducing GATA-3 production [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Both TGF-Î² and IL-10 can suppress Th cells function by inhibiting the migration of DCs to mesenteric lymph nodes (MLNs) as well as decreasing their activation [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. FigureÂ <a href="#Fig3" class="usa-link">3</a>A illustrates the interactions between the T cells mentioned and their secreted cytokines.</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/c3c9cfd39ae0/13287_2025_4549_Fig3_HTML.jpg" loading="lazy" id="d33e1189" height="585" width="718" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immune mechanisms of intestinal inflammation and immunomodulation of intestinal inflammation treated with ADSCs. (<strong>A</strong>) The immune systems activate during gut inflammation, with adaptive immunity showing increased Th cells and decreased Tregs, while innate immunity involves the activation and migration of innate immune cells, both contributing to inflammation and potential intestinal fibrosis. (<strong>B</strong>) ADSCs reduce intestinal inflammation and modulate immunity by decreasing Th cells and increasing Tregs, blocking Th proliferation, and promoting Tregs growth through anti-inflammatory factors. They also convert MÏ†s to anti-inflammatory types, mature DCs, reduce neutrophil recruitment and reduce cytotoxic effects of NK cells</p></figcaption></figure><p id="Par34">ADSCs have been shown to regulate adaptive immune responses through multiple mechanisms. Research indicates that patients with inflammatory bowel disease often have reduced numbers of Tregs in peripheral blood and intestinal mucosa, and the reduction of Tregs hinders their effective suppression of immune function, leading to prolonged immune responses [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. MSCs mature DC1, thereby lowering tumor necrosis factor-Î± (TNF-Î±) level, while maturing DC2 to enhance interleukin-10 (IL-10) secretion, resulting in an increase in Tregs numbers [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Furthermore, MSCs can also secrete IL-10 which further accelerate the proliferation of Tregs [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. These suggest that ADSCs can play an immunomodulatory role by activating Tregs to suppress immune responses. In addition, the TNFR and TLR expressed by MSCs are crucial for migration and immune regulation. When TLR ligands bind to TLRs, on the one hand, they activate the nuclear translocation of NF-ÎºB, thereby inducing T cell suppression; on the other hand, they can activate MSCs to secrete IL-6, promoting the maturation of DCs, which in turn leads to T cells suppression in trans [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>].</p>
<p id="Par35">Another research indicated that the soluble HLA -G5 secreted by MSCs can inhibit T cell proliferation while simultaneously increasing the number of Tregs. Additionally, IL-10 secreted by MSCs promotes the production of HLA-G5, establishing a positive feedback loop for immunoregulation [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. In summary, ADSCs regulate the immune regulation by secreting or activating various cytokines and substances that either promote or hinder cell proliferation. FigureÂ <a href="#Fig3" class="usa-link">3</a>B illustrates the role of ADSCs in regulating the gut adaptive immune response.</p></section><section id="Sec10"><h4 class="pmc_sec_title">ADSCs involved in the establishment of innate immune homeostasis</h4>
<p id="Par36">The innate immune response serves as the bodyâ€™s first line of defense against pathogens. Activation of the innate immune system is dependent on the interaction of DAMPs and PAMPs with PRRs expressed by IICs. When pathogens invade the intestine, these innate immune cells can migrate to the affected area, leading to intestinal inflammation.</p>
<p id="Par37">There are several types of PRRs, typically including NLRs and TLRs. Nucleotide-binding oligomerization domain (NOD) family includes NOD1 and NOD2, which can be stimulated by various components of bacterial peptidoglycan. The NOD1 and NOD2 signals mediate the activation of the NF-ÎºB pathway through TRAF2, TRAF5 and RIPK2 respectively [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>], thereby generating pro-inflammatory effects. And TLR usually shares a common signaling pathway with IL-1R. When ligand binds to TLR, the TIR domain-containing junctions, MyD88 and TIRAP, are recruited to the receptor, which subsequently induces different cascade reactions to activate NF-ÎºB transcription, leading to the production of pro-inflammatory cytokines and type I IFN respectively [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>].</p>
<p id="Par38">Innate immune cells contribute to intestinal inflammation through diverse mechanisms. Neutrophils directly promote tissue inflammation and injury by releasing proteases like matrix metalloproteinases (MMP) and neutrophil elastase (NE) while altering membrane properties through reactive oxygen species release [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. At the same time, neutrophils can aggravate the damage of the intestinal mucosal barrier by releasing NETs [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. In particular, the dual role of NETs in IBD will be discussed below. MÏ†s play an equally important role in immune regulation. In the intestinal inflammatory response, MÏ†s are activated to resist pathogen invasion through phagocytosis. MÏ†s also produce TGF-Î²1, which together with connective tissue growth factor (CTGF) and fibroblast activation protein (FAP) promotes myofibroblast proliferation. Thus, excessive MÏ†s activation leads to intestinal fibrosis [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. In addition, it has been shown that intestinal MÏ†s lacking IL-10 receptors produce more IL-23, which further stimulates IL-22 secretion by Th17 and ILC3 cells, thereby inducing neutrophil recruitment [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. DCs, as common antigen-presenting cells, play irreplaceable roles in both adaptive and innate immunity. Studies have shown that DCs derived from Crohnâ€™s disease patients express higher levels of CD40 and release more pro-inflammatory factors, such as IL-6, IL-12, and IL-18, than in healthy individuals, thereby mediating the activation of Th1 cells [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Innate lymphoid cells (ILCs) include natural killer cells (NK cells), ILC1, ILC2, and ILC3.In the setting of intestinal inflammation, it is primarily NK cells and ILC1s that can contribute to the development of inflammation. These cells are dependent on the transcription factor T-bet for the secretion of TNF and IFN-Î³ when stimulated by IL-12 and IL-5, which act against viruses, intracellular bacteria and parasites, but also exacerbate inflammation [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>, <a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>].</p>
<p id="Par39">MSCs can regulate innate immune cells at the site of inflammation. It was shown that neutrophil arginase activity was increased by MSCs treatment and exhibited an immunosuppressive phenotype, which inhibited the proliferation of CD4<sup>+</sup> T cells [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. As for MÏ†s, MSCs can exert an immunomodulatory function through the production of immunosuppressive molecules such as prostaglandin E2 (PGE), which promotes the polarization of MÏ†s from a M1MÏ† to an M2MÏ†, which enhances anti-inflammatory capacity while reducing the overall inflammatory effect [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. Additionally, studies reveal that TSG-6 produced by MSCs has an inhibitory impact not only on the signaling ability of NF-ÎºB in MÏ†s, but also on the maturation of DCs [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. MSCs mitigate innate immune responses preventing antigen presentation from DCs to T cells. Moreover, the expression of NK cell-activated receptors (including NKp30, NKp44, 2B4, and NKG2D) was reduced after administration of MSCs-derived exosomes, and MSCs were shown to modulate the innate immune response by inhibiting NK cell function via TGF-Î² [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. The involvement of ADSCs in regulating the intestinal innate immune response is illustrated in Fig.Â <a href="#Fig3" class="usa-link">3</a>B.</p></section></section><section id="Sec11"><h3 class="pmc_sec_title">Anti-inflammatory effects</h3>
<p id="Par41">Inflammation is a vital and intricate biological process of the body, which serves a protective function. The inflammatory responses relies on intricate interactions among the immune system, vasculature, and tissues [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. Inflammation arises when the body is exposed to infection, stimulation, or injured. During the acute phase of inflammation, if the injury remains unresolved, it can transition into chronic inflammation, activating the adaptive immune response and potentially leading to immune-mediated inflammatory diseases, such as inflammatory bowel disease (IBD) within digestive diseases.</p>
<p id="Par42">IBD has emerged as a particularly noteworthy intestinal inflammatory disorder, characterized by its distinctive immunological profile featuring dysregulated mucosal immunity and chronic intestinal inflammation. MSCs have shown promise in modulating these inflammatory responses, thereby not only help ameliorating inflammatory diseases but also promoting tissue regeneration through cell differentiation. Previous studies indicate that MSCs can selectively migrate to the areas of local inflammation in IBD mice, including regions like lamina propria, muscle layer, submucosa and mesenteric lymph nodes [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. MSCs, particularly ADSCs, promote the differentiation of regulatory Tregs and M2MÏ†s, thereby facilitating anti-inflammatory activities through the diverse array of cytokines they release. This mechanism is fundamental to the anti-inflammatory properties exhibited by ADSCs [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. As these cytokines accumulate at the site of inflammation, they hold potential for treating chronic conditions like IBD effectively. Therefore, leveraging the anti-inflammatory properties of ADSCs is essential for addressing intestinal diseases as well as other body injuries.</p>
<section id="Sec12"><h4 class="pmc_sec_title">Mechanisms of the inflammatory response</h4>
<p id="Par43">To elucidate the anti-inflammatory mechanism of ADSCs, it is imperative to first outline the underlying processes of inflammation before investigating how ADSCs exert their inhibitory influence on the inflammatory cascade. The inflammatory response is contingent upon the characteristics of the initial triggering stimulus as well as its specific anatomical location; however, this response fundamentally adheres to a shared mechanism [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. Initially, PRRs located on the cell surface detect harmful stimuli. Subsequently, this recognition activates various inflammatory pathways, which initiate intracellular signaling cascades via pathways such as MAPK, NF-ÎºB, and JAK-STAT. Following this, the activation of immune cells occurs, which stimulates the production of pro-inflammatory cytokines, culminating in the release of inflammatory markers. Ultimately, the synthesis of these inflammatory mediators facilitates the recruitment of additional immune cells to the sites of localized inflammation.</p></section><section id="Sec13"><h4 class="pmc_sec_title">ADSCs exert anti-inflammatory effects by modulating innate immune cells</h4>
<p id="Par44">Neutrophils represent the most pivotal component among innate immune cells in the progression of inflammatory responses. In this review, we have mentioned in Sect.Â <a href="#Sec10" class="usa-link">ADSCs involved in the establishment of innate immune homeostasis</a> that ADSCs play an anti-inflammatory role in the intestinal inflammatory environment by regulating intrinsic immune cells, such as MÏ†s, DCs, and NK cells, so here we focus on the mechanism of neutrophils in inflammation and how ADSCs play an anti-inflammatory role by regulating neutrophils.</p>
<p id="Par45">Neutrophils are the predominant type of immune cells in the human body, constituting approximately 70% of the total white blood cell population [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Neutrophils can swiftly migrate to the site of tissue injury, attracting additional immune cells by producing an array of chemokines, cytokines and leukotrienes. Furthermore, they may directly release proteolytic enzymes such as MMP and NE, which contribute to tissue damage [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>].</p>
<p id="Par46">Neutrophils are crucial in the context of intestinal inflammation, they arrive at the site of inflammation in a cascade manner and mediate the inflammatory response through the release of reactive oxygen species, the formation of neutrophil extracellular traps (NETs), and phagocytosis.</p>
<p id="Par47">The fundamental process underlying neutrophil recruitment is outlined as follows [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. Initially, neutrophils flow through the bloodstream while interacting with the endothelial cells through deformational movements characterized by rolling and trapping. Subsequently, the interaction initiates a multistep signaling cascade that leads to conformational changes in integrin, leading to their activation and subsequent cell adhesion. Following adhesion, neutrophils exhibit slower movement along the endothelium, a phenomenon called â€œcrawling,â€ which can be occur either parallel or against blood flow directionality. Upon migrating into tissues at infection sites, these cells engage pathogens through various mechanisms, including phagocytosis, formation of NETs, production of reactive oxygen species (ROS) and granule secretion. Thus, neutrophils serve a critical protective function for the host organism.</p>
<p id="Par48">The role of NETs in neutrophil-mediated inflammatory responses represents an emerging field with promising research opportunities that warrants comprehensive investigation. NETs are specialized filamentous formations expelled by neutrophils, comprising DNA, histones, and various cytokines. Upon exposure to infections, inflammatory triggers, or other stimuli, neutrophils discharge intracellular chromatin along with granule proteins, resulting in the formation of a fragile network structure referred to as NETs. These antimicrobial granules within neutrophils combine with phagosomes to facilitate the ingestion and destruction of bacterial pathogens [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>].</p>
<p id="Par49">Research has indicated that patients with IBD exhibit a marked elevation in the secretion of NETs, resulting in their accumulation within intestinal tissue, which contribute to the development and inflammatory processes associated with IBD [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. The primary pathways involved in the production of NETs include the activation of the REDD1/NETosis/IL-1Î² signaling axis as well as the interaction between anti-neutrophil cytoplasmic antibodies (ANCA) and neutrophils. Under conditions of hypoxia, pathogen invasion, and hormonal fluctuations, the levels of the transcriptional regulator EDD1 are augmented, which in turn promotes autophagy and the subsequent release of NETs from neutrophils [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Furthermore, ANCA may be implicated in NETs-mediated pathology associated with IBD. Specifically, plasma cells produce ANCA, which can bind to the surface of neutrophils, thereby activating neutrophils and facilitating the release of NETs. Additionally, ANCA binds to protease 3 (PR3) or MPO97 granules, which further amplifies the activation of neutrophil by binding to the FcÎ³ receptor [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>] as depicted in Fig.Â <a href="#Fig4" class="usa-link">4</a>A.</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/fe1a5c9ebaba/13287_2025_4549_Fig4_HTML.jpg" loading="lazy" id="d33e1283" height="455" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pro-inflammatory and anti-inflammatory effects of NETs. (<strong>A</strong>) The REDD1/NETosis/IL-1Î² axis can activate intestinal inflammatory responses. Moreover, ANCA binds to the surface of neutrophils, activates neutrophils and promotes NETs release. (<strong>B</strong>) NETs can exert an anti-inflammatory effect. First, NETs can downregulate IL-6 and upregulate IL-10 secretion in LPS-activated MÏ†s in RA. Secondly, NETs can directly promote the reduction of inflammation by degrading cytokines and chemokines such as IL-1Î², IL-6, MIP-1, and TNF via serine proteases in gout</p></figcaption></figure><p id="Par50">Although NETs can facilitate inflammation under certain conditions, they have also shown beneficial effects in attenuating excessive immune responses under different circumstances. For example, research has indicated that NETs can suppress IL-6 while enhancing IL-10 secretion in LPS-activated MÏ†s associated with rheumatoid arthritis (RA) [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. Similarly, NETs play a crucial role in resolving inflammation by degrading significant mediators, including cytokines and chemokines such as IL-1Î², IL-6, and MIP-1, as well as TNF, predominantly through the action of serine proteases [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>] as shown in Fig.Â <a href="#Fig4" class="usa-link">4</a>B.</p>
<p id="Par52">Given the strong correlation between NETs and the mediation of intestinal inflammation, therapeutic strategies targeting NETs show some promise in IBD. Regarding the anti-inflammatory mechanism of ADSCs, it has been shown that ADSCs can reduce inflammation and treat inflammatory diseases by inhibiting the formation of NETs. Study has shown that ADSCs can effectively inhibit neovascularization associated with corneal wound healing (CWH) by impeding the formation of local NETs, thereby suppressing the inflammatory response [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. Additionally, a separate investigation demonstrated that ADSCs can alleviate inflammation caused by <em>Propionibacterium acnes</em> colonizing hair follicles, known as acne vulgaris, by inhibiting the formation of NETs [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. These findings open up novel therapeutic pathways for ADSCs to treat inflammatory diseases. While there is currently a lack of research examining the specific mechanisms by which ADSCs inhibit NET production in the context of intestinal disorders, this indicates a potential direction for future studies to explore the role of NET inhibition in the treatment of IBD.</p></section><section id="Sec14"><h4 class="pmc_sec_title">Indirect and direct suppression of adaptive immune cells by ADSCs</h4>
<p id="Par53">The action of ADSCs on adaptive immune cells is intricately linked to their modulation of innate immune responses. Specifically, ADSCs play a crucial role in sustaining antigen-presenting cells, such as DCs, MÏ†s, in a state characterized by immaturity or anti-inflammatory properties through the secretion of various cytokines. This mechanism effectively hinders the activation of effector T cells while simultaneously facilitating the generation of Tregs [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. Furthermore, the direct suppressive impact of ADSCs on adaptive immune cells is evidenced by their capacity to inhibit the activation of CD8<sup>+</sup> T cells and the differentiation of Th1 and Th17 cells. This is achieved via the release of several immunosuppressive factors, including NO, IDO, PGE, TGF-Î², HO1, LIF, PDL1, and HGF [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>].</p></section><section id="Sec15"><h4 class="pmc_sec_title">Migration of ADSCs to inflammatory tissues</h4>
<p id="Par54">The ability of ADSCs to preferentially migrate to inflammatory tissues is important for alleviating the inflammatory response. Current research indicates that the in vivo experiments show that exogenous MSCs can exhibit anti-inflammatory effects and reduce the severity of inflammation [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. One study utilized the green fluorescent dye PKH67 to track exogenously administered MSCs in inflamed colonic mucosa. These MSCs were found primarily in the lamina propria of the inflamed rectum, particularly near the base of crypts. In contrast, they were not detected in non-inflamed areas like the proximal colon [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>].</p>
<p id="Par55">Migration of MSCs into inflamed tissues is influenced by a variety of factors. MSCs possess cell surface receptors that include growth factors, cytokines/chemokines, adhesion molecules, and TLRs [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. These receptors interact with their corresponding signals that regulate MSCs migration, a process often referred to as homing, which involves several steps. Firstly, in response to cytokines such as TNF-Î± and IL-1, MSCs express integrin Î²1 and/or integrin Î±4/Î²1 complex and migrate to endothelial cells marked by VCAM-1 expression at the site of local inflammation. Next, upon tissue injury, MSCs may express CXCR4 which facilitates their interactions with endothelial cells along with increasing SDF-1 levels. Finally, MSCs complete their migration into the ECM through interactions with integrins and fibronectin, which are regulated by bFGF, TLRs, or MMP-2 produced by the MSCs [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]as shown in Fig.Â <a href="#Fig5" class="usa-link">5</a>.</p>
<figure class="fig xbox font-sm" id="Fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/d89309846b90/13287_2025_4549_Fig5_HTML.jpg" loading="lazy" id="d33e1398" height="664" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Underlying mechanism model of ADSCs in immune regulation, anti-inflammation and tissue repair in gastrointestinal tract. The immunomodulatory role of ADSCs is predominantly demonstrated through the promotion of Tregs, M2MÏ†s and immature DCs alongside the suppression of Th, M1MÏ†s, mature DCs, neutrophil and NK cells proliferation. ADSCs migrate to inflammatory sites and subsequently localize within the ECM, where they mediate anti-inflammatory effects through a three-step mechanistic cascade. Furthermore, the tissue repair capabilities of ADSCs are evident in their ability to restore endothelial cells through the release of various cytokines and EVs, while concurrently exhibiting certain anti-inflammatory properties</p></figcaption></figure></section></section><section id="Sec16"><h3 class="pmc_sec_title">ADSCs facilitate regeneration of tissue</h3>
<p id="Par57">ADSCs are integral to the processes of tissue repair and regeneration, particularly concerning the restoration of the intestinal epithelium. These cells possess the ability to proliferate and undergo differentiation into a variety of cell types, including intestinal epithelial cells (IECs), smooth muscle cells, and endothelial cells, thereby playing a significant role in the regenerative and reparative mechanisms of gastrointestinal tissues. Furthermore, ADSCs can also secrete a range of growth factors such as VEGF, HGF, epidermal growth factor (EGF), alongside anti-inflammatory cytokines including IL-10 and TGF-Î². Collectively, these factors promote angiogenesis and support the healing of the intestinal mucosa while also reducing the inflammatory response, thus facilitating overall wound healing.</p>
<section id="Sec17"><h4 class="pmc_sec_title">Mechanism of ADSCs in tissue repair and regeneration</h4>
<p id="Par58">ADSCs have demonstrated great promise in promoting tissue regeneration and alleviating intestinal inflammation through various mechanisms. ADSCs are mesoderm-derived stem cells that can differentiate into various tissue types, including bone, cardiac, uroepithelial, and skin tissues [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. The cytokines secreted by ADSCs primarily influence tissue regeneration through the following three ways [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. First, they secrete cytokines such as Il-1Î², IL-6, and IL-10, which activate the NF-ÎºB signaling cascade, JAK/STAT, and JAK1/Tyk2 pathways by binding to their respective receptors [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. Among them, the JAK1/Tyk2 signaling pathway, activated by IL-10, exerts anti-inflammatory effects. Second, ADSCs promote endothelial cell proliferation and angiogenesis by secreting TGF-Î², VEGF, PGF, and Angl, which initiate critical signaling pathways including TGF-Î²/SMAD, Ras/MAPK pathway, PI3K/AKT, as well as RhoA/ROCK signaling pathway to regulate cellular proliferation along with capillary formation [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]. Lastly, ADSCs influence tissue injury and repair through paracrine effects via extracellular vesicles (EVs), which are often called ADSC-exosomes. These lipid bilayer structures encapsulate numerous biologically active molecules, such as angiogenic miRNAs and growth factors like VEGFA, FGF, IGF, and PDGF, which subsequently activate intracellular signaling cascades, including PI3K/AKT, Mek/Erk, RAF/MAPK, JAK/STAT, and NF-ÎºB pathways, to promote both cell proliferation and angiogenesis [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>].</p></section><section id="Sec18"><h4 class="pmc_sec_title">ADSCs contribute to tissue regeneration of gastrotomy closure</h4>
<p id="Par59">Current studies have indicated that ADSCs can promote tissue regeneration following gastrectomy closure in animal models [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. In a study, male Wistar rats underwent gastrectomy closure surgery, with the experimental group receiving locally autografted ADSCs in the submucosa around the suture area. Seven days post-injection, histological analyses revealed that the ADSCs facilitated angiogenesis and collagen deposition, leading to improved healing outcomes. By day 28 of the experiment, the regenerated tissue closely resembled the native structure. The cytokines secreted by ADSCs were quantified by ELISA, revealing the presence of HGF, VEGF and TGF-Î² in the supernatant and HGF content was significantly higher than VEGF. This finding aligns with the previous conclusion indicating that ADSCs can improve secrete growth factors which accelerate the formation of neovascularization and promote the regeneration of damaged tissues. In conclusion, there is strong evidence suggesting that ADSCs may facilitate tissue regeneration at the closed area of gastrectomy by accelerating angiogenesis and reducing fibrosis in the early stages. Subsequently, ADSCs mitigate excessive fibrosis while aiding in regenerating tissue that closely mimics the natural structure through paracrine mechanisms. These results also highlight the potential application of ADSCs in treating human gastrectomy closures or other types of wound healing.</p></section><section id="Sec19"><h4 class="pmc_sec_title">ADSCs promote tissue healing and regeneration of intestinal inflammation</h4>
<p id="Par60">In the realm of regenerative medicine, research has illuminated the remarkable potential of ADSCs in fostering the healing process of ulceration and tissue devastation stemming from intestinal inflammation. A key study performed on a rat model of TNBS-induced colitis highlighted the diverse advantages associated with the submucosal injection of ADSCs [<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>].</p>
<p id="Par61">In the research, rats with TNBS-induced colitis that received ADSC injections exhibited a marked reduction in colon weight and colonic ulceration, suggesting an improvement in colonic edema associated linked to inflammatory responses. Histological analyses further corroborated these findings, revealing improved regeneration of the colonic epithelium alongside a decrease in inflammatory cell infiltration and edema in the ADSC-treated group when compared to the control group, which was administered PBS. To further understand the localization of ADSCs within inflammatory tissues, the study employed FISH to track the presence of Y-chromosome positive cells. The results demonstrated that ADSCs preferentially clustered in the submucosal layer, although a limited number were also identified in the mucosal and lamina propria layers, indicating the potential for ADSCs to migrate and engage across various tissue layers.</p>
<p id="Par62">In addition to facilitating tissue repair by reducing inflammatory cell infiltration, ADSCs can also regenerate tissues, especially endothelial cells, by secreting growth factors. Specifically, the secretion of growth factors such as HGF and VEGF by ADSCs are believed to play a pivotal role in fostering tissue regeneration [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>]. These bioactive molecules collectively stimulate cell proliferation, encourage angiogenesis, and dampen inflammatory responses, thereby facilitating the healing process. HGF, for instance, is a potent mitogen that promotes the proliferation and differentiation of various cell types, including epithelial and endothelial cells [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. VEGF is a vascular permeability factor that stimulates angiogenesis, the formation of new blood vessels. By augmenting blood flow to damaged regions, VEGF promotes the delivery of oxygen and nutrients necessary for effective tissue repair.</p>
<p id="Par63">Collectively, these findings highlight the enormous therapeutic prospects of ADSCs in addressing intestinal inflammation and its associated complications. By promoting the regeneration of injured tissues and modulating the inflammatory response, ADSCs offer a promising alternative to conventional therapies.</p></section><section id="Sec20"><h4 class="pmc_sec_title">Other types of stem cells involved in tissue regeneration</h4>
<p id="Par64">Other types of stem cells are also important for tissue repair, although their function in the gut has not fully understood. Notable stem cells include embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and periodontal ligament stem cells (PDLSCs), all of which have good application prospects in regenerative medicine.</p>
<p id="Par65">ESCs, derived from the inner cell mass of the blastocyst, exhibit remarkable potential for tissue regeneration due to their capacity to differentiate into virtually any cell type present in the organism. However, ethical dilemmas and practical challenges have hindered their applications [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. PDLSCs, on the other hand, possess the ability to differentiate into multiple cell types vital for periodontal tissue engineering and are primarily employed in the regeneration of periodontal ligament or cementum tissues [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]. Similar to ESCs, iPSCs are generated by reprogramming adult somatic cells into a pluripotent state, enabling differentiation into diverse cell types and offering significant potential for tissue regeneration due to their unique properties.</p></section></section></section><section id="Sec21"><h2 class="pmc_sec_title">Clinical application of ADSCs in digestive system disease</h2>
<p id="Par66">Currently, the majority of clinical investigations concerning ADSCs predominantly emphasize their application in addressing conditions such as wound healing, multiple sclerosis, tissue injuries, age-related ailments, diabetes, Parkinsonâ€™s disease, as well as in the regeneration of bone and cartilage, stroke management, and spinal cord injuries [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Therefore, it is promising to address the role of ADSCs in the treatment of digestive diseases.</p>
<section id="Sec22"><h3 class="pmc_sec_title">Potential mechanism of ADSCs alleviating IBD</h3>
<p id="Par67">Initially, clinical investigations centered on ADSCs primarily targeted regenerative medicine, particularly in the restoration of cartilage and the remediation of bone defects. However, as research into the mechanisms by which ADSCs facilitate tissue repair has progressed, it has become increasingly clear that clinical benefits do not solely arise from the differentiation capacity of ADSCs into chondrocytes or osteoblasts but rather from their immunomodulatory properties. This understanding has prompted a significant pivot in research focus towards evaluating the therapeutic efficacy of ADSCs in treating inflammatory conditions, such as rheumatoid arthritis and CD [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Current evidence suggests that ADSCs show considerable promise for treatment of inflammatory disorders. A considerable body of research, including numerous clinical trials, has been dedicated to investigating the role of ADSCs in the treatment of IBD. The pathophysiology and clinical aspects of IBD will be elaborated upon in the following sections.</p>
<section id="Sec23"><h4 class="pmc_sec_title">Diversity and complexity of pathogenesis of IBD</h4>
<p id="Par68">Inflammatory bowel disease (IBD) represents a persistent and recurrent inflammatory condition of the gastrointestinal tract, primarily encompassing in two principal forms: ulcerative colitis (UC) and Crohnâ€™s disease (CD). UC mainly impacts the mucosal layer of the colon, causing inflammation and ulceration of the mucosal surface, and is characterized by continuous inflammation process within the colon. In contrast, CD usually involves any segment of the gastrointestinal tract but most frequently presents in regions such as the terminal ileum and colon. This condition is marked by transmural inflammatory damage to the intestinal wall, which can subsequently result in ulceration and the formation of fistulas.</p>
<p id="Par69">The pathogenesis of IBD is multifaceted and results from an intricate interplay of genetic factors, environmental influences, the integrity of the intestinal barrier, and mechanisms of immune response [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. Genetic factors have an impact on the occurrence of IBD upon its classification as a polygenic disease with a familial aggregation pattern. Environmental influences, notably microbial composition, play a pivotal role since gut microbiota serves as crucial intermediaries linking external environments with internal physiological states. The intestinal barrier comprises IECs and innate immune cells that maintain the balance between the luminal contents and the mucosal surfaces, which effectively defend against pathogen invasion. When innate immune cells are deficient or foreign antigens break through the intestinal mucosal barrier, DCs, together with other antigen presenting cells, trigger a series of immune responses and initiate inflammatory responses. This disruption of the immune balance leads to leukocyte migration into the intestinal mucosa accompanied by sustained T cell-mediated cellular immunity, which ultimately leads to the development of CD or UC. UC represents a chronic inflammatory condition primarily affecting the distal colon and rectum manifesting symptoms such as abdominal pain, diarrhoea and muco-purulent stools [<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. A significant aspect contributing to the pathogenesis of UC is the imbalance within the immune system. Patients exhibit imbalance between Th1/Th2 cells activities within the colonic tissues where inflammatory cells are persistently activated leading to their accumulation along with upregulation of IL-1, IL-1 receptor, IL-6, IL-8 and TNF-Î³ [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>]. The pathways of activation that are implicated in this chronic condition include the NF-ÎºB, PI3K/Akt, and JAK/STAT signaling cascades. Abnormalities in these regulatory mechanisms induce aberrant signal transduction, further contributing to the immunological imbalance that triggers UC [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>].</p>
<p id="Par70">Central to the dynamics of the NF-ÎºB signaling pathway are key mediators such as NF-ÎºB itself, TNF-Î±, and other associated factors that are instrumental concerning pathogenesis of UC. The activation of NF-ÎºB causes the release of NF-ÎºB-associated factor complexes into the nucleus and promotes nuclear translocation, which not only regulates the expression of genes, involved in cell proliferation but also influences apoptosis, thereby playing an active role in the hostâ€™s inflammatory response. Furthermore, TNF-Î± is critical in stimulating the release of C-reactive protein. Following the onset of inflammation, a significant influx of TNF-Î± at the inflammatory site generates localized hypoxic conditions, which subsequently activate HIF-1Î±, subsequently increases the rate of IL âˆ’â€‰10 and COX âˆ’â€‰2 synthesis, thereby aggravating the local inflammatory response [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>].</p>
<p id="Par71">CD, a subtype of chronic gastrointestinal inflammation, is characterized by skip lesions and transmural inflammation that affect the entire gastrointestinal tract. The terminal ileum and proximal sections of the large intestine are commonly affected sites in CD [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. Typically, the initial clinical manifestations of CD are marked by prominent inflammatory phenotypes; however, as the condition progresses, complications such as stenosis, fistulas, or abscesses may develop, leading to the need for surgical procedures in nearly 50% of those diagnosed [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>].</p>
<p id="Par72">The pathological mechanism underlying CD encompass the destruction of intestinal barrier integrity and the activation of mediators linked to inflammation. Deficiencies in gut barrier composition or inflammation can contribute to CD pathogenesis. For example, mutations in genes encoding connexin and inflammatory factor receptors may adversely affect the functionality of IECs. Studies have demonstrated that alterations in the expression and positioning of Claudin 2/5/8 contribute to discontinuous tight junctions and compromise barrier dysfunction in CD [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]. Simultaneously, endoplasmic reticulum stress (ERS) occurs within IEC may initiate pathological unfolded protein response (UPR) alongside inflammatory response, which is recognized as a crucial factor in the etiology CD [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. ERS leads to the upregulation of NKG2D ligands, which subsequently activates NK cells and ILC1s, thereby mediating inflammation processes [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>].The signaling pathways of STAT3 and NF-ÎºB within IECs are of paramount importance; deficiencies in proteins associated with these pathways can similarly trigger the pathology of CD [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>].</p>
<p id="Par73">Additionally, impairments in antimicrobial peptide production by innate immune cells or intestinal intraepithelial lymphocytes (IELs) as well as dysfunctions involving proteins linked to immune response pathways, also contribute significantly to CD progression [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. Mutations across various genes, such as NOD2, ATG16L1, LRRK2, XBP1, and IRGM, lead to activation of innate immune proteins, which in turn activate the NF-ÎºB signaling cascades responsible for mediating inflammatory responses, while concurrently altering Paneth cell functions and resulting in dysregulated secretion of antimicrobial peptides. Moreover, study has shown that activated DCs under inflammatory conditions express TLR2, TLR4, and costimulatory receptors, which promote the production of pro-inflammatory cytokines and thus facilitate the onset of CD [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]. Notably, IELs secreted elevated levels of IL-17Â A, IFN-Î³, and TNF-É‘ in individuals diagnosed with CD [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. Consequently, dysfunctionality of IELs such as hyperactivity of cytotoxic T lymphocytes or aberrant reductions in their anti-inflammatory capabilities can further exacerbate inflammatory manifestations and lead to the development of CD.</p>
<p id="Par74">Adaptive immune system activation is a hallmark feature shared by both UC and CD. In particular, the intestinal infiltrates observed in CD often include Th1/17 cell subsets. The involvement of T cell-mediated adaptive immunity in the induction of gastrointestinal inflammation has been discussed in Sect. <a href="#Sec9" class="usa-link">ADSCs involving in adaptive immunity</a>, so it will not be further elaborated upon in this section.</p></section><section id="Sec24"><h4 class="pmc_sec_title">Insight into ADSCs in the treatment of UC</h4>
<p id="Par75">Studies have demonstrated that ADSCs can be utilized in the treatment of colitis. A pivotal investigation utilizing a DSS-induced murine colitis model demonstrated that the combined Rg1 and ADSCs therapy significantly attenuated colonic inflammation [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]. In the study, ADSCs were extracted from AT harvested from human abdominal and gluteal regions, with intravenous administration of ADSCs to mice alongside oral delivery of Rg1 via tube feeding. The results from histopathological examinations and immunofluorescence assays demonstrated a notable reduction in inflammatory cell infiltration EV within colonic tissues in the group treated with ADSCs. Furthermore, flow cytometric analysis revealed that Th17 cells populations were markedly elevated in the DSS group compared to those receiving Rg1, ADSC or ADSCâ€‰+â€‰Rg1 groups, suggesting that both ADSC and Rg1 contribute to maintaining intestinal homeostasis by regulating Treg/Th17 balance as illustrated in Fig.Â <a href="#Fig6" class="usa-link">6</a>A.</p>
<figure class="fig xbox font-sm" id="Fig6"><h5 class="obj_head">Fig. 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366020_13287_2025_4549_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ac/12366020/6791ac5847c0/13287_2025_4549_Fig6_HTML.jpg" loading="lazy" id="d33e1752" height="502" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mode diagram of the role and mechanisms of ADSCs in the treatment of IBD, gastric disorders, CRC, and liver diseases. (<strong>A</strong>) In the treatment of IBD, ADSCs mainly exert their immunomodulatory function. However, ADSCs from IBD patients (P-ADSCs) may exert an immunosuppressive function that is inferior to that of ADSCs from healthy individuals (H-ADSCs). (<strong>B</strong>) ADSCs reduce ECM deposition in colorectal fibrosis by suppressing gene expression, inhibiting fibroblast activation, and promoting M2MÏ† activation. In CRC, ADSCs can either promote or inhibit tumor development by regulating immune cell activity and inhibiting the Wnt pathway, or by secreting IL-6, Cyr61, and ANGPTL4. (<strong>C</strong>) ADSCs treat hepatic fibrosis by lecturing collagen fibers and differentiating into stem cells, while treating hepatocellular carcinoma by inhibiting oncogenic markers and metalloproteinases to reduce tumor migration. (<strong>D</strong>) In gastric cancer (GC), ADSCs can play either promoting or inhibiting roles equally. And the promotion of gastrectomy closure is mainly through the repair of fibrous and vascular tissues</p></figcaption></figure><p id="Par76">While it is well-established that ADSCs can modulate the immune response and are employed therapeutically for UC, evidence suggests that ADSCs derived from patients suffering from inflammatory or autoimmune conditions may exhibit immunosuppressive deficiencies [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]. Comparative experiments were conducted to evaluate differentiation capacity, proliferation rates, secretion profiles, and immunosuppressive functions between healthy donor-derived (H-ADSC) versus UC patient-derived (P-ADSC) cells. The efficacy of P-ADSCs was ultimately assessed in mouse models of acute or chronic colitis, revealing a reduced proliferative capacity and diminished osteogenic and chondrogenic differentiation potential compared to H-ADSCs. Additionally, P-ADSCs secreted lower levels of PGE, IDO, and TNFAIP6 when stimulated by inflammatory factors, contributing to their compromised immunological effectiveness. Collectively, the therapeutic impact exhibited by P-ADSCs was inferior compared to H-ADSCs as shown in Fig.Â <a href="#Fig6" class="usa-link">6</a>A. This study suggests for the first time that autologous transplantation of ADSCs may not be the best approach for UC patients, raising questions about the clinical feasibility of ADSC treatment for this condition.</p></section><section id="Sec25"><h4 class="pmc_sec_title">Think deeply about the role of ADSCs in the treatment of CD</h4>
<p id="Par77">A hallmark of CD is the presence of fistulae, with 40â€“50% of CD patients suffering from complication, and among them, 50% exhibit fistulae. The therapeutic application of ADSCs for perianal fistulae was first documented in 2003 by GarcÃ­a-Olmo et al.. who achieved successful closure of a rectovaginal fistula in a CD patient using autologous ADSCs administration, establishing a milestone in cellular therapy for fistulizing CD. This patient, aged 33 at the time of the study, had developed perianal pus four years prior, having been diagnosed with perianal CD. Multiple surgical interventions had failed to yield improvement. Prior to treatment with ADSCs, she received local anesthesia and systemic sedation while an initial adipose aspirate was harvested from subcutaneous tissue around the umbilicus. A week post-surgery, despite signs of inflammation in her wound, complete closure of the fistula was achieved without any observed fecal incontinence or vaginal flatulence. However, One month later, she experienced another flare-up of CD accompanied by suppurative symptoms, although minor signs of a perianal fistula re-emerged, no recurrence of the rectovaginal fistula was noted [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]. This trial highlighted the potential efficacy of ADSCs in managing CD, however, it primarily facilitated closure of the fistula but may lead to recurrence of CD.</p>
<p id="Par78">In subsequent investigations, ADSCs have been extensively utilized for treating CD associated with perianal fistula. Etienne et al.. conducted a comprehensive review summarizing previous studies and ongoing clinical trials involving ADSCs in this context. Among published literature on this subject matter, most clinical trials remain in early stages (phase I and II), with only one Phase III trial having reached completion thus far. In a singular controlled Phase III study, the rate of complete fistula healing was significantly higher compared to the placebo group [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]. One investigation involved injecting freshly harvested autologous AT into perianal fistulas among patients suffering from CD to evaluate ADSC efficacy for CD treatment. Remarkably, complete healing was reported in 57% of cases following the injection of this freshly collected tissue, while cessation or reduction in secretion from the lesions occurred at rates of 14% and 5%, respectively [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]. These findings suggest that the use of freshly harvested autologous AT shows considerable promise as a future therapeutic option for managing perianal fistulas in CD, representing a hopeful combined approach to effectively treating challenging cases involving these fistulas.</p></section><section id="Sec26"><h4 class="pmc_sec_title">Recent advances in the treatment of IBD with ADSCs</h4>
<p id="Par79">Recent investigations published in 2024 indicate that MSCs can mitigate inflammatory responses by engaging in the ubiquitin modification. This involvement allows them to influence various signaling pathways, such as NF-ÎºB, NOD, TGF-Î², and TNF-Î±, which are pertinent in the management of IBD [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>]. Currently, the underlying mechanisms through which ubiquitination mediates the relay of inflammatory signals and subsequently instigates IBD remain inadequately explored, necessitating further investigation. Nevertheless, these findings imply that subsequent research could focus on the role of ADSCs in regulating ubiquitination as a potential therapeutic approach for IBD, thereby laying a foundational experimental basis for clinical applications. Furthermore, MSCs have been shown to significantly influence antimicrobial activity and may engage in direct or indirect interactions with gut microbiota [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. MSCs exert an anti-inflammatory role by directly affecting abundance of certain bacterial strains, thereby diminishing the levels of pathogenic bacteria while enhancing the proliferation of beneficial microbial populations. Meanwhile, MSCs also modulate the gut microbiota indirectly through the regulation of the hostâ€™s immune response. This indicates that the modulation of intestinal microbiota by MSCs constitutes a significant mechanism through which these cells may contribute to the therapeutic management of IBD. Future investigations could further examine ADSCs, which present notable advantages over traditional MSCs, to assess their potential for treating IBD from a multifaceted approach.</p></section></section><section id="Sec27"><h3 class="pmc_sec_title">ADSCs as a novel highlight in the treatment of colorectal cancer</h3>
<p id="Par80">Stem cells have emerged as a promising novel approach in cancer therapy, prompting extensive investigation across multiple disciplines. Among the various stem cell therapies, hematopoietic stem cells have been recognized as a standard therapeutic option for leukemia and other hematologic cancers. Recent literature indicates the current studys on ADSCs primarily target their potential applications in breast and ovarian cancer treatment, with ongoing debate regarding their role in tumor growth modulation. Some studies suggest that ADSCs can exert an anti-cancer role by facilitating apoptosis in cancer cells [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>]. Other studies believe that ADSCs contribute to the proliferation of cancer cells through the secretion of diverse cytokines or by fusing with these malignant cells, thereby facilitating their growth and metastatic potential [<a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>â€“<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>]. Nonetheless, research focusing on the specific roles and underlying mechanisms of ADSCs in gastrointestinal malignancies remains insufficient. The subsequent discussion will address the biphasic effects of ADSCs on colorectal cancer (CRC).</p>
<section id="Sec28"><h4 class="pmc_sec_title">Double-edged sword role of ADSCs in colorectal cancer</h4>
<p id="Par81">Regarding the therapeutic effect of ADSCs on CRC, various studies have yielded inconsistent findings. This discrepancy can largely be attributed to the interplay between ADSCs and immune cells within the tumor microenvironment (TME), where these cells exhibit a dual function of both immunosurveillance and immunoediting [<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>].</p>
<p id="Par82">The tumor-suppressive effects of ADSCs are primarily exhibited through the regulation of immune cells activity within the TME, thus fulfilling a crucial role in immunological surveillance. This encompasses: i) promoting Î³Î´ T cells to produce IFN-Î³, IFN-Î±/Î², which play a pivotal role in triggering apoptosis in cancer cells [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>], ii) the enhancement of B cells activity, leading to the production of antibodies that facilitate tumor eradication [<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>], and iii) the orchestration of NK cells remodeling, thereby augmenting anti-tumor activity [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>]. Moreover, MSCs migrate into tumor sites release anti-tumorigenic factors via paracrine signaling, resulting in the resensitization of primary tumors and the induction of cancer cell apoptosis. Simultaneously, infiltrating MSCs contribute to tissue repair mechanisms through their differentiation potential [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. ADSCs facilitate tumors predominantly by persistently modifying and influencing the hostâ€™s anti-tumor immune mechanisms. This interaction consequently shapes the immunogenicity of tumors and affects clonal selection, ultimately shifting the equilibrium to favor tumor development, a phenomenon referred to as immunoediting [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]. The intricate mechanism entails the infiltration of MSCs into the TME via chemotactic signals. Once within the tumor tissue, these cells engage in a secretory communication with the tumor cells, releasing various soluble factors that promote angiogenesis and exert immunosuppressive effects, thereby aiding in tumor proliferation [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>].</p>
<p id="Par83">On the one hand, ADSCs demonstrate specific anti-cancer properties. Evidence supports that MSCs attenuate colon cancer progression by influencing the immune constituents within the colorectal TME. In adenocarcinomas (ADKs) derived from rats treated with MSCs, a decrease in the presence of infiltrating CD68<sup>+</sup> MÏ†s was observed, alongside an increase in the infiltration of CD3<sup>+</sup> lymphocytes. This alteration in immune cell composition is associated with improved prognostic outcomes and a reduction in negative effects related to tumors, including CRC [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]. Furthermore, MSCs were found to reduce the activity of NK and regulatory Th17 (rTh17) cell, limit Tregs recruitment, and decrease the presence of CD8<sup>+</sup> lymphocytes and endothelial cells. Conversely, MSCs were shown to restore the activity of Th17 cells, contributing to the modulation of tumor immunity [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]. Regarding CRC that arises from inflammatory bowel disease (IBD), research has indicated that BMSCs can mitigate CRC by directing MSCs to the inflamed intestinal region via the DF-1/CXCR4 signaling pathway [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>]. Additionally, investigations have demonstrated the capacity to directly target tumor cells and inhibit their proliferation. Specifically, studies have shown that ADSCs can suppress cancer cell growth through the secretion of Dickkopf-1 (DKK-1), a known negative regulator of the Wnt signaling pathway [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. Furthermore, the secretome obtained from ADSCs, referred to as AMSCs-Se, has the potential to exert an anti-colon cancer effect by promoting apoptosis in cancer cells [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. These findings indicate that ADSCs, as a kind of MSCs, may similarly contribute to an anti-CRC role through comparable pathways.</p>
<p id="Par84">On the other hand, evidence supporting the role of ADSCs in promoting CRC development and metastasis is more compelling. It is widely acknowledged that tumor progression occurs through three distinct phases, such as tumorigenesis, promotion and progression. Regarding tumorigenesis and growth specifically, some evidences indicate that ADSCs facilitate the proliferation of CRCs via IL-6 production [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>]. Furthermore, ADSCs mediate cancer progression via activating the JAK2/STAT3 signaling pathway in breast and colon cancer cells by secreting IL-6. In terms of tumor development and metastatic behavior, it has been shown that ADSCs-derived Cyr61 enhances CRC cells migration and invasion via the Î±VÎ²5/FAK/NF-ÎºB signaling cascade [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Concurrently, it has been shown that exosomes secreted from CRC facilitate the Cyr 61 transcription within ADSCs. Additionally, a separate study revealed that ADSCs trigger peritoneal metastasis of CRC by enhancing glycolysis activity while simultaneously diminishing apoptosis resistance [<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. This process entails the activation of the TGF-Î²1/SMAD3 signaling cascade, in conjunction with the upregulation of the ANGPTL4 expression, which collectively promotes an invasive phenotype in tumor cells.</p>
<p id="Par85">Collectively, there remains debate concerning the impact of ADSCs on the progression of CRC, with some studies suggesting beneficial effects alongside reports of detrimental outcomes. The dual roles of ADSCs in either promoting or suppressing CRC are depicted in Fig.Â <a href="#Fig6" class="usa-link">6</a>B.</p></section><section id="Sec29"><h4 class="pmc_sec_title">Potential target role of ADSCs in the diagnosis and treatment of CRC</h4>
<p id="Par86">While the evidence supporting the role of ADSCs in promoting tumor proliferation and migration is compelling, their homing ability and regenerative differentiation present important markers for the diagnosis and treatment of CRC. EVs and exosomes derived from ADSCs can function as targeted drug delivery systems for tumor cells. Moreover, ADSCs possess the ability to secrete angiogenic cytokines and growth factors that not only bolster endogenous repair processes but also alleviate fibrosis.</p>
<p id="Par87">EVs isolated from ADSCs function as nanocarriers with strong binding affinity for tumor cells, enabling real-time imaging of tumor localization and delineation [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. In addition, due to their inherent properties as natural nanovesicles, exosomes have garnered considerable attention for their carrier capabilities. Research has been conducted to isolate MSCs from ADSCs to obtain adequate quantities of exosomes suitable for drug delivery applications. In these studies, SN38, as a hydrophobic agent, was encapsulated within exosomes decorated with MUC1 aptamers specifically targeting MUC1-overexpressing cells. Findings indicated that SN38/Exo-Apt could be effectively utilized in treating CRC [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. Regarding the reduction of tissue fibrosis, recent evidence released in 2024 indicate that ADSCs can ameliorate radiation-induced colorectal fibrosis (RICF) by rectifying dysbiosis and reinstating a healthy colonic microbiota [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. RICF represents a chronic complication associated with pelvic radiotherapy in the management of CRC, and this discovery offers important perspectives on potential therapeutic approaches to mitigate RICF.</p></section></section><section id="Sec30"><h3 class="pmc_sec_title">The role of ADSCs in managing fibrosis</h3>
<p id="Par88">The dual role of ADSCs in fibrotic diseases has garnered widespread attention. Research indicates that MSCs play a multifaceted and often paradoxical role in the progression of fibrotic conditions Specifically, while tissue-resident MSCs possess the capability to differentiate into myofibroblasts, consequently facilitating the advancement of fibrosis, the administration of exogenous MSCs appears to mitigate fibrotic diseases. This alleviation is achieved through mechanisms such as inflammation modulation, damaged tissue regeneration, ECM remodeling, and the regulation of post-transplantation cellular stress responses [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. Owing to their distinctive regenerative and paracrine characteristics, MSCs are regarded as a promising therapeutic strategy for an array of gastrointestinal disorders, including hepatic fibrosis, ulcerative colitis, acute liver injury, and nonalcoholic fatty liver disease [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>].</p>
<section id="Sec31"><h4 class="pmc_sec_title">Roles of ADSCs in alleviating liver fibrosis and hepatocellular carcinoma</h4>
<p id="Par89">ADSCs have shown significant promise in the treatment of hepatic injury, particularly in addressing hepatic fibrosis and hepatocellular carcinoma (HCC).</p>
<p id="Par90">Numerous experimental models have elucidated the role of ADSCs in collagen fibers degradation and the mitigation of liver fibrosis. The study established a mouse model of carbon tetrachloride(CCl<sub>4</sub>)-induced liver injury, demonstrating that basic fibroblast growth factor (bFGF) facilitates the trans-differentiation of ADSCs into hepatic lineage cells both in vitro and in vivo [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]. Transplantation of bFGF-treated ADSCs significantly contributes to the regression of hepatic fibrosis in CCl<sub>4</sub>-induced mice. Another study indicated that ADSCs transplantation may aid recovery from chronic liver injury [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. ADSCs derived from patients were isolated, cultured, and then injected into rats suffering from chronic liver fibrosis induced by thioacetamide (TAA). Histopathological analyses revealed a marked reduction in hepatic fibrosis and inflammatory activity following ADSC transplantation, along with reduced levels of Î±-smooth muscle actin and increased the expression levels of MMP-9. These findings suggest that ADSCs can effectively mitigate chemically induced hepatic fibrosis while promoting restoration of liver function.</p>
<p id="Par91">HCC is an aggressive malignancy characterized by high rate of intrahepatic metastasis, often managed through surgical resection. Cell therapy has emerged as a promising alternative to conventional surgical approaches for HCC treatment. Research indicates that ADSCs can effectively inhibit HCC cell proliferation while promoting apoptosis under laboratory conditions [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>], which is mediated through down-regulation of Akt signaling pathways to suppress HCC cellular growth. Another study involving co-cultured systems with HCC cell lines and ADSCs, significant inhibition was observed regarding HCC cells proliferation rates along with enhanced apoptotic activity. Furthermore, ADSCs demonstrated the ability to inhibited migration capabilities within HepG2 and PLC-PRF-5 cells potentially via upregulation of tissue inhibitors such as TIMP-1, TIMP-2 and TIMP-3 [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>] as depicted in Fig.Â <a href="#Fig6" class="usa-link">6</a>C.</p>
<p id="Par92">Moreover, ADSCs may serve as adjuvant therapies for patients suffering from hepatic cancer. Currently employed radiotherapy (RT) is frequently utilized for advanced-stage HCC patients who are not suitable for surgery or transplantation. However, its prognostic outcomes remain suboptimal. A recent study evaluated the anticancer effects of combining ADSCs with RT on various HCC cell lines, revealing interactions between IFITM1 interacted with STAT3 along with MMP which inhibited the downstream expression related to p53 activation as well as reduced cysteine-asparaginase production during combined treatment of RT and ADSCs, ultimately leading to lower tumor cell proliferation rates [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]. These suggest that incorporating ADSCs could potentially improve the effectiveness of RT for individuals diagnosed with HCC.</p></section><section id="Sec32"><h4 class="pmc_sec_title">Potential of ADSCs to inhibit colorectal fibrosis</h4>
<p id="Par93">Fibrosis is characterized by the excessive accumulation of ECM components, particularly collagen, and is typically associated with a chronic inflammatory response triggered by various factors [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. Research utilizing a mouse model for acute colitis has demonstrated that MSCs can inhibit the differentiation of myofibroblasts from fibroblasts stimulated with TGF-Î², leading to enhanced mucosal repair, diminished inflammation, and reduced intestinal fibrosis [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]. Studies have been extensively investigated in the context of radiation-induced colorectal fibrosis. In an in vitro study involving irradiated co-culture with human MSCs, findings indicated that these stem cells could effectively suppress colorectal fibrosis by down-regulating genes associated with ECM, preventing the activation of pro-fibroblasts, and fostering the Th2/M2 immune response [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>] (Fig.Â <a href="#Fig6" class="usa-link">6</a>B). Simultaneously, the investigation highlighted the synergistic functions of HGF and TSG-6 in mediating the antifibrotic properties of MSCs, underscoring the importance of multiple factors secreted by therapeutic MSCs [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. Moreover, evidence indicates that treatment with ADSCs influences the Th17 cell population and attenuates the ECM deposition triggered by irradiation, consequently mitigating damage to the intestinal mucosa and reducing fibrosis [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. These findings highlight the promising use of ADSCs in the treatment of radiation proctitis.</p></section><section id="Sec33"><h4 class="pmc_sec_title">ADSCs for fibrosis in other systems</h4>
<p id="Par94">Beyond their established function in addressing hepatic and colorectal fibrosis, ADSCs have been the subject of extensive investigation regarding their therapeutic applications across various bodily systems. A comprehensive review highlights the antifibrotic properties of MSCs in multiple organ systems. Specifically, MSCs have demonstrated efficacy in treating and mitigating fibrosis in models representing cardiac, hepatic, renal, pulmonary, peritoneal, pancreatic, cutaneous, and rectal fibrosis. Furthermore, clinical trials have confirmed the beneficial effects of MSCs on fibrosis resulting from cardiac, hepatic, renal, and pelvic radiotherapy. Findings from both preclinical and clinical investigations underscore that MSCs combat fibrosis through mechanisms such as immunosuppression, inhibition of TGF-Î² signaling pathways, alleviation of hypoxia and oxidative stress, as well as the restoration of ECM degradation [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Thus, there exists great potential for the application of MSCs, particularly ADSCs, in the treatment of systemic fibrotic disorders.</p></section></section><section id="Sec34"><h3 class="pmc_sec_title">The double-edged sword role of ADSCs in stomach disorders</h3>
<p id="Par95">The potential role of ADSCs in gastric cancer treatment is still a topic of debate, as there are only a limited number of studies on this subject.</p>
<p id="Par96">Some studies indicate that ADSCs can inhibit the proliferation of gastric cancer cells, while others have shown that they can promote cancer cells growth and migration. Specifically, ADSCs have been shown to effectively inhibit the proliferation of HGC-27 cell lines by inducing apoptosis in an ex vivo setting [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. Conversely, evidence suggests that ADSCs might facilitate the growth and migration of gastric cancer cells via the SDF-1/CXCR4 axis [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. This result contradicts what we mentioned in the anti-colon cancer effect that ADSCs alleviate IBD-induced CRC through SDF-1/CXCR4 pathway. This observation prompts further investigation into the mechanistic role of the SDF-1/CXCR4 axis in mediating tumor-stem cell interactions. Furthermore, investigations have explored the application of ADSCs in tissue regeneration for gastrotomy closure. In early stages post-surgery, ADSCs appear to enhance tissue regeneration by accelerating angiogenesis and fibrosis [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. In the late stage, they may mitigate excessive fibrosis development. These findings indicate that the regenerative properties of ADSCs could be utilized to alleviate postoperative complications associated with digestive surgery as shown in Fig.Â <a href="#Fig6" class="usa-link">6</a>D.</p></section><section id="Sec35"><h3 class="pmc_sec_title">ADSCs in treating radiation-induced injuries</h3>
<p id="Par97">Radiotherapy is predominantly employed in the management of pelvic malignant tumors, including prostate cancer, cervical cancer, uterine cancer and ovarian cancer [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. While this therapeutic approach is effective in curtailing tumor proliferation, it is imperative to acknowledge the potential repercussions on adjacent healthy tissues, as well as the possibility of adverse reactions. Among the negative outcomes associated with pelvic radiotherapy are radiation-induced proctitis or proctopathy. This condition can manifest in two distinct forms: acute and chronic. The acute variant occurs in nearly all patients, whereas the chronic variant persists over an extended period and significantly affects the intestinal function. Frequently observed symptoms encompass diarrhea, tenesmus, rectal mucus or blood discharge, urinary urgency, incontinence, and pain, with rectal bleeding being the most prevalent symptom [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>].The underlying mechanism by which pelvic radiotherapy causes damage to normal tissues involves the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) as a result of ionizing radiation exposure. This process results in oxidative stress, which subsequently inflicts harm on DNA and mitochondria [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]. The resultant tissue injuries are associated with prolonged inflammation, vascular impairment, and the development of fibrosis resulting from the accumulation of ECM matrix components [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>].</p>
<p id="Par98">Preclinical studies indicate that MSCs can alleviate gastrointestinal injury following pelvic radiotherapy by inhibiting ulcer, inducing intestinal villus regeneration, improving anal sphincter regeneration and contraction, enhancing small intestinal epithelial cell turnover, and inhibiting small intestinal epithelial cell apoptosis [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. Despite the significant therapeutic potential of MSCs in addressing radiation-induced side effects, they do not contribute to the amelioration of DNA damage resulting from radiation exposure and lack the capacity to perform DNA repair functions [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. The continued proliferation of MSCs in the presence of a damaged DNA template may result in the onset of tumorigenesis. Consequently, it is imperative to comprehend the mechanisms through which adult stem cells modulate tumor proliferation, as this knowledge is essential for the future utilization of MSCs, and even adipose-derived stem cells (ADSCs), in the realm of pelvic radiotherapy.</p></section></section><section id="Sec36"><h2 class="pmc_sec_title">Limitations and challenges with clinical applications of ADSCs</h2>
<p id="Par100">While ADSCs exhibit considerable potential within regenerative medicine, it is crucial to address the limitations pertaining to cell heterogeneity, standardization processes, regulatory considerations, tissue yield variability, and inconsistencies in clinical outcomes to ensure their safe and effective application in therapeutic settings.</p>
<section id="Sec37"><h3 class="pmc_sec_title">Intrinsic variability and heterogeneity</h3>
<p id="Par101">The inherent variability of ADSCs presents a significant challenge in clinical applications, primarily, largely influenced by factors related to tissue origin and donor characteristics [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. Variables specific to the donor, such as age, gender, body mass index (BMI), and underlying health conditions, impact the phenotype, morphology, differentiation potential, and overall functionality of ADSCs [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]. Furthermore, ADSCs obtained from different tissue sources exhibit variations in their proliferative and differentiation abilities, immunomodulation and other functions, which ultimately impact the clinical outcome.</p>
<p id="Par102">The heterogeneity of MSCs can be broadly categorized into three types: heterogeneity stemming from tissue sources, donor-related heterogeneity, and heterogeneity introduced by culture conditions based on the mechanisms governing their generation [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]. In the context of ADSCs, MSCs sourced from a single AT site exhibit uniformity in tissue origin. The main influencing factors of donor heterogeneity include age, gender and metabolic index (MBI). Older age, high BMI (&gt;â€‰30Â kg/m<sup>2</sup>), diabetes mellitus or prior exposure to RT and endocrine therapy have been shown to diminish both the proliferative capacity and differentiation potential of ADSCs [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. Emerging evidence indicates that different in collection sites significantly influences the yield rates and differentiation profiles of ADSCs, with higher detection rates are observed when harvesting from thigh regions compared to abdominal areas or medial knee sites [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Additionally, culture-induced heterogeneity arises from the use of animal-derived serum used during ADSCs culture processes, while exogenous growth factors may also interfere with the differentiation pathways and proliferation rates of these cells. Therefore, to reduce these associated risks, it is imperative to select appropriate tissue sources and donors, and to reduce the interference of the culture environment with ADSCs.</p></section><section id="Sec38"><h3 class="pmc_sec_title">Immunogenicity and genetic stability</h3>
<p id="Par103">Immunogenicity is another factor that plays a key role in the application of ADSCs. Immunogenicity refers to the long-term expansion of ADSCs showing different immunomodulatory characteristics. In the ADSCs culture process, 10â€“20% FBS or calf serum is usually used. However, animal-derived products may contain viruses, prions, mycoplasma, and exogenous growth factors, which may cause an immune response in patients, thus interfering with the differentiation and proliferation of ADSCs [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. Therefore, in order to avoid these risks, media without animal serum should be developed. Genetic stability after manipulation and amplification is another major concern for ADSCs in therapy. The possible adverse differentiation of ADSCs and their interaction with tumor cells need to be monitored and managed in real time.</p></section><section id="Sec39"><h3 class="pmc_sec_title">Risks of ADSC in clinical treatment</h3>
<p id="Par104">Despite the extensive research and clinical application of ADSCs in addressing a range of medical conditions, it is imperative to acknowledge the potential adverse effects associated with their use. For instance, a phase I clinical trial evaluating the effects of spray transplantation of allogeneic ADSCs in patients with ischemic cardiomyopathy reported the occurrence of pleural effusion as an adverse reaction among those treated with these stem cells [<a href="#CR162" class="usa-link" aria-describedby="CR162">162</a>]. Furthermore, a separate study documented instances of severe bilateral vision impairment following the intravitreal administration of autologous ADSCs aimed at treating age-related macular degeneration [<a href="#CR163" class="usa-link" aria-describedby="CR163">163</a>].</p>
<p id="Par105">Additionally, the risk of tumorigenicity associated with ADSC therapies warrants careful consideration. As previously mentioned, while certain studies have indicated that ADSCs can inhibit cancer cell proliferation, a considerable number of investigations have also reported their potential to promote cancer cell proliferation and metastasis. Consequently, the safety profile of ADSCs in cancer therapy necessitates further exploration. It is crucial to highlight, however, that the most findings suggesting cancer-promoting effects were derived from in vitro studies or animal models, leaving the clinical relevance of these observations uncertain.</p></section><section id="Sec40"><h3 class="pmc_sec_title">Regulatory considerations</h3>
<p id="Par106">The clinical application of ADSCs is confronted with numerous ethical. Primarily, there exists an ethical imperative to guarantee the sufficiency and legitimacy of informed consent, which must be voluntarily provided by patients or subjects, fully comprehending all potential risks and advantages associated with the treatment. Furthermore, safeguarding patientsâ€™ confidential information is critically important. Consequently, any handling of personal health data must adhere rigorously to privacy protection standards. Riskâ€“benefit evaluation also remains a pivotal aspect of ethical scrutiny, ensuring that the prospective advantages of the treatment surpass the associated risks and that appropriate risk management strategies are in place. The regulation of the clinical application of ADSCs necessitates a rigorous approach to qualification and standards control. It is imperative that medical institutions and researchers possess the requisite qualifications and infrastructure, which encompass appropriate licenses, specialized departmental credentials, certified health technicians, and pertinent technical expertise. Concurrently, stringent quality control measures must be enforced throughout the processes of preparation, storage, and transportation of ADSC preparations. This is essential to ensure compliance with established quality standards and requirements. Furthermore, the utilization of ADSCs must adhere to both Good Tissue Practice (GTP) rules and Good Manufacturing Practices (GMP) [<a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>]. GTPâ€™s primary objective is to safeguard â€œhuman cells, tissues, or cellular or tissue-based productsâ€ (HCT/P) from potential contamination by infectious agents while simultaneously ensuring their structural integrity and functionality by upholding rigorous quality and safety standards. GMP is established to monitor the processing and manufacturing stages of each cell product meticulously [<a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>]. It is worth mentioning that automated machinery employed for the isolation of adipose-derived stem cells (ADSCs) is classified by the U.S. Food and Drug Administration (FDA) as a Class III medical device, which necessitates stringent regulatory oversight; however, this classification has also posed challenges to its clinical application [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. Furthermore, FDA regulations require that ADSCs transplants be minimally manipulated without enzymatic treatment and utilized within the same surgical procedure. As a result, there is an immediate necessity for the formulation of enzyme-free techniques that are not only economically viable but also reproducible, facilitating the generation of high-caliber ADSCs that are appropriate for clinical use [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. Finally, global collaboration significantly influences the ethical and regulatory dimensions associated with the clinical use of ADSCs. Gaining insights from the progressive methodologies and experiences of different nations in stem cell clinical applications can facilitate the robust advancement of worldwide stem cell research and its applications.</p>
<p id="Par107">Overall, the ethical governance and regulatory framework surrounding the clinical application of ADSCs require concerted efforts from medical institutions, researchers, regulatory bodies, patients, and various societal stakeholders. This collective endeavor is essential to guarantee the safety and ethical integrity of these applications while fostering their responsible advancement in fields such as gastrointestinal health.</p></section></section><section id="Sec41"><h2 class="pmc_sec_title">Outlook and future directions of ADSCs</h2>
<p id="Par108">Although preliminary data suggest ADSCs may ameliorate digestive disorders, several hurdles must be tackled before clinical implementation. It is essential to consider various factors that may impact the effectiveness and feasibility of this treatment approach.</p>
<section id="Sec42"><h3 class="pmc_sec_title">Mitigating tumorigenesis risk</h3>
<p id="Par109">To mitigate the oncogenic potential of ADSCs during therapeutic interventions, it is imperative to conduct a comprehensive exploration of the underlying mechanisms by which ADSCs contribute to tumorigenesis and tumor progression. Additionally, enhancing the regulation and monitoring of ADSCs throughout their clinical application is essential. While the assertion that ADSCs facilitate tumor proliferation in colorectal and gastric cancers is compelling, the mechanistic understanding remains inadequate, with discrepancies evident in the literature regarding the dual rolesâ€”promotional versus inhibitoryâ€”of the SDF-1/CXCR4 signaling pathway. Furthermore, comprehensive characterization along with stringent quality control protocols must be established for the utilization of ADSCs to ensure that there are no transformed or genetically unstable cells. In the event that unstable or mutated cell populations are detected during clinical use, it is imperative to eradicate the transplanted ADSCs populations through the incorporation of suicide genes [<a href="#CR166" class="usa-link" aria-describedby="CR166">166</a>]. Regular imaging following ADSCs injection is also essential for overseeing any potential tumorigenic activities linked to these cells. Additionally, enhancing the targeting efficacy of ADSCs towards specific tissues pertinent to disease treatment, while concurrently reducing off-target effects, will significantly promote the progress of precision medicine initiatives.</p></section><section id="Sec43"><h3 class="pmc_sec_title">Expansion of possible areas of application</h3>
<p id="Par110">ADSCs are presently undergoing evaluation in clinical trials targeting various applications, including facial rejuvenation, keloid management, reconstructive procedures, treatment for alopecia, arthritis therapy, periodontal interventions, and healing of diabetic wounds [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Nevertheless, a significant number of these studies remain confined to the preclinical stage, indicating that the existing clinical evidence is inadequate to facilitate the broad application of ADSCs in medical practice. Several constraints contribute to this situation, such as limited patient cohorts, primarily brief observation duration, a lack of standardization in AT grafts, shortcomings in clinical protocols and guidelines, as well as subjective methods employed for assessing clinical outcomes [<a href="#CR167" class="usa-link" aria-describedby="CR167">167</a>]. ADSCs hold great promise for gastrointestinal applications, including the treatment of immune-related disorders, facilitation of hepatic fibrosis recovery, and therapy for gastrointestinal cancers.</p></section><section id="Sec44"><h3 class="pmc_sec_title">Deepening research on homing mechanisms</h3>
<p id="Par111">The homing ability of ADSCs is intricately linked not only to their role in mitigating inflammation but also serves as a crucial mechanism influencing tumor formation either by promoting or inhibiting it. Consequently, it is imperative to investigate the homing mechanisms of ADSCs to elucidate their immunomodulatory roles and the paradoxical effects they exert on tumor dynamics. While existing studies are examining the homing process of ADSCs and the associated signaling pathways, numerous inquiries remain unanswered, necessitating a more comprehensive understanding of these mechanisms prior to their clinical utilization. Specifically, there is a need to elucidate how to increase the number of ADSCs heading for the target sites and the localizations of quiescent ADSCs in the body and the micro-structures of their niches [<a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>].</p></section><section id="Sec45"><h3 class="pmc_sec_title">Focus on the advantages of ADSC-EVs in clinical application</h3>
<p id="Par112">EVs are nanoscale bilayer lipid membrane structures secreted by donor cells [<a href="#CR169" class="usa-link" aria-describedby="CR169">169</a>]. EVs contain a variety of biomolecules, including lipids, proteins, compounds, multi-molecular complexes, DNA, RNA (such as siRNA, miRNA, lncRNA, circRNA, etc.), and even intact subcellular organelles [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>]. ADSC-derived extracellular vesicles (ADSC-EVs) preserve therapeutically relevant biological activities of their parental cells while mitigating safety concerns associated with live cell transplantation. A large amount of evidence supports the role of ADSC-EVs in accelerating tissue regeneration and inhibiting inflammation. Recent review published in 2024 summarized that ADSC-EVs have been used in the clinical treatment of Alzheimerâ€™s disease, COVID-19, periodontitis and other diseases [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>]. The immunomodulatory and regenerative properties of ADSC-EVs also provide cell-free treatment options for IBD patients and new ideas for clinical application. The application of ADSC-EVs can avoid problems such as the need for vascularization and the potential risk of tumorigenesis, thus providing a safer and more simplified method [<a href="#CR171" class="usa-link" aria-describedby="CR171">171</a>]. Before ADSC-EVs can be translated into clinical practice on a large scale, their isolation, purification, storage, and accuracy tables must be standardized, while further elucidating their therapeutic mechanisms.</p></section><section id="Sec46"><h3 class="pmc_sec_title">Optimizing treatment strategies</h3>
<p id="Par113">Existing research demonstrates the ADSCs can ameliorate gastrointestinal disorders mainly by reduction of intestinal inflammation. However, there is a need for further optimization of therapeutic processes encompassing dosage determination, exploring different administration methods, and timing to enhance the overall effectiveness of these treatments. Additionally, the exploration of exosomes components derived from ADSCs is crucial for developing new therapeutic strategies as part of this optimization process. Standardizing ADSC-exosome isolation, characterization, and quantification protocols is critical to ensure therapeutic reproducibility and enable GMP-compliant production [<a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>].</p></section></section><section id="Sec47"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par114">ADSCs are one of the highly promising types of MSCs in the field of regenerative medicine because their application raises fewer ethical issues than BMSCs and UC-MSCs. This review summarizes the immunomodulatory, anti-inflammatory, and tissue-repairing roles and mechanisms of ADSCs in the gastrointestinal tract, along with the advice of their preclinical studies and clinical trials in the treatment of digestive disorders, which guides the future direction of ADSCs research in the gastrointestinal field.</p>
<p id="Par115">Despite ADSCsâ€™ ambivalent role in tumor immunity (including pro-metastatic effects), their application in inflammation-associated tumors and EV-based therapeutics remains clinically viable, opening novel therapeutic avenues.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We appreciate <a href="http://www.biorender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.biorender.com</a> for all the figures in this review. The authors declare that they have not use AI-generated work in this manuscript.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ADSCs</dt>
<dd><p id="Par119">Adipose derived stem cells</p></dd>
<dt>ADSC-EVs</dt>
<dd><p id="Par120">ADSC-derived EVs</p></dd>
<dt>AFP-A</dt>
<dd><p id="Par121">fetoprotein</p></dd>
<dt>AT</dt>
<dd><p id="Par122">Adipose tissue</p></dd>
<dt>bFGF</dt>
<dd><p id="Par123">Basic fibroblast growth factor</p></dd>
<dt>BMI</dt>
<dd><p id="Par124">Body mass index</p></dd>
<dt>BMPs</dt>
<dd><p id="Par125">bone morphogenetic proteins</p></dd>
<dt>BMSCs</dt>
<dd><p id="Par126">Bone marrow stem cells</p></dd>
<dt>CAM</dt>
<dd><p id="Par127">Cell adhesion molecule</p></dd>
<dt>CD</dt>
<dd><p id="Par128">Crohnâ€™s disease</p></dd>
<dt>CRC</dt>
<dd><p id="Par129">Colorectal cancer</p></dd>
<dt>CTGF</dt>
<dd><p id="Par130">Connective tissue growth factor</p></dd>
<dt>DAMPs</dt>
<dd><p id="Par131">Damage-associated molecular patterns</p></dd>
<dt>DCs</dt>
<dd><p id="Par132">Dendritic cells</p></dd>
<dt>DCP</dt>
<dd><p id="Par133">Des-gamma-carboxyprothrombin</p></dd>
<dt>ECM</dt>
<dd><p id="Par134">Extracellular matrix</p></dd>
<dt>EGF</dt>
<dd><p id="Par135">Epidermal growth factor</p></dd>
<dt>ERS</dt>
<dd><p id="Par136">Endoplasmic reticulum stress</p></dd>
<dt>ESCs</dt>
<dd><p id="Par137">Embryonic stem cells</p></dd>
<dt>EVs</dt>
<dd><p id="Par138">Extracellular vesicles</p></dd>
<dt>FAP</dt>
<dd><p id="Par139">Fibroblast activation protein</p></dd>
<dt>FDA</dt>
<dd><p id="Par140">Food and Drug Administration</p></dd>
<dt>GVHD</dt>
<dd><p id="Par141">graft-versus-host disease</p></dd>
<dt>H-ADSC</dt>
<dd><p id="Par142">Healthy donor-derived adipose derived stem cell</p></dd>
<dt>HCC</dt>
<dd><p id="Par143">Hepatocellular carcinoma</p></dd>
<dt>HGF</dt>
<dd><p id="Par144">Hepatocyte growth factor</p></dd>
<dt>IBD</dt>
<dd><p id="Par145">Inflammatory bowel disease</p></dd>
<dt>ICAM-1</dt>
<dd><p id="Par146">Intercellular Adhesion Molecule-1</p></dd>
<dt>IECs</dt>
<dd><p id="Par147">Intestinal epithelial cells</p></dd>
<dt>IELs</dt>
<dd><p id="Par148">Intestinal intraepithelial lymphocytes</p></dd>
<dt>IICs</dt>
<dd><p id="Par149">Innate immune cells</p></dd>
<dt>IL-10</dt>
<dd><p id="Par150">Interleukin-10</p></dd>
<dt>ILCs</dt>
<dd><p id="Par151">Innate lymphocytes</p></dd>
<dt>IFATS</dt>
<dd><p id="Par152">International Federation of Adipose Therapeutics</p></dd>
<dt>IRAK IL-1</dt>
<dd><p id="Par153">Receptor-associated kinase</p></dd>
<dt>iPSCs</dt>
<dd><p id="Par154">Induced pluripotent stem cells</p></dd>
<dt>LFA-3</dt>
<dd><p id="Par155">Lymphocyte functional antigen-3</p></dd>
<dt>MÏ†s</dt>
<dd><p id="Par156">Macrophages</p></dd>
<dt>MACS</dt>
<dd><p id="Par157">Magnetic-activated cell sorting</p></dd>
<dt>MLNs</dt>
<dd><p id="Par158">Mesenteric lymph nodes</p></dd>
<dt>MMP</dt>
<dd><p id="Par159">Matrix metalloproteinases</p></dd>
<dt>MSC</dt>
<dd><p id="Par160">Mesenchymal stem cell</p></dd>
<dt>NE</dt>
<dd><p id="Par161">Neutrophil elastase</p></dd>
<dt>NETs</dt>
<dd><p id="Par162">Neutrophil extracellular traps</p></dd>
<dt>NK cells</dt>
<dd><p id="Par163">Natural killer cells</p></dd>
<dt>NLRs</dt>
<dd><p id="Par164">NOD-like receptors</p></dd>
<dt>P-ADSC</dt>
<dd><p id="Par165">Patient-derived adipose derived stem cell</p></dd>
<dt>PAMPs</dt>
<dd><p id="Par166">Pathogen-associated molecular patterns</p></dd>
<dt>PDLSCs</dt>
<dd><p id="Par167">Periodontal ligament stem cells</p></dd>
<dt>PLA</dt>
<dd><p id="Par168">Processed lipoaspirate</p></dd>
<dt>PPARÎ³</dt>
<dd><p id="Par169">Peroxisome proliferator-activated receptorÎ³</p></dd>
<dt>PGE</dt>
<dd><p id="Par170">Prostaglandin E2</p></dd>
<dt>Prg4</dt>
<dd><p id="Par171">Proteoglycan 4</p></dd>
<dt>PRRs</dt>
<dd><p id="Par172">Pattern recognition receptors</p></dd>
<dt>RICF</dt>
<dd><p id="Par173">Radiation-induced colorectal fibrosis</p></dd>
<dt>ROS</dt>
<dd><p id="Par174">Reactive oxygen species</p></dd>
<dt>RT</dt>
<dd><p id="Par175">Radiotherapy</p></dd>
<dt>SLE</dt>
<dd><p id="Par176">Systemic lupus erythematosus</p></dd>
<dt>SVF</dt>
<dd><p id="Par177">Stromal vascular fraction</p></dd>
<dt>TGF-Î²</dt>
<dd><p id="Par178">Transforming growth factor-Î²</p></dd>
<dt>Th</dt>
<dd><p id="Par179">T helper (cell)</p></dd>
<dt>Thy-1</dt>
<dd><p id="Par180">Thymus cell antigen 1</p></dd>
<dt>TLRs</dt>
<dd><p id="Par181">Toll-like receptors</p></dd>
<dt>TNF-Î±</dt>
<dd><p id="Par182">Tumor necrosis factor-Î±</p></dd>
<dt>TRAF6</dt>
<dd><p id="Par183">TNF receptor-associated factor 6</p></dd>
<dt>Tregs regulatory</dt>
<dd><p id="Par184">T cells</p></dd>
<dt>UC</dt>
<dd><p id="Par185">Ulcerative colitis</p></dd>
<dt>UC</dt>
<dd><p id="Par186">MSCs-Umbilical cord-mesenchymal stem cells</p></dd>
<dt>UPR</dt>
<dd><p id="Par187">Unfolded protein response</p></dd>
<dt>VCAM-1</dt>
<dd><p id="Par188">Vascular cell adhesion molecule-1</p></dd>
<dt>VEGF</dt>
<dd><p id="Par189">Vascular endothelial growth factor</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>J.T.Z, analyzed references and wrote the original manuscript; S.Z.X, analyzed data and wrote the original manuscript; X.H.L, analyzed data and wrote the original manuscript; W.K.S, analyzed, organized data, and wrote the manuscript; B.Y.W, analyzed, organized data, and tables; H.L.W, prepared, and organized figures and tables; Y.W, organized, polished figures, and reviewed articles; R.X. H, organized, polished figures and review article; Y.Z.L, polished tables and figure; L.G, revised and edited article; X.L, revised and edited article; J.D.X, acquired funding, administrated project, supervised, reviewed and edited. All authors discussed the manuscript and approved of the final version.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study is funded by Natural Science Foundation of Beijing (No.7242211 JD Xu) and National Natural Science Foundation of China (No.82174056 and 82474161 JD Xu). All funding bodies did not influence the study at any stage (i.e., writing the manuscript).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par116">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par117">The authors declare that they have no competing interests.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Ethical approval and consent to participate</h3>
<p id="Par118">This systematic review synthesizes existing literature and excludes original research activities, including experiments or data collection involving human subjects or human-derived materials. Ethics approval and consent to participate are not applicable to this manuscript.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisherâ€™s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Jiatong Zhao, Shuzi Xin and Xiaohui Liu these authors are equally contribution to the manuscript.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Mazini L, Rochette L, Amine M, Malka G. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs). Int J Mol Sci. 2019;20(10):2523.
</cite> [<a href="https://doi.org/10.3390/ijms20102523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6566837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31121953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mazini%20L,%20Rochette%20L,%20Amine%20M,%20Malka%20G.%20Regenerative%20capacity%20of%20adipose%20derived%20stem%20cells%20(ADSCs),%20comparison%20with%20mesenchymal%20stem%20cells%20(MSCs).%20Int%20J%20Mol%20Sci.%202019;20(10):2523." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213(2):341â€“7.
</cite> [<a href="https://doi.org/10.1002/jcp.21200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17620285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caplan%20AI.%20Adult%20mesenchymal%20stem%20cells%20for%20tissue%20engineering%20versus%20regenerative%20medicine.%20J%20Cell%20Physiol.%202007;213(2):341%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986â€“8001.
</cite> [<a href="https://doi.org/10.3390/ijms140917986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3794764/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24005862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20HJ,%20Bae%20YK,%20Kim%20M,%20Kwon%20SJ,%20Jeon%20HB,%20Choi%20SJ,%20et%20al.%20Comparative%20analysis%20of%20human%20mesenchymal%20stem%20cells%20from%20bone%20marrow,%20adipose%20tissue,%20and%20umbilical%20cord%20blood%20as%20sources%20of%20cell%20therapy.%20Int%20J%20Mol%20Sci.%202013;14(9):17986%E2%80%938001." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>VallÃ©e M, CÃ´tÃ© JF, Fradette J. Adipose-tissue engineering: taking advantage of the properties of human adipose-derived stem/stromal cells. Pathol Biol (Paris). 2009;57(4):309â€“17.
</cite> [<a href="https://doi.org/10.1016/j.patbio.2008.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18534784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vall%C3%A9e%20M,%20C%C3%B4t%C3%A9%20JF,%20Fradette%20J.%20Adipose-tissue%20engineering:%20taking%20advantage%20of%20the%20properties%20of%20human%20adipose-derived%20stem/stromal%20cells.%20Pathol%20Biol%20(Paris).%202009;57(4):309%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Shi YY, Nacamuli RP, Salim A, Longaker MT. The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg. 2005;116(6):1686â€“96.
</cite> [<a href="https://doi.org/10.1097/01.prs.0000185606.03222.a9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16267433/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20YY,%20Nacamuli%20RP,%20Salim%20A,%20Longaker%20MT.%20The%20osteogenic%20potential%20of%20adipose-derived%20mesenchymal%20cells%20is%20maintained%20with%20aging.%20Plast%20Reconstr%20Surg.%202005;116(6):1686%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Zhao Q, Ren H, Han Z. Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases. J Cell Immunotherapy. 2016;2(1):3â€“20.</cite> [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Q,%20Ren%20H,%20Han%20Z.%20Mesenchymal%20stem%20cells:%20Immunomodulatory%20capability%20and%20clinical%20potential%20in%20immune%20diseases.%20J%20Cell%20Immunotherapy.%202016;2(1):3%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Dong L, Li X, Leng W, Guo Z, Cai T, Ji X, et al. Adipose stem cells in tissue regeneration and repair: from bench to bedside. Regen Ther. 2023;24:547â€“60.
</cite> [<a href="https://doi.org/10.1016/j.reth.2023.09.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10579872/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37854632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20L,%20Li%20X,%20Leng%20W,%20Guo%20Z,%20Cai%20T,%20Ji%20X,%20et%20al.%20Adipose%20stem%20cells%20in%20tissue%20regeneration%20and%20repair:%20from%20bench%20to%20bedside.%20Regen%20Ther.%202023;24:547%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Cao Y, Yan J, Dong Z, Wang J, Jiang X, Cui T, et al. Adipose-derived mesenchymal stem cells are ideal for the Cell-based treatment of refractory wounds: strong potential for angiogenesis. Stem Cell Reviews Rep. 2024;20(1):313â€“28.</cite> [<a href="https://doi.org/10.1007/s12015-023-10641-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37874529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao%20Y,%20Yan%20J,%20Dong%20Z,%20Wang%20J,%20Jiang%20X,%20Cui%20T,%20et%20al.%20Adipose-derived%20mesenchymal%20stem%20cells%20are%20ideal%20for%20the%20Cell-based%20treatment%20of%20refractory%20wounds:%20strong%20potential%20for%20angiogenesis.%20Stem%20Cell%20Reviews%20Rep.%202024;20(1):313%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Al-Ghadban S, Bunnell BA. Adipose Tissue-Derived stem cells: Immunomodulatory effects and therapeutic potential. Physiol (Bethesda). 2020;35(2):125â€“33.</cite> [<a href="https://doi.org/10.1152/physiol.00021.2019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32027561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Al-Ghadban%20S,%20Bunnell%20BA.%20Adipose%20Tissue-Derived%20stem%20cells:%20Immunomodulatory%20effects%20and%20therapeutic%20potential.%20Physiol%20(Bethesda).%202020;35(2):125%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Skrypnyk M. Current progress and limitations of research regarding the therapeutic use of adipose-derived stem cells: literature review. J Umm Al-Qura Univ Appl Sci. 2024:1â€“13.</cite>
</li>
<li id="CR11">
<span class="label">11.</span><cite>Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279â€“95.
</cite> [<a href="https://doi.org/10.1091/mbc.E02-02-0105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC138633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12475952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zuk%20PA,%20Zhu%20M,%20Ashjian%20P,%20De%20Ugarte%20DA,%20Huang%20JI,%20Mizuno%20H,%20et%20al.%20Human%20adipose%20tissue%20is%20a%20source%20of%20multipotent%20stem%20cells.%20Mol%20Biol%20Cell.%202002;13(12):4279%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett. 2003;89(2â€“3):267â€“70.
</cite> [<a href="https://doi.org/10.1016/s0165-2478(03)00108-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14556988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Ugarte%20DA,%20Alfonso%20Z,%20Zuk%20PA,%20Elbarbary%20A,%20Zhu%20M,%20Ashjian%20P,%20et%20al.%20Differential%20expression%20of%20stem%20cell%20mobilization-associated%20molecules%20on%20multi-lineage%20cells%20from%20adipose%20tissue%20and%20bone%20marrow.%20Immunol%20Lett.%202003;89(2%E2%80%933):267%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Lu C, Amin MA, Fox DA. CD13/Aminopeptidase N is a potential therapeutic target for inflammatory disorders. J Immunol. 2020;204(1):3â€“11.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1900868" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6997018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31848300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20C,%20Amin%20MA,%20Fox%20DA.%20CD13/Aminopeptidase%20N%20is%20a%20potential%20therapeutic%20target%20for%20inflammatory%20disorders.%20J%20Immunol.%202020;204(1):3%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Margadant C, Monsuur HN, Norman JC, Sonnenberg A. Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol. 2011;23(5):607â€“14.
</cite> [<a href="https://doi.org/10.1016/j.ceb.2011.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21924601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Margadant%20C,%20Monsuur%20HN,%20Norman%20JC,%20Sonnenberg%20A.%20Mechanisms%20of%20integrin%20activation%20and%20trafficking.%20Curr%20Opin%20Cell%20Biol.%202011;23(5):607%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87(1):1â€“13.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8547630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Krause%20DS,%20Fackler%20MJ,%20Civin%20CI,%20May%20WS.%20CD34:%20structure,%20biology,%20and%20clinical%20utility.%20Blood.%201996;87(1):1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Kronenwett R, Martin S, Haas R. The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells. Stem Cells. 2000;18(5):320â€“30.
</cite> [<a href="https://doi.org/10.1634/stemcells.18-5-320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11007916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kronenwett%20R,%20Martin%20S,%20Haas%20R.%20The%20role%20of%20cytokines%20and%20adhesion%20molecules%20for%20mobilization%20of%20peripheral%20blood%20stem%20cells.%20Stem%20Cells.%202000;18(5):320%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med. 1991;173(3):599â€“607.
</cite> [<a href="https://doi.org/10.1084/jem.173.3.599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2118814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1997648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miyake%20K,%20Weissman%20IL,%20Greenberger%20JS,%20Kincade%20PW.%20Evidence%20for%20a%20role%20of%20the%20integrin%20VLA-4%20in%20lympho-hemopoiesis.%20J%20Exp%20Med.%201991;173(3):599%E2%80%93607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Maio M, Del Vecchio L. Expression and functional role of CD54/Intercellular adhesion Molecule-1 (ICAM-1) on human blood cells. Leuk Lymphoma. 1992;8(1â€“2):23â€“33.
</cite> [<a href="https://doi.org/10.3109/10428199209049814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1362919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maio%20M,%20Del%20Vecchio%20L.%20Expression%20and%20functional%20role%20of%20CD54/Intercellular%20adhesion%20Molecule-1%20(ICAM-1)%20on%20human%20blood%20cells.%20Leuk%20Lymphoma.%201992;8(1%E2%80%932):23%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Zhang Y, Liu Q, Yang S, Liao Q. CD58 immunobiology at a glance. Front Immunol. 2021;12:705260.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.705260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8218816/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34168659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Liu%20Q,%20Yang%20S,%20Liao%20Q.%20CD58%20immunobiology%20at%20a%20glance.%20Front%20Immunol.%202021;12:705260." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Aljohani AH, Al-Mousa H, Arnaout R, Al-Dhekri H, Mohammed R, Alsum Z, et al. Clinical and immunological characterization of combined immunodeficiency due to TFRC mutation in eight patients. J Clin Immunol. 2020;40(8):1103â€“10.
</cite> [<a href="https://doi.org/10.1007/s10875-020-00851-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7449781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32851577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aljohani%20AH,%20Al-Mousa%20H,%20Arnaout%20R,%20Al-Dhekri%20H,%20Mohammed%20R,%20Alsum%20Z,%20et%20al.%20Clinical%20and%20immunological%20characterization%20of%20combined%20immunodeficiency%20due%20to%20TFRC%20mutation%20in%20eight%20patients.%20J%20Clin%20Immunol.%202020;40(8):1103%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Saalbach A, Anderegg U. Thy-1: more than a marker for mesenchymal stromal cells. Faseb J. 2019;33(6):6689â€“96.
</cite> [<a href="https://doi.org/10.1096/fj.201802224R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30811954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saalbach%20A,%20Anderegg%20U.%20Thy-1:%20more%20than%20a%20marker%20for%20mesenchymal%20stromal%20cells.%20Faseb%20J.%202019;33(6):6689%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739â€“49.
</cite> [<a href="https://doi.org/10.1634/stemcells.2007-0197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17656645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chamberlain%20G,%20Fox%20J,%20Ashton%20B,%20Middleton%20J.%20Concise%20review:%20mesenchymal%20stem%20cells:%20their%20phenotype,%20differentiation%20capacity,%20immunological%20features,%20and%20potential%20for%20homing.%20Stem%20Cells.%202007;25(11):2739%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Sans M, PanÃ©s J, Ardite E, Elizalde JI, Arce Y, Elena M, et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology. 1999;116(4):874â€“83.
</cite> [<a href="https://doi.org/10.1016/s0016-5085(99)70070-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10092309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sans%20M,%20Pan%C3%A9s%20J,%20Ardite%20E,%20Elizalde%20JI,%20Arce%20Y,%20Elena%20M,%20et%20al.%20VCAM-1%20and%20ICAM-1%20mediate%20leukocyte-endothelial%20cell%20adhesion%20in%20rat%20experimental%20colitis.%20Gastroenterology.%201999;116(4):874%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun. 2001;289(2):519â€“24.
</cite> [<a href="https://doi.org/10.1006/bbrc.2001.6013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11716504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barry%20F,%20Boynton%20R,%20Murphy%20M,%20Haynesworth%20S,%20Zaia%20J.%20The%20SH-3%20and%20SH-4%20antibodies%20recognize%20distinct%20epitopes%20on%20CD73%20from%20human%20mesenchymal%20stem%20cells.%20Biochem%20Biophys%20Res%20Commun.%202001;289(2):519%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991;78(1):55â€“62.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2070060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Simmons%20PJ,%20Torok-Storb%20B.%20Identification%20of%20stromal%20cell%20precursors%20in%20human%20bone%20marrow%20by%20a%20novel%20monoclonal%20antibody,%20STRO-1.%20Blood.%201991;78(1):55%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Miana VV, GonzÃ¡lez EAP. Adipose tissue stem cells in regenerative medicine. Ecancermedicalscience. 2018;12:822.
</cite> [<a href="https://doi.org/10.3332/ecancer.2018.822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5880231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29662535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miana%20VV,%20Gonz%C3%A1lez%20EAP.%20Adipose%20tissue%20stem%20cells%20in%20regenerative%20medicine.%20Ecancermedicalscience.%202018;12:822." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211â€“28.
</cite> [<a href="https://doi.org/10.1089/107632701300062859" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11304456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zuk%20PA,%20Zhu%20M,%20Mizuno%20H,%20Huang%20J,%20Futrell%20JW,%20Katz%20AJ,%20et%20al.%20Multilineage%20cells%20from%20human%20adipose%20tissue:%20implications%20for%20cell-based%20therapies.%20Tissue%20Eng.%202001;7(2):211%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Feisst V, Meidinger S, Locke MB. From bench to bedside: use of human adipose-derived stem cells. Stem Cells Cloning. 2015;8:149â€“62.
</cite> [<a href="https://doi.org/10.2147/SCCAA.S64373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4636091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26586955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feisst%20V,%20Meidinger%20S,%20Locke%20MB.%20From%20bench%20to%20bedside:%20use%20of%20human%20adipose-derived%20stem%20cells.%20Stem%20Cells%20Cloning.%202015;8:149%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Tsekouras A, Mantas D, Tsilimigras DI, Moris D, Kontos M, Zografos GC. Comparison of the viability and yield of Adipose-Derived stem cells (ASCs) from different donor areas. Vivo. 2017;31(6):1229â€“34.</cite> [<a href="https://doi.org/10.21873/invivo.11196" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5756658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29102952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsekouras%20A,%20Mantas%20D,%20Tsilimigras%20DI,%20Moris%20D,%20Kontos%20M,%20Zografos%20GC.%20Comparison%20of%20the%20viability%20and%20yield%20of%20Adipose-Derived%20stem%20cells%20(ASCs)%20from%20different%20donor%20areas.%20Vivo.%202017;31(6):1229%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Raposio E, Simonacci F, Perrotta RE. Adipose-derived stem cells: comparison between two methods of isolation for clinical applications. Ann Med Surg (Lond). 2017;20:87â€“91.
</cite> [<a href="https://doi.org/10.1016/j.amsu.2017.07.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5508488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28736612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raposio%20E,%20Simonacci%20F,%20Perrotta%20RE.%20Adipose-derived%20stem%20cells:%20comparison%20between%20two%20methods%20of%20isolation%20for%20clinical%20applications.%20Ann%20Med%20Surg%20(Lond).%202017;20:87%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Tragoonlugkana P, Chitchongyingcharoen N, Pruksapong C, Hassan S, Ngamkham K, Kamprom W, et al. The use of human platelet lysate as a coating substance for Adipose-Derived stem cell expansion. FBL. 2024;29(2):88.
</cite> [<a href="https://doi.org/10.31083/j.fbl2902088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38420820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tragoonlugkana%20P,%20Chitchongyingcharoen%20N,%20Pruksapong%20C,%20Hassan%20S,%20Ngamkham%20K,%20Kamprom%20W,%20et%20al.%20The%20use%20of%20human%20platelet%20lysate%20as%20a%20coating%20substance%20for%20Adipose-Derived%20stem%20cell%20expansion.%20FBL.%202024;29(2):88." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Li C, Wei S, Xu Q, Sun Y, Ning X, Wang Z. Application of ADSCs and their exosomes in Scar prevention. Stem Cell Rev Rep. 2022;18(3):952â€“67.
</cite> [<a href="https://doi.org/10.1007/s12015-021-10252-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8942892/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34510359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20C,%20Wei%20S,%20Xu%20Q,%20Sun%20Y,%20Ning%20X,%20Wang%20Z.%20Application%20of%20ADSCs%20and%20their%20exosomes%20in%20Scar%20prevention.%20Stem%20Cell%20Rev%20Rep.%202022;18(3):952%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Hou HW, Xue P, Wang Y, Li YK. Liraglutide regulates proliferation, differentiation, and apoptosis of preosteoblasts through a signaling network of notch/wnt/hedgehog signaling pathways. Eur Rev Med Pharmacol Sci. 2020;24(23):12408â€“22.
</cite> [<a href="https://doi.org/10.26355/eurrev_202012_24037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33336762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hou%20HW,%20Xue%20P,%20Wang%20Y,%20Li%20YK.%20Liraglutide%20regulates%20proliferation,%20differentiation,%20and%20apoptosis%20of%20preosteoblasts%20through%20a%20signaling%20network%20of%20notch/wnt/hedgehog%20signaling%20pathways.%20Eur%20Rev%20Med%20Pharmacol%20Sci.%202020;24(23):12408%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Tsang EJ, Wu B, Zuk P. MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res. 2018;59(2):129â€“46.
</cite> [<a href="https://doi.org/10.1080/03008207.2017.1313248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6200338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28398098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsang%20EJ,%20Wu%20B,%20Zuk%20P.%20MAPK%20signaling%20has%20stage-dependent%20osteogenic%20effects%20on%20human%20adipose-derived%20stem%20cells%20in%20vitro.%20Connect%20Tissue%20Res.%202018;59(2):129%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Alverdy AK, Pakvasa M, Zhao C, Mostafa S, Liu W, Luo W, et al. Imiquimod acts synergistically with BMP9 through the Notch pathway as an osteoinductive agent in vitro. Plast Reconstr Surg. 2019;144(5):1094â€“103.
</cite> [<a href="https://doi.org/10.1097/PRS.0000000000006159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31385892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alverdy%20AK,%20Pakvasa%20M,%20Zhao%20C,%20Mostafa%20S,%20Liu%20W,%20Luo%20W,%20et%20al.%20Imiquimod%20acts%20synergistically%20with%20BMP9%20through%20the%20Notch%20pathway%20as%20an%20osteoinductive%20agent%20in%20vitro.%20Plast%20Reconstr%20Surg.%202019;144(5):1094%E2%80%93103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Hutchings G, Janowicz K, Moncrieff L, Dompe C, Strauss E, Kocherova I, et al. The proliferation and differentiation of Adipose-Derived stem cells in neovascularization and angiogenesis. Int J Mol Sci. 2020;21(11):3790.
</cite> [<a href="https://doi.org/10.3390/ijms21113790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7312564/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32471255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hutchings%20G,%20Janowicz%20K,%20Moncrieff%20L,%20Dompe%20C,%20Strauss%20E,%20Kocherova%20I,%20et%20al.%20The%20proliferation%20and%20differentiation%20of%20Adipose-Derived%20stem%20cells%20in%20neovascularization%20and%20angiogenesis.%20Int%20J%20Mol%20Sci.%202020;21(11):3790." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Lu GM, Rong YX, Liang ZJ, Hunag DL, Wu FX, Ma YF, et al. FGF2-induced PI3K/Akt signaling evokes greater proliferation and adipogenic differentiation of human adipose stem cells from breast than from abdomen or thigh. Aging. 2020;12(14):14830â€“48.
</cite> [<a href="https://doi.org/10.18632/aging.103547" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7425436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32706337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20GM,%20Rong%20YX,%20Liang%20ZJ,%20Hunag%20DL,%20Wu%20FX,%20Ma%20YF,%20et%20al.%20FGF2-induced%20PI3K/Akt%20signaling%20evokes%20greater%20proliferation%20and%20adipogenic%20differentiation%20of%20human%20adipose%20stem%20cells%20from%20breast%20than%20from%20abdomen%20or%20thigh.%20Aging.%202020;12(14):14830%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Liu X, Li Z, Liu H, Zhu Y, Xia D, Wang S, et al. Flufenamic acid inhibits adipogenic differentiation of mesenchymal stem cells by antagonizing the PI3K/AKT signaling pathway. Stem Cells Int. 2020;2020(1):1540905.
</cite> [<a href="https://doi.org/10.1155/2020/1540905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7102471/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32256607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Li%20Z,%20Liu%20H,%20Zhu%20Y,%20Xia%20D,%20Wang%20S,%20et%20al.%20Flufenamic%20acid%20inhibits%20adipogenic%20differentiation%20of%20mesenchymal%20stem%20cells%20by%20antagonizing%20the%20PI3K/AKT%20signaling%20pathway.%20Stem%20Cells%20Int.%202020;2020(1):1540905." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Chijimatsu R, Saito T. Mechanisms of synovial joint and articular cartilage development. Cell Mol Life Sci. 2019;76(20):3939â€“52.
</cite> [<a href="https://doi.org/10.1007/s00018-019-03191-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11105481/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31201464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chijimatsu%20R,%20Saito%20T.%20Mechanisms%20of%20synovial%20joint%20and%20articular%20cartilage%20development.%20Cell%20Mol%20Life%20Sci.%202019;76(20):3939%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Zhao L, Yang G, Zhao X. Rho-associated protein kinases play an important role in the differentiation of rat adipose-derived stromal cells into cardiomyocytes in vitro. PLoS ONE. 2014;9(12):e115191.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0115191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4270751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25522345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20L,%20Yang%20G,%20Zhao%20X.%20Rho-associated%20protein%20kinases%20play%20an%20important%20role%20in%20the%20differentiation%20of%20rat%20adipose-derived%20stromal%20cells%20into%20cardiomyocytes%20in%20vitro.%20PLoS%20ONE.%202014;9(12):e115191." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Fan LJ, Xiao QR, Lin KS, Wang SY, Li ZF, Li CZ, et al. [Comparison of endothelial differentiation capacity of adipose-derived stem cells and bone marrow mesenchymal stem cells from rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2016;36(9):1247â€“54.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27687659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan%20LJ,%20Xiao%20QR,%20Lin%20KS,%20Wang%20SY,%20Li%20ZF,%20Li%20CZ,%20et%20al.%20%5BComparison%20of%20endothelial%20differentiation%20capacity%20of%20adipose-derived%20stem%20cells%20and%20bone%20marrow%20mesenchymal%20stem%20cells%20from%20rats%5D.%20Nan%20Fang%20Yi%20Ke%20Da%20Xue%20Xue%20Bao.%202016;36(9):1247%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Hirashima M. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int. 2009;84(3):95â€“101.
</cite> [<a href="https://doi.org/10.1007/s12565-009-0026-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19259767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hirashima%20M.%20Regulation%20of%20endothelial%20cell%20differentiation%20and%20arterial%20specification%20by%20VEGF%20and%20Notch%20signaling.%20Anat%20Sci%20Int.%202009;84(3):95%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Inestrosa NC, Varela-Nallar L. Wnt signalling in neuronal differentiation and development. Cell Tissue Res. 2015;359(1):215â€“23.
</cite> [<a href="https://doi.org/10.1007/s00441-014-1996-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25234280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Inestrosa%20NC,%20Varela-Nallar%20L.%20Wnt%20signalling%20in%20neuronal%20differentiation%20and%20development.%20Cell%20Tissue%20Res.%202015;359(1):215%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Li C, Xie Z, Xing Z, Zhu H, Zhou W, Xie S, et al. The Notch signaling pathway regulates differentiation of NG2 cells into oligodendrocytes in demyelinating diseases. Cell Mol Neurobiol. 2022;42(7):1â€“11.
</cite> [<a href="https://doi.org/10.1007/s10571-021-01089-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11421596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33826017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20C,%20Xie%20Z,%20Xing%20Z,%20Zhu%20H,%20Zhou%20W,%20Xie%20S,%20et%20al.%20The%20Notch%20signaling%20pathway%20regulates%20differentiation%20of%20NG2%20cells%20into%20oligodendrocytes%20in%20demyelinating%20diseases.%20Cell%20Mol%20Neurobiol.%202022;42(7):1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Shi Y, He G, Lee WC, McKenzie JA, Silva MJ, Long F. Gli1 identifies osteogenic progenitors for bone formation and fracture repair. Nat Commun. 2017;8(1):2043.
</cite> [<a href="https://doi.org/10.1038/s41467-017-02171-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5725597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29230039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20Y,%20He%20G,%20Lee%20WC,%20McKenzie%20JA,%20Silva%20MJ,%20Long%20F.%20Gli1%20identifies%20osteogenic%20progenitors%20for%20bone%20formation%20and%20fracture%20repair.%20Nat%20Commun.%202017;8(1):2043." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Houschyar KS, Tapking C, Borrelli MR, Popp D, Duscher D, Maan ZN, et al. Wnt pathway in bone repair and Regeneration - What do we know so Far. Front Cell Dev Biol. 2018;6:170.
</cite> [<a href="https://doi.org/10.3389/fcell.2018.00170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6330281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30666305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Houschyar%20KS,%20Tapking%20C,%20Borrelli%20MR,%20Popp%20D,%20Duscher%20D,%20Maan%20ZN,%20et%20al.%20Wnt%20pathway%20in%20bone%20repair%20and%20Regeneration%20-%20What%20do%20we%20know%20so%20Far.%20Front%20Cell%20Dev%20Biol.%202018;6:170." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Li D, Sun J, Zhong TP. Wnt signaling in heart development and regeneration. Curr Cardiol Rep. 2022;24(10):1425â€“38.
</cite> [<a href="https://doi.org/10.1007/s11886-022-01756-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35925512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20D,%20Sun%20J,%20Zhong%20TP.%20Wnt%20signaling%20in%20heart%20development%20and%20regeneration.%20Curr%20Cardiol%20Rep.%202022;24(10):1425%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Goumans MJ, Ten Dijke P. TGF-Î² signaling in control of cardiovascular function. Cold Spring Harb Perspect Biol. 2018;10(2):a022210.
</cite> [<a href="https://doi.org/10.1101/cshperspect.a022210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5793760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28348036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goumans%20MJ,%20Ten%20Dijke%20P.%20TGF-%CE%B2%20signaling%20in%20control%20of%20cardiovascular%20function.%20Cold%20Spring%20Harb%20Perspect%20Biol.%202018;10(2):a022210." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Waldner M, Zhang W, James IB, Allbright K, Havis E, Bliley JM, et al. Characteristics and Immunomodulating functions of Adipose-Derived and bone Marrow-Derived mesenchymal stem cells across defined human leukocyte antigen barriers. Front Immunol. 2018;9:1642.
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.01642" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6066508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30087676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Waldner%20M,%20Zhang%20W,%20James%20IB,%20Allbright%20K,%20Havis%20E,%20Bliley%20JM,%20et%20al.%20Characteristics%20and%20Immunomodulating%20functions%20of%20Adipose-Derived%20and%20bone%20Marrow-Derived%20mesenchymal%20stem%20cells%20across%20defined%20human%20leukocyte%20antigen%20barriers.%20Front%20Immunol.%202018;9:1642." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652â€“64.
</cite> [<a href="https://doi.org/10.1056/NEJMra2002697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33382932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chang%20JT.%20Pathophysiology%20of%20inflammatory%20bowel%20diseases.%20N%20Engl%20J%20Med.%202020;383(27):2652%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Bassler K, Schulte-Schrepping J, Warnat-Herresthal S, Aschenbrenner AC, Schultze JL. The myeloid cell Compartment-Cell by cell. Annu Rev Immunol. 2019;37:269â€“93.
</cite> [<a href="https://doi.org/10.1146/annurev-immunol-042718-041728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30649988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bassler%20K,%20Schulte-Schrepping%20J,%20Warnat-Herresthal%20S,%20Aschenbrenner%20AC,%20Schultze%20JL.%20The%20myeloid%20cell%20Compartment-Cell%20by%20cell.%20Annu%20Rev%20Immunol.%202019;37:269%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Saez A, Herrero-Fernandez B, Gomez-Bris R, SÃ¡nchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023;24(2):1526.
</cite> [<a href="https://doi.org/10.3390/ijms24021526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9863490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36675038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saez%20A,%20Herrero-Fernandez%20B,%20Gomez-Bris%20R,%20S%C3%A1nchez-Martinez%20H,%20Gonzalez-Granado%20JM.%20Pathophysiology%20of%20inflammatory%20bowel%20disease:%20innate%20immune%20system.%20Int%20J%20Mol%20Sci.%202023;24(2):1526." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13(1):3â€“10.
</cite> [<a href="https://doi.org/10.1016/j.autrev.2013.06.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23774107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geremia%20A,%20Biancheri%20P,%20Allan%20P,%20Corazza%20GR,%20Di%20Sabatino%20A.%20Innate%20and%20adaptive%20immunity%20in%20inflammatory%20bowel%20disease.%20Autoimmun%20Rev.%202014;13(1):3%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8(9):967â€“74.
</cite> [<a href="https://doi.org/10.1038/ni1488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17581537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20L,%20Ivanov%20II,%20Spolski%20R,%20Min%20R,%20Shenderov%20K,%20Egawa%20T,%20et%20al.%20IL-6%20programs%20T(H)-17%20cell%20differentiation%20by%20promoting%20sequential%20engagement%20of%20the%20IL-21%20and%20IL-23%20pathways.%20Nat%20Immunol.%202007;8(9):967%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Hirahara K, Aoki A, Nakayama T. Pathogenic helper T cells. Allergol Int. 2021;70(2):169â€“73.
</cite> [<a href="https://doi.org/10.1016/j.alit.2021.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33637414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hirahara%20K,%20Aoki%20A,%20Nakayama%20T.%20Pathogenic%20helper%20T%20cells.%20Allergol%20Int.%202021;70(2):169%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Oâ€™Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med. 2004;10(8):801â€“5.
</cite> [<a href="https://doi.org/10.1038/nm0804-801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15286781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?O%E2%80%99Garra%20A,%20Vieira%20P.%20Regulatory%20T%20cells%20and%20mechanisms%20of%20immune%20system%20control.%20Nat%20Med.%202004;10(8):801%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE. TNF downmodulates the function of human CD4â€‰+â€‰CD25hi T-regulatory cells. Blood. 2006;108(1):253â€“61.
</cite> [<a href="https://doi.org/10.1182/blood-2005-11-4567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1895836/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16537805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Valencia%20X,%20Stephens%20G,%20Goldbach-Mansky%20R,%20Wilson%20M,%20Shevach%20EM,%20Lipsky%20PE.%20TNF%20downmodulates%20the%20function%20of%20human%20CD4%E2%80%89+%E2%80%89CD25hi%20T-regulatory%20cells.%20Blood.%202006;108(1):253%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Gorelik L, Fields PE, Flavell RA. Cutting edge: TGF-beta inhibits Th type 2 development through Inhibition of GATA-3 expression. J Immunol. 2000;165(9):4773â€“7.
</cite> [<a href="https://doi.org/10.4049/jimmunol.165.9.4773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11045997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gorelik%20L,%20Fields%20PE,%20Flavell%20RA.%20Cutting%20edge:%20TGF-beta%20inhibits%20Th%20type%202%20development%20through%20Inhibition%20of%20GATA-3%20expression.%20J%20Immunol.%202000;165(9):4773%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Singh B, Read S, Asseman C, MalmstrÃ¶m V, Mottet C, Stephens LA, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001;182(1):190â€“200.
</cite> [<a href="https://doi.org/10.1034/j.1600-065x.2001.1820115.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11722634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh%20B,%20Read%20S,%20Asseman%20C,%20Malmstr%C3%B6m%20V,%20Mottet%20C,%20Stephens%20LA,%20et%20al.%20Control%20of%20intestinal%20inflammation%20by%20regulatory%20T%20cells.%20Immunol%20Rev.%202001;182(1):190%E2%80%93200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Li Z, Arijs I, De Hertogh G, Vermeire S, Noman M, Bullens D, et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to Infliximab. Inflamm Bowel Dis. 2010;16(8):1299â€“310.
</cite> [<a href="https://doi.org/10.1002/ibd.21229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20196149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Z,%20Arijs%20I,%20De%20Hertogh%20G,%20Vermeire%20S,%20Noman%20M,%20Bullens%20D,%20et%20al.%20Reciprocal%20changes%20of%20Foxp3%20expression%20in%20blood%20and%20intestinal%20mucosa%20in%20IBD%20patients%20responding%20to%20Infliximab.%20Inflamm%20Bowel%20Dis.%202010;16(8):1299%E2%80%93310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. Mesenchymal stem cells: mechanisms of Immunomodulation and homing. Cell Transpl. 2010;19(6):667â€“79.</cite> [<a href="https://doi.org/10.3727/096368910X508762" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2957533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20525442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yagi%20H,%20Soto-Gutierrez%20A,%20Parekkadan%20B,%20Kitagawa%20Y,%20Tompkins%20RG,%20Kobayashi%20N,%20et%20al.%20Mesenchymal%20stem%20cells:%20mechanisms%20of%20Immunomodulation%20and%20homing.%20Cell%20Transpl.%202010;19(6):667%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4â€‰+â€‰CD25highFOXP3â€‰+â€‰regulatory T cells. Stem Cells. 2008;26(1):212â€“22.
</cite> [<a href="https://doi.org/10.1634/stemcells.2007-0554" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17932417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Selmani%20Z,%20Naji%20A,%20Zidi%20I,%20Favier%20B,%20Gaiffe%20E,%20Obert%20L,%20et%20al.%20Human%20leukocyte%20antigen-G5%20secretion%20by%20human%20mesenchymal%20stem%20cells%20is%20required%20to%20suppress%20T%20lymphocyte%20and%20natural%20killer%20function%20and%20to%20induce%20CD4%E2%80%89+%E2%80%89CD25highFOXP3%E2%80%89+%E2%80%89regulatory%20T%20cells.%20Stem%20Cells.%202008;26(1):212%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Clarke TB, Weiser JN. Intracellular sensors of extracellular bacteria. Immunol Rev. 2011;243:9â€“25.
</cite> [<a href="https://doi.org/10.1111/j.1600-065X.2011.01039.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21884164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clarke%20TB,%20Weiser%20JN.%20Intracellular%20sensors%20of%20extracellular%20bacteria.%20Immunol%20Rev.%202011;243:9%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783â€“801.
</cite> [<a href="https://doi.org/10.1016/j.cell.2006.02.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16497588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akira%20S,%20Uematsu%20S,%20Takeuchi%20O.%20Pathogen%20recognition%20and%20innate%20immunity.%20Cell.%202006;124(4):783%E2%80%93801." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Drury B, Hardisty G, Gray RD, Ho GT. Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cell Mol Gastroenterol Hepatol. 2021;12(1):321â€“33.
</cite> [<a href="https://doi.org/10.1016/j.jcmgh.2021.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8166923/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33689803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drury%20B,%20Hardisty%20G,%20Gray%20RD,%20Ho%20GT.%20Neutrophil%20extracellular%20traps%20in%20inflammatory%20bowel%20disease:%20pathogenic%20mechanisms%20and%20clinical%20translation.%20Cell%20Mol%20Gastroenterol%20Hepatol.%202021;12(1):321%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23(3):279â€“87.
</cite> [<a href="https://doi.org/10.1038/nm.4294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28267716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jorch%20SK,%20Kubes%20P.%20An%20emerging%20role%20for%20neutrophil%20extracellular%20traps%20in%20noninfectious%20disease.%20Nat%20Med.%202017;23(3):279%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Pakshir P, Hinz B. The big five in fibrosis: macrophages, myofibroblasts, matrix, mechanics, and miscommunication. Matrix Biol. 2018;68â€“69:81â€“93.</cite> [<a href="https://doi.org/10.1016/j.matbio.2018.01.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29408013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pakshir%20P,%20Hinz%20B.%20The%20big%20five%20in%20fibrosis:%20macrophages,%20myofibroblasts,%20matrix,%20mechanics,%20and%20miscommunication.%20Matrix%20Biol.%202018;68%E2%80%9369:81%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Bernshtein B, Curato C, Ioannou M, Thaiss CA, Gross-Vered M, Kolesnikov M, et al. IL-23-producing IL-10RÎ±-deficient gut macrophages elicit an IL-22-driven Proinflammatory epithelial cell response. Sci Immunol. 2019;4(36):eaau6571.
</cite> [<a href="https://doi.org/10.1126/sciimmunol.aau6571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6697185/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31201258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bernshtein%20B,%20Curato%20C,%20Ioannou%20M,%20Thaiss%20CA,%20Gross-Vered%20M,%20Kolesnikov%20M,%20et%20al.%20IL-23-producing%20IL-10R%CE%B1-deficient%20gut%20macrophages%20elicit%20an%20IL-22-driven%20Proinflammatory%20epithelial%20cell%20response.%20Sci%20Immunol.%202019;4(36):eaau6571." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Giuffrida P, Corazza GR, Di Sabatino A. Old and new lymphocyte players in inflammatory bowel disease. Dig Dis Sci. 2018;63(2):277â€“88.
</cite> [<a href="https://doi.org/10.1007/s10620-017-4892-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29275447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giuffrida%20P,%20Corazza%20GR,%20Di%20Sabatino%20A.%20Old%20and%20new%20lymphocyte%20players%20in%20inflammatory%20bowel%20disease.%20Dig%20Dis%20Sci.%202018;63(2):277%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Guo Y, Liu Y, Rui B, Lei Z, Ning X, Liu Y, et al. Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity. Front Immunol. 2023;14:1171680.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1171680" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10249960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37304260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20Y,%20Liu%20Y,%20Rui%20B,%20Lei%20Z,%20Ning%20X,%20Liu%20Y,%20et%20al.%20Crosstalk%20between%20the%20gut%20microbiota%20and%20innate%20lymphoid%20cells%20in%20intestinal%20mucosal%20immunity.%20Front%20Immunol.%202023;14:1171680." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Hu X, Zhou Y, Dong K, Sun Z, Zhao D, Wang W, et al. Programming of the development of Tumor-Promoting neutrophils by mesenchymal stromal cells. Cell Physiol Biochem. 2014;33(6):1802â€“14.
</cite> [<a href="https://doi.org/10.1159/000362959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24923759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20X,%20Zhou%20Y,%20Dong%20K,%20Sun%20Z,%20Zhao%20D,%20Wang%20W,%20et%20al.%20Programming%20of%20the%20development%20of%20Tumor-Promoting%20neutrophils%20by%20mesenchymal%20stromal%20cells.%20Cell%20Physiol%20Biochem.%202014;33(6):1802%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Vasandan AB, Jahnavi S, Shashank C, Prasad P, Kumar A, Prasanna SJ. Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE(2)-dependent mechanism. Sci Rep. 2016;6:38308.
</cite> [<a href="https://doi.org/10.1038/srep38308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5133610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27910911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vasandan%20AB,%20Jahnavi%20S,%20Shashank%20C,%20Prasad%20P,%20Kumar%20A,%20Prasanna%20SJ.%20Human%20mesenchymal%20stem%20cells%20program%20macrophage%20plasticity%20by%20altering%20their%20metabolic%20status%20via%20a%20PGE(2)-dependent%20mechanism.%20Sci%20Rep.%202016;6:38308." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Liu Y, Yin Z, Zhang R, Yan K, Chen L, Chen F, et al. MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6. Biochem Biophys Res Commun. 2014;450(4):1409â€“15.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2014.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25014173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Yin%20Z,%20Zhang%20R,%20Yan%20K,%20Chen%20L,%20Chen%20F,%20et%20al.%20MSCs%20inhibit%20bone%20marrow-derived%20DC%20maturation%20and%20function%20through%20the%20release%20of%20TSG-6.%20Biochem%20Biophys%20Res%20Commun.%202014;450(4):1409%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Fan Y, Herr F, Vernochet A, Mennesson B, Oberlin E, Durrbach A. Human fetal liver mesenchymal stem cell-Derived exosomes impair natural killer cell function. Stem Cells Dev. 2018;28(1):44â€“55.</cite> [<a href="https://doi.org/10.1089/scd.2018.0015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30328799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan%20Y,%20Herr%20F,%20Vernochet%20A,%20Mennesson%20B,%20Oberlin%20E,%20Durrbach%20A.%20Human%20fetal%20liver%20mesenchymal%20stem%20cell-Derived%20exosomes%20impair%20natural%20killer%20cell%20function.%20Stem%20Cells%20Dev.%202018;28(1):44%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Taams LS. Inflammation and immune resolution. Clin Exp Immunol. 2018;193(1):1â€“2.
</cite> [<a href="https://doi.org/10.1111/cei.13155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6037995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29987840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taams%20LS.%20Inflammation%20and%20immune%20resolution.%20Clin%20Exp%20Immunol.%202018;193(1):1%E2%80%932." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>GrÃ©goire C, Lechanteur C, Briquet A, Baudoux Ã‰, Baron F, Louis E, et al. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;45(2):205â€“21.
</cite> [<a href="https://doi.org/10.1111/apt.13864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27878827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gr%C3%A9goire%20C,%20Lechanteur%20C,%20Briquet%20A,%20Baudoux%20%C3%89,%20Baron%20F,%20Louis%20E,%20et%20al.%20Review%20article:%20mesenchymal%20stromal%20cell%20therapy%20for%20inflammatory%20bowel%20diseases.%20Aliment%20Pharmacol%20Ther.%202017;45(2):205%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Anderson P, Souza-Moreira L, Morell M, Caro M, Oâ€™Valle F, Gonzalez-Rey E, et al. Adipose-derived mesenchymal stromal cells induce Immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 2013;62(8):1131â€“41.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2012-302152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22637701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Anderson%20P,%20Souza-Moreira%20L,%20Morell%20M,%20Caro%20M,%20O%E2%80%99Valle%20F,%20Gonzalez-Rey%20E,%20et%20al.%20Adipose-derived%20mesenchymal%20stromal%20cells%20induce%20Immunomodulatory%20macrophages%20which%20protect%20from%20experimental%20colitis%20and%20sepsis.%20Gut.%202013;62(8):1131%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204â€“18.
</cite> [<a href="https://doi.org/10.18632/oncotarget.23208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5805548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29467962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20L,%20Deng%20H,%20Cui%20H,%20Fang%20J,%20Zuo%20Z,%20Deng%20J,%20et%20al.%20Inflammatory%20responses%20and%20inflammation-associated%20diseases%20in%20organs.%20Oncotarget.%202018;9(6):7204%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Margraf A, Lowell CA, Zarbock A. Neutrophils in acute inflammation: current concepts and translational implications. Blood. 2022;139(14):2130â€“44.
</cite> [<a href="https://doi.org/10.1182/blood.2021012295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9728535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34624098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Margraf%20A,%20Lowell%20CA,%20Zarbock%20A.%20Neutrophils%20in%20acute%20inflammation:%20current%20concepts%20and%20translational%20implications.%20Blood.%202022;139(14):2130%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532â€“5.
</cite> [<a href="https://doi.org/10.1126/science.1092385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15001782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brinkmann%20V,%20Reichard%20U,%20Goosmann%20C,%20Fauler%20B,%20Uhlemann%20Y,%20Weiss%20DS,%20et%20al.%20Neutrophil%20extracellular%20traps%20kill%20bacteria.%20Science.%202004;303(5663):1532%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Bennike TB, Carlsen TG, Ellingsen T, Bonderup OK, Glerup H, BÃ¸gsted M, et al. Neutrophil extracellular traps in ulcerative colitis: A proteome analysis of intestinal biopsies. Inflamm Bowel Dis. 2015;21(9):2052â€“67.
</cite> [<a href="https://doi.org/10.1097/MIB.0000000000000460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4603666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25993694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bennike%20TB,%20Carlsen%20TG,%20Ellingsen%20T,%20Bonderup%20OK,%20Glerup%20H,%20B%C3%B8gsted%20M,%20et%20al.%20Neutrophil%20extracellular%20traps%20in%20ulcerative%20colitis:%20A%20proteome%20analysis%20of%20intestinal%20biopsies.%20Inflamm%20Bowel%20Dis.%202015;21(9):2052%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Angelidou I, Chrysanthopoulou A, Mitsios A, Arelaki S, Arampatzioglou A, Kambas K, et al. REDD1/Autophagy pathway is associated with Neutrophil-Driven IL-1Î² inflammatory response in active ulcerative colitis. J Immunol. 2018;200(12):3950â€“61.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1701643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29712770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Angelidou%20I,%20Chrysanthopoulou%20A,%20Mitsios%20A,%20Arelaki%20S,%20Arampatzioglou%20A,%20Kambas%20K,%20et%20al.%20REDD1/Autophagy%20pathway%20is%20associated%20with%20Neutrophil-Driven%20IL-1%CE%B2%20inflammatory%20response%20in%20active%20ulcerative%20colitis.%20J%20Immunol.%202018;200(12):3950%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Ribon M, Seninet S, Mussard J, Sebbag M, Clavel C, Serre G, et al. Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37. J Autoimmun. 2019;98:122â€“31.
</cite> [<a href="https://doi.org/10.1016/j.jaut.2019.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30704942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ribon%20M,%20Seninet%20S,%20Mussard%20J,%20Sebbag%20M,%20Clavel%20C,%20Serre%20G,%20et%20al.%20Neutrophil%20extracellular%20traps%20exert%20both%20pro-%20and%20anti-inflammatory%20actions%20in%20rheumatoid%20arthritis%20that%20are%20modulated%20by%20C1q%20and%20LL-37.%20J%20Autoimmun.%202019;98:122%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Schauer C, Janko C, Munoz LE, Zhao Y, KienhÃ¶fer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511â€“7.
</cite> [<a href="https://doi.org/10.1038/nm.3547" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24784231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schauer%20C,%20Janko%20C,%20Munoz%20LE,%20Zhao%20Y,%20Kienh%C3%B6fer%20D,%20Frey%20B,%20et%20al.%20Aggregated%20neutrophil%20extracellular%20traps%20limit%20inflammation%20by%20degrading%20cytokines%20and%20chemokines.%20Nat%20Med.%202014;20(5):511%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Shang Q, Chu Y, Li Y, Han Y, Yu D, Liu R, et al. Adipose-derived mesenchymal stromal cells promote corneal wound healing by accelerating the clearance of neutrophils in cornea. Cell Death Dis. 2020;11(8):707.
</cite> [<a href="https://doi.org/10.1038/s41419-020-02914-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7450061/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32848141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shang%20Q,%20Chu%20Y,%20Li%20Y,%20Han%20Y,%20Yu%20D,%20Liu%20R,%20et%20al.%20Adipose-derived%20mesenchymal%20stromal%20cells%20promote%20corneal%20wound%20healing%20by%20accelerating%20the%20clearance%20of%20neutrophils%20in%20cornea.%20Cell%20Death%20Dis.%202020;11(8):707." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Yu H, Zhang B, Zhan Y, Yi Y, Jiang Q, Zhang Q, et al. Neutrophil extracellular trap-related mechanisms in acne vulgaris inspire a novel treatment strategy with adipose-derived stem cells. Sci Rep. 2024;14(1):1521.
</cite> [<a href="https://doi.org/10.1038/s41598-024-51931-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10794178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38233540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20H,%20Zhang%20B,%20Zhan%20Y,%20Yi%20Y,%20Jiang%20Q,%20Zhang%20Q,%20et%20al.%20Neutrophil%20extracellular%20trap-related%20mechanisms%20in%20acne%20vulgaris%20inspire%20a%20novel%20treatment%20strategy%20with%20adipose-derived%20stem%20cells.%20Sci%20Rep.%202024;14(1):1521." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ. 2014;21(2):216â€“25.
</cite> [<a href="https://doi.org/10.1038/cdd.2013.158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3890955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24185619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20S,%20Xie%20N,%20Li%20W,%20Yuan%20B,%20Shi%20Y,%20Wang%20Y.%20Immunobiology%20of%20mesenchymal%20stem%20cells.%20Cell%20Death%20Differ.%202014;21(2):216%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493â€“507.
</cite> [<a href="https://doi.org/10.1038/s41581-018-0023-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29895977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20Y,%20Wang%20Y,%20Li%20Q,%20Liu%20K,%20Hou%20J,%20Shao%20C,%20et%20al.%20Immunoregulatory%20mechanisms%20of%20mesenchymal%20stem%20and%20stromal%20cells%20in%20inflammatory%20diseases.%20Nat%20Rev%20Nephrol.%202018;14(8):493%E2%80%93507." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003;100(14):8407â€“11.
</cite> [<a href="https://doi.org/10.1073/pnas.1432929100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC166242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12815096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ortiz%20LA,%20Gambelli%20F,%20McBride%20C,%20Gaupp%20D,%20Baddoo%20M,%20Kaminski%20N,%20et%20al.%20Mesenchymal%20stem%20cell%20engraftment%20in%20lung%20is%20enhanced%20in%20response%20to%20bleomycin%20exposure%20and%20ameliorates%20its%20fibrotic%20effects.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202003;100(14):8407%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Tanaka F, Tominaga K, Ochi M, Tanigawa T, Watanabe T, Fujiwara Y, et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 2008;83(23):771â€“79.
</cite> [<a href="https://doi.org/10.1016/j.lfs.2008.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18950645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tanaka%20F,%20Tominaga%20K,%20Ochi%20M,%20Tanigawa%20T,%20Watanabe%20T,%20Fujiwara%20Y,%20et%20al.%20Exogenous%20administration%20of%20mesenchymal%20stem%20cells%20ameliorates%20dextran%20sulfate%20sodium-induced%20colitis%20via%20anti-inflammatory%20action%20in%20damaged%20tissue%20in%20rats.%20Life%20Sci.%202008;83(23):771%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15(10):730â€“38.
</cite> [<a href="https://doi.org/10.1038/gt.2008.39" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18401438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spaeth%20E,%20Klopp%20A,%20Dembinski%20J,%20Andreeff%20M,%20Marini%20F.%20Inflammation%20and%20tumor%20microenvironments:%20defining%20the%20migratory%20itinerary%20of%20mesenchymal%20stem%20cells.%20Gene%20Ther.%202008;15(10):730%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Zhang Q, Piao C, Xu J, Wang Y, Liu T, Ma H, et al. ADSCs-exo attenuates hepatic ischemia-reperfusion injury after hepatectomy by inhibiting Endoplasmic reticulum stress and inflammation. J Cell Physiol. 2023;238(3):659â€“69.
</cite> [<a href="https://doi.org/10.1002/jcp.30968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36780378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Q,%20Piao%20C,%20Xu%20J,%20Wang%20Y,%20Liu%20T,%20Ma%20H,%20et%20al.%20ADSCs-exo%20attenuates%20hepatic%20ischemia-reperfusion%20injury%20after%20hepatectomy%20by%20inhibiting%20Endoplasmic%20reticulum%20stress%20and%20inflammation.%20J%20Cell%20Physiol.%202023;238(3):659%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Jiang W, Zhang J, Zhang X, Fan C, Huang J. VAP-PLGA microspheres (VAP-PLGA) promote adipose-derived stem cells (ADSCs)-induced wound healing in chronic skin ulcers in mice via PI3K/Akt/HIF-1Î± pathway. Bioengineered. 2021;12(2):10264â€“84.
</cite> [<a href="https://doi.org/10.1080/21655979.2021.1990193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8810082/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34720043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20W,%20Zhang%20J,%20Zhang%20X,%20Fan%20C,%20Huang%20J.%20VAP-PLGA%20microspheres%20(VAP-PLGA)%20promote%20adipose-derived%20stem%20cells%20(ADSCs)-induced%20wound%20healing%20in%20chronic%20skin%20ulcers%20in%20mice%20via%20PI3K/Akt/HIF-1%CE%B1%20pathway.%20Bioengineered.%202021;12(2):10264%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Papadopoulos N, Lennartsson J. The PDGF/PDGFR pathway as a drug target. Mol Aspects Med. 2018;62:75â€“88.
</cite> [<a href="https://doi.org/10.1016/j.mam.2017.11.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29137923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Papadopoulos%20N,%20Lennartsson%20J.%20The%20PDGF/PDGFR%20pathway%20as%20a%20drug%20target.%20Mol%20Aspects%20Med.%202018;62:75%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Komiyama S, Sakakura C, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, et al. Adipose-derived stem cells enhance tissue regeneration of gastrotomy closure. J Surg Res. 2013;185(2):945â€“52.
</cite> [<a href="https://doi.org/10.1016/j.jss.2013.05.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24095024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Komiyama%20S,%20Sakakura%20C,%20Murayama%20Y,%20Komatsu%20S,%20Shiozaki%20A,%20Kuriu%20Y,%20et%20al.%20Adipose-derived%20stem%20cells%20enhance%20tissue%20regeneration%20of%20gastrotomy%20closure.%20J%20Surg%20Res.%202013;185(2):945%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Ando Y, Inaba M, Sakaguchi Y, Tsuda M, Quan GK, Omae M, et al. Subcutaneous adipose tissueâ€“derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)â€“induced colitis in rats. Inflamm Bowel Dis. 2008;14(6):826â€“38.
</cite> [<a href="https://doi.org/10.1002/ibd.20382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18253953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ando%20Y,%20Inaba%20M,%20Sakaguchi%20Y,%20Tsuda%20M,%20Quan%20GK,%20Omae%20M,%20et%20al.%20Subcutaneous%20adipose%20tissue%E2%80%93derived%20stem%20cells%20facilitate%20colonic%20mucosal%20recovery%20from%202,4,6-trinitrobenzene%20sulfonic%20acid%20(TNBS)%E2%80%93induced%20colitis%20in%20rats.%20Inflamm%20Bowel%20Dis.%202008;14(6):826%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292â€“8.
</cite> [<a href="https://doi.org/10.1161/01.CIR.0000121425.42966.F1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14993122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rehman%20J,%20Traktuev%20D,%20Li%20J,%20Merfeld-Clauss%20S,%20Temm-Grove%20CJ,%20Bovenkerk%20JE,%20et%20al.%20Secretion%20of%20angiogenic%20and%20antiapoptotic%20factors%20by%20human%20adipose%20stromal%20cells.%20Circulation.%202004;109(10):1292%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med. 1997;156(6):1937â€“44.
</cite> [<a href="https://doi.org/10.1164/ajrccm.156.6.9611057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9412578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yaekashiwa%20M,%20Nakayama%20S,%20Ohnuma%20K,%20Sakai%20T,%20Abe%20T,%20Satoh%20K,%20et%20al.%20Simultaneous%20or%20delayed%20administration%20of%20hepatocyte%20growth%20factor%20equally%20represses%20the%20fibrotic%20changes%20in%20murine%20lung%20injury%20induced%20by%20bleomycin.%20A%20morphologic%20study.%20Am%20J%20Respir%20Crit%20Care%20Med.%201997;156(6):1937%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Yamanaka S. Pluripotent stem cell-Based cell Therapy-Promise and challenges. Cell Stem Cell. 2020;27(4):523â€“31.
</cite> [<a href="https://doi.org/10.1016/j.stem.2020.09.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33007237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamanaka%20S.%20Pluripotent%20stem%20cell-Based%20cell%20Therapy-Promise%20and%20challenges.%20Cell%20Stem%20Cell.%202020;27(4):523%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Hu L, Liu Y, Wang S. Stem cell-based tooth and periodontal regeneration. Oral Dis. 2018;24(5):696â€“705.
</cite> [<a href="https://doi.org/10.1111/odi.12703" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28636235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20L,%20Liu%20Y,%20Wang%20S.%20Stem%20cell-based%20tooth%20and%20periodontal%20regeneration.%20Oral%20Dis.%202018;24(5):696%E2%80%93705." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155â€“65.
</cite> [<a href="https://doi.org/10.1016/j.mayocp.2018.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6386158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30611442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ramos%20GP,%20Papadakis%20KA.%20Mechanisms%20of%20disease:%20inflammatory%20bowel%20diseases.%20Mayo%20Clin%20Proc.%202019;94(1):155%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>OrdÃ¡s I, Eckmann L, Talamini M, Baumgart DC. Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606â€“19.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(12)60150-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22914296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ord%C3%A1s%20I,%20Eckmann%20L,%20Talamini%20M,%20Baumgart%20DC.%20Sandborn%20WJ.%20Ulcerative%20colitis.%20Lancet.%202012;380(9853):1606%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Pelaseyed T, BergstrÃ¶m JH, Gustafsson JK, Ermund A, Birchenough GM, SchÃ¼tte A, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the Gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260(1):8â€“20.
</cite> [<a href="https://doi.org/10.1111/imr.12182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4281373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24942678/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pelaseyed%20T,%20Bergstr%C3%B6m%20JH,%20Gustafsson%20JK,%20Ermund%20A,%20Birchenough%20GM,%20Sch%C3%BCtte%20A,%20et%20al.%20The%20mucus%20and%20mucins%20of%20the%20goblet%20cells%20and%20enterocytes%20provide%20the%20first%20defense%20line%20of%20the%20Gastrointestinal%20tract%20and%20interact%20with%20the%20immune%20system.%20Immunol%20Rev.%202014;260(1):8%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Guo M, Wang X. Pathological mechanism and targeted drugs of ulcerative colitis: A review. Med (Baltim). 2023;102(37):e35020.</cite> [<a href="https://doi.org/10.1097/MD.0000000000035020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10508406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37713856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20M,%20Wang%20X.%20Pathological%20mechanism%20and%20targeted%20drugs%20of%20ulcerative%20colitis:%20A%20review.%20Med%20(Baltim).%202023;102(37):e35020." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Liu NN, Zhao N, Cai N. The effect and mechanism of celecoxib in hypoxia-induced survivin up-regulation in HUVECs. Cell Physiol Biochem. 2015;37(3):991â€“1001.
</cite> [<a href="https://doi.org/10.1159/000430225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26393789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20NN,%20Zhao%20N,%20Cai%20N.%20The%20effect%20and%20mechanism%20of%20celecoxib%20in%20hypoxia-induced%20survivin%20up-regulation%20in%20HUVECs.%20Cell%20Physiol%20Biochem.%202015;37(3):991%E2%80%931001." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohnâ€™s disease. Nat Rev Dis Primers. 2020;6(1):22.
</cite> [<a href="https://doi.org/10.1038/s41572-020-0156-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32242028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roda%20G,%20Chien%20Ng%20S,%20Kotze%20PG,%20Argollo%20M,%20Panaccione%20R,%20Spinelli%20A,%20et%20al.%20Crohn%E2%80%99s%20disease.%20Nat%20Rev%20Dis%20Primers.%202020;6(1):22." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohnâ€™s disease. Lancet. 2017;389(10080):1741â€“55.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)31711-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27914655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Torres%20J,%20Mehandru%20S,%20Colombel%20J-F,%20Peyrin-Biroulet%20L.%20Crohn%E2%80%99s%20disease.%20Lancet.%202017;389(10080):1741%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Zeissig S, BÃ¼rgel N, GÃ¼nzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of Claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active crohnâ€™s disease. Gut. 2007;56(1):61â€“72.
</cite> [<a href="https://doi.org/10.1136/gut.2006.094375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1856677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16822808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zeissig%20S,%20B%C3%BCrgel%20N,%20G%C3%BCnzel%20D,%20Richter%20J,%20Mankertz%20J,%20Wahnschaffe%20U,%20et%20al.%20Changes%20in%20expression%20and%20distribution%20of%20Claudin%202,%205%20and%208%20lead%20to%20discontinuous%20tight%20junctions%20and%20barrier%20dysfunction%20in%20active%20crohn%E2%80%99s%20disease.%20Gut.%202007;56(1):61%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134(5):743â€“56.
</cite> [<a href="https://doi.org/10.1016/j.cell.2008.07.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2586148/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18775308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaser%20A,%20Lee%20AH,%20Franke%20A,%20Glickman%20JN,%20Zeissig%20S,%20Tilg%20H,%20et%20al.%20XBP1%20links%20ER%20stress%20to%20intestinal%20inflammation%20and%20confers%20genetic%20risk%20for%20human%20inflammatory%20bowel%20disease.%20Cell.%202008;134(5):743%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Hosomi S, Grootjans J, Tschurtschenthaler M, Krupka N, Matute JD, Flak MB, et al. Intestinal epithelial cell Endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation. J Exp Med. 2017;214(10):2985â€“97.
</cite> [<a href="https://doi.org/10.1084/jem.20162041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5626394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28747426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hosomi%20S,%20Grootjans%20J,%20Tschurtschenthaler%20M,%20Krupka%20N,%20Matute%20JD,%20Flak%20MB,%20et%20al.%20Intestinal%20epithelial%20cell%20Endoplasmic%20reticulum%20stress%20promotes%20MULT1%20up-regulation%20and%20NKG2D-mediated%20inflammation.%20J%20Exp%20Med.%202017;214(10):2985%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Willson TA, Jurickova I, Collins M, Denson LA. Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice. Inflamm Bowel Dis. 2013;19(3):512â€“25.
</cite> [<a href="https://doi.org/10.1097/MIB.0b013e31828028ad" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4330009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23429443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Willson%20TA,%20Jurickova%20I,%20Collins%20M,%20Denson%20LA.%20Deletion%20of%20intestinal%20epithelial%20cell%20STAT3%20promotes%20T-lymphocyte%20STAT3%20activation%20and%20chronic%20colitis%20following%20acute%20dextran%20sodium%20sulfate%20injury%20in%20mice.%20Inflamm%20Bowel%20Dis.%202013;19(3):512%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005;129(1):50â€“65.
</cite> [<a href="https://doi.org/10.1053/j.gastro.2005.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16012934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hart%20AL,%20Al-Hassi%20HO,%20Rigby%20RJ,%20Bell%20SJ,%20Emmanuel%20AV,%20Knight%20SC,%20et%20al.%20Characteristics%20of%20intestinal%20dendritic%20cells%20in%20inflammatory%20bowel%20diseases.%20Gastroenterology.%202005;129(1):50%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Regner EH, Ohri N, Stahly A, Gerich ME, Fennimore BP, Ir D, et al. Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota. Arthritis Res Ther. 2018;20(1):149.
</cite> [<a href="https://doi.org/10.1186/s13075-018-1639-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6053728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30029674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Regner%20EH,%20Ohri%20N,%20Stahly%20A,%20Gerich%20ME,%20Fennimore%20BP,%20Ir%20D,%20et%20al.%20Functional%20intraepithelial%20lymphocyte%20changes%20in%20inflammatory%20bowel%20disease%20and%20spondyloarthritis%20have%20disease%20specific%20correlations%20with%20intestinal%20microbiota.%20Arthritis%20Res%20Ther.%202018;20(1):149." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Zhang R, Zhang Q, Chen Y, Zhao Q, Zhang B, Wang L, et al. Combined treatment with Rg1 and adipose-derived stem cells alleviates DSS-induced colitis in a mouse model. Stem Cell Res Ther. 2022;13(1):272.
</cite> [<a href="https://doi.org/10.1186/s13287-022-02940-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9210677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35729638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20R,%20Zhang%20Q,%20Chen%20Y,%20Zhao%20Q,%20Zhang%20B,%20Wang%20L,%20et%20al.%20Combined%20treatment%20with%20Rg1%20and%20adipose-derived%20stem%20cells%20alleviates%20DSS-induced%20colitis%20in%20a%20mouse%20model.%20Stem%20Cell%20Res%20Ther.%202022;13(1):272." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Wu X, Mu Y, Yao J, Lin F, Wu D, Ma Z. Adipose-Derived stem cells from patients with ulcerative colitis exhibit impaired immunosuppressive function. Front Cell Dev Biol. 2022;10:822772.
</cite> [<a href="https://doi.org/10.3389/fcell.2022.822772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8894714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35252190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20X,%20Mu%20Y,%20Yao%20J,%20Lin%20F,%20Wu%20D,%20Ma%20Z.%20Adipose-Derived%20stem%20cells%20from%20patients%20with%20ulcerative%20colitis%20exhibit%20impaired%20immunosuppressive%20function.%20Front%20Cell%20Dev%20Biol.%202022;10:822772." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>GarcÃ­a-Olmo D, GarcÃ­a-Arranz M, GarcÃ­a LG, Cuellar ES, Blanco IF, Prianes LA, et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal crohnâ€™s disease: a new cell-based therapy. Int J Colorectal Dis. 2003;18(5):451â€“54.
</cite> [<a href="https://doi.org/10.1007/s00384-003-0490-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12756590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garc%C3%ADa-Olmo%20D,%20Garc%C3%ADa-Arranz%20M,%20Garc%C3%ADa%20LG,%20Cuellar%20ES,%20Blanco%20IF,%20Prianes%20LA,%20et%20al.%20Autologous%20stem%20cell%20transplantation%20for%20treatment%20of%20rectovaginal%20fistula%20in%20perianal%20crohn%E2%80%99s%20disease:%20a%20new%20cell-based%20therapy.%20Int%20J%20Colorectal%20Dis.%202003;18(5):451%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Buscail E, Le Cosquer G, Gross F, Lebrin M, Bugarel L, Deraison C, et al. Adipose-Derived stem cells in the treatment of perianal fistulas in crohnâ€™s disease: rationale, clinical results and perspectives. Int J Mol Sci. 2021;22(18):9967.
</cite> [<a href="https://doi.org/10.3390/ijms22189967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8470328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34576129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Buscail%20E,%20Le%20Cosquer%20G,%20Gross%20F,%20Lebrin%20M,%20Bugarel%20L,%20Deraison%20C,%20et%20al.%20Adipose-Derived%20stem%20cells%20in%20the%20treatment%20of%20perianal%20fistulas%20in%20crohn%E2%80%99s%20disease:%20rationale,%20clinical%20results%20and%20perspectives.%20Int%20J%20Mol%20Sci.%202021;22(18):9967." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Dige A, Hougaard HT, Agnholt J, Pedersen BG, Tencerova M, Kassem M, et al. Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with crohnâ€™s disease. Gastroenterology. 2019;156(8):2208â€“e161.
</cite> [<a href="https://doi.org/10.1053/j.gastro.2019.02.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30772343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dige%20A,%20Hougaard%20HT,%20Agnholt%20J,%20Pedersen%20BG,%20Tencerova%20M,%20Kassem%20M,%20et%20al.%20Efficacy%20of%20injection%20of%20freshly%20collected%20autologous%20adipose%20tissue%20into%20perianal%20fistulas%20in%20patients%20with%20crohn%E2%80%99s%20disease.%20Gastroenterology.%202019;156(8):2208%E2%80%93e161." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Liao HX, Mao X, Wang L, Wang N, Ocansey DKW, Wang B, et al. The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination. Front Immunol. 2024;15:1423069.
</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1423069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11341407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39185411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liao%20HX,%20Mao%20X,%20Wang%20L,%20Wang%20N,%20Ocansey%20DKW,%20Wang%20B,%20et%20al.%20The%20role%20of%20mesenchymal%20stem%20cells%20in%20attenuating%20inflammatory%20bowel%20disease%20through%20ubiquitination.%20Front%20Immunol.%202024;15:1423069." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Qiao Y, Tang X, Liu Z, Ocansey DKW, Zhou M, Shang A, et al. Therapeutic prospects of mesenchymal stem cell and their derived exosomes in the regulation of the gut microbiota in inflammatory bowel disease. Pharmaceuticals (Basel). 2024;17(5):607.
</cite> [<a href="https://doi.org/10.3390/ph17050607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11124012/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38794176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiao%20Y,%20Tang%20X,%20Liu%20Z,%20Ocansey%20DKW,%20Zhou%20M,%20Shang%20A,%20et%20al.%20Therapeutic%20prospects%20of%20mesenchymal%20stem%20cell%20and%20their%20derived%20exosomes%20in%20the%20regulation%20of%20the%20gut%20microbiota%20in%20inflammatory%20bowel%20disease.%20Pharmaceuticals%20(Basel).%202024;17(5):607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Ren J, Kong W, Lu F, Li Y. Adipose-derived stem cells (ADSCs) inhibit the expression of anti-apoptosis proteins through up-regulation of ATF4 on breast cancer cells. Ann Transl Med. 2021;9(16):1300.
</cite> [<a href="https://doi.org/10.21037/atm-21-3746" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8422111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34532437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ren%20J,%20Kong%20W,%20Lu%20F,%20Li%20Y.%20Adipose-derived%20stem%20cells%20(ADSCs)%20inhibit%20the%20expression%20of%20anti-apoptosis%20proteins%20through%20up-regulation%20of%20ATF4%20on%20breast%20cancer%20cells.%20Ann%20Transl%20Med.%202021;9(16):1300." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Suzuki H, Yokoi A, Uno K, Yoshida K, Kitagawa M, Asano-Inami E, et al. Small extracellular vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of MicroRNAs in ovarian cancer. Biochem Biophys Res Commun. 2023;680:211â€“19.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2023.09.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37782986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suzuki%20H,%20Yokoi%20A,%20Uno%20K,%20Yoshida%20K,%20Kitagawa%20M,%20Asano-Inami%20E,%20et%20al.%20Small%20extracellular%20vesicles%20from%20adipose-derived%20stem%20cells%20suppress%20cell%20proliferation%20by%20delivering%20the%20let-7%20family%20of%20MicroRNAs%20in%20ovarian%20cancer.%20Biochem%20Biophys%20Res%20Commun.%202023;680:211%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Chan YW, So C, Yau KL, Chiu KC, Wang X, Chan FL, et al. Adipose-derived stem cells and cancer cells fuse to generate cancer stem cell-like cells with increased tumorigenicity. J Cell Physiol. 2020;235(10):6794â€“807.
</cite> [<a href="https://doi.org/10.1002/jcp.29574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31994190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chan%20YW,%20So%20C,%20Yau%20KL,%20Chiu%20KC,%20Wang%20X,%20Chan%20FL,%20et%20al.%20Adipose-derived%20stem%20cells%20and%20cancer%20cells%20fuse%20to%20generate%20cancer%20stem%20cell-like%20cells%20with%20increased%20tumorigenicity.%20J%20Cell%20Physiol.%202020;235(10):6794%E2%80%93807." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Wang YY, Hung AC, Wu YC, Lo S, Chen HD, Chen YK, et al. ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model. Sci Rep. 2022;12(1):15437.
</cite> [<a href="https://doi.org/10.1038/s41598-022-19290-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9475041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36104403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20YY,%20Hung%20AC,%20Wu%20YC,%20Lo%20S,%20Chen%20HD,%20Chen%20YK,%20et%20al.%20ADSCs%20stimulated%20by%20resistin%20promote%20breast%20cancer%20cell%20malignancy%20via%20CXCL5%20in%20a%20breast%20cancer%20coculture%20model.%20Sci%20Rep.%202022;12(1):15437." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Goto H, Shimono Y, Funakoshi Y, Imamura Y, Toyoda M, Kiyota N, et al. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin. Oncogene. 2019;38(6):767â€“79.
</cite> [<a href="https://doi.org/10.1038/s41388-018-0477-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30177835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goto%20H,%20Shimono%20Y,%20Funakoshi%20Y,%20Imamura%20Y,%20Toyoda%20M,%20Kiyota%20N,%20et%20al.%20Adipose-derived%20stem%20cells%20enhance%20human%20breast%20cancer%20growth%20and%20cancer%20stem%20cell-like%20properties%20through%20adipsin.%20Oncogene.%202019;38(6):767%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Zhang W, Torres-Rojas C, Yue J, Zhu BM. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance. Exp Biol Med (Maywood). 2021;246(16):1810â€“15.
</cite> [<a href="https://doi.org/10.1177/15353702211023846" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8381698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34229470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20W,%20Torres-Rojas%20C,%20Yue%20J,%20Zhu%20BM.%20Adipose-derived%20stem%20cells%20in%20ovarian%20cancer%20progression,%20metastasis,%20and%20chemoresistance.%20Exp%20Biol%20Med%20(Maywood).%202021;246(16):1810%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Papait A, Stefani FR, Cargnoni A, Magatti M, Parolini O, Silini AR. The multifaceted roles of MSCs in the tumor microenvironment: interactions with immune cells and exploitation for therapy. Front Cell Dev Biol. 2020;8:447.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.00447" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7317293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32637408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Papait%20A,%20Stefani%20FR,%20Cargnoni%20A,%20Magatti%20M,%20Parolini%20O,%20Silini%20AR.%20The%20multifaceted%20roles%20of%20MSCs%20in%20the%20tumor%20microenvironment:%20interactions%20with%20immune%20cells%20and%20exploitation%20for%20therapy.%20Front%20Cell%20Dev%20Biol.%202020;8:447." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137â€“48.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2004.07.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15308095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dunn%20GP,%20Old%20LJ,%20Schreiber%20RD.%20The%20immunobiology%20of%20cancer%20immunosurveillance%20and%20immunoediting.%20Immunity.%202004;21(2):137%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Yuen GJ, Demissie E, Pillai S. B lymphocytes and cancer: a love-hate relationship. Trends Cancer. 2016;2(12):747â€“57.
</cite> [<a href="https://doi.org/10.1016/j.trecan.2016.10.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5472356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28626801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuen%20GJ,%20Demissie%20E,%20Pillai%20S.%20B%20lymphocytes%20and%20cancer:%20a%20love-hate%20relationship.%20Trends%20Cancer.%202016;2(12):747%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Zhang H, Cao X, Gui R, Li Y, Zhao X, Mei J, et al. Mesenchymal stem/stromal cells in solid tumor microenvironment: orchestrating NK cell remodeling and therapeutic insights. Int Immunopharmacol. 2024;142:113181.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2024.113181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39305890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20H,%20Cao%20X,%20Gui%20R,%20Li%20Y,%20Zhao%20X,%20Mei%20J,%20et%20al.%20Mesenchymal%20stem/stromal%20cells%20in%20solid%20tumor%20microenvironment:%20orchestrating%20NK%20cell%20remodeling%20and%20therapeutic%20insights.%20Int%20Immunopharmacol.%202024;142:113181." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Rivera-Cruz CM, Shearer JJ, Figueiredo Neto M, Figueiredo ML. The Immunomodulatory effects of mesenchymal stem cell polarization within the tumor microenvironment niche. Stem Cells Int. 2017;2017:4015039.
</cite> [<a href="https://doi.org/10.1155/2017/4015039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5664329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29181035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rivera-Cruz%20CM,%20Shearer%20JJ,%20Figueiredo%20Neto%20M,%20Figueiredo%20ML.%20The%20Immunomodulatory%20effects%20of%20mesenchymal%20stem%20cell%20polarization%20within%20the%20tumor%20microenvironment%20niche.%20Stem%20Cells%20Int.%202017;2017:4015039." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>FranÃ§ois S, Usunier B, Forgue-Lafitte ME, Lâ€™Homme B, Benderitter M, Douay L, et al. Mesenchymal stem cell administration attenuates colon cancer progression by modulating the immune component within the colorectal tumor microenvironment. Stem Cells Transl Med. 2019;8(3):285â€“300.
</cite> [<a href="https://doi.org/10.1002/sctm.18-0117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6392393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30451398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fran%C3%A7ois%20S,%20Usunier%20B,%20Forgue-Lafitte%20ME,%20L%E2%80%99Homme%20B,%20Benderitter%20M,%20Douay%20L,%20et%20al.%20Mesenchymal%20stem%20cell%20administration%20attenuates%20colon%20cancer%20progression%20by%20modulating%20the%20immune%20component%20within%20the%20colorectal%20tumor%20microenvironment.%20Stem%20Cells%20Transl%20Med.%202019;8(3):285%E2%80%93300." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Zheng XB, He XW, Zhang LJ, Qin HB, Lin XT, Liu XH, et al. Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice. Gastroenterol Rep (Oxf). 2019;7(2):127â€“38.
</cite> [<a href="https://doi.org/10.1093/gastro/goy017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6454852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30976426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20XB,%20He%20XW,%20Zhang%20LJ,%20Qin%20HB,%20Lin%20XT,%20Liu%20XH,%20et%20al.%20Bone%20marrow-derived%20CXCR4-overexpressing%20MSCs%20display%20increased%20homing%20to%20intestine%20and%20ameliorate%20colitis-associated%20tumorigenesis%20in%20mice.%20Gastroenterol%20Rep%20(Oxf).%202019;7(2):127%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian C, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia. 2009;23(5):925â€“33.
</cite> [<a href="https://doi.org/10.1038/leu.2008.384" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19148141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20Y,%20Sun%20Z,%20Han%20Q,%20Liao%20L,%20Wang%20J,%20Bian%20C,%20et%20al.%20Human%20mesenchymal%20stem%20cells%20inhibit%20cancer%20cell%20proliferation%20by%20secreting%20DKK-1.%20Leukemia.%202009;23(5):925%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Khodayar MJ, Rezaei Tazangi F, Samimi A, Alidadi H. Adipose-Derived mesenchymal stem cells secretome induces apoptosis in colon carcinoma HT-29 cells. Jentashapir J Cell Mol Biol. 2022;13(4):e133934.</cite> [<a href="https://scholar.google.com/scholar_lookup?Khodayar%20MJ,%20Rezaei%20Tazangi%20F,%20Samimi%20A,%20Alidadi%20H.%20Adipose-Derived%20mesenchymal%20stem%20cells%20secretome%20induces%20apoptosis%20in%20colon%20carcinoma%20HT-29%20cells.%20Jentashapir%20J%20Cell%20Mol%20Biol.%202022;13(4):e133934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Wei HJ, Zeng R, Lu JH, Lai WF, Chen WH, Liu HY, et al. Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 production. Oncotarget. 2015;6(10):7713â€“26.
</cite> [<a href="https://doi.org/10.18632/oncotarget.3481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4480711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25797257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20HJ,%20Zeng%20R,%20Lu%20JH,%20Lai%20WF,%20Chen%20WH,%20Liu%20HY,%20et%20al.%20Adipose-derived%20stem%20cells%20promote%20tumor%20initiation%20and%20accelerate%20tumor%20growth%20by%20interleukin-6%20production.%20Oncotarget.%202015;6(10):7713%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Liang Z, Liu H, Zhang Y, Xiong L, Zeng Z, He X, et al. Cyr61 from adipose-derived stem cells promotes colorectal cancer metastasis and vasculogenic mimicry formation via integrin Î±(V) Î²(5). Mol Oncol. 2021;15(12):3447â€“67.
</cite> [<a href="https://doi.org/10.1002/1878-0261.12998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8637569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33999512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20Z,%20Liu%20H,%20Zhang%20Y,%20Xiong%20L,%20Zeng%20Z,%20He%20X,%20et%20al.%20Cyr61%20from%20adipose-derived%20stem%20cells%20promotes%20colorectal%20cancer%20metastasis%20and%20vasculogenic%20mimicry%20formation%20via%20integrin%20%CE%B1(V)%20%CE%B2(5).%20Mol%20Oncol.%202021;15(12):3447%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Zhu C, Teng L, Lai Y, Yao X, Fang Y, Wang Z, et al. Adipose-derived stem cells promote Glycolysis and peritoneal metastasis via TGF-Î²1/SMAD3/ANGPTL4 axis in colorectal cancer. Cell Mol Life Sci. 2024;81(1):189.
</cite> [<a href="https://doi.org/10.1007/s00018-024-05215-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11033247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38643448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20C,%20Teng%20L,%20Lai%20Y,%20Yao%20X,%20Fang%20Y,%20Wang%20Z,%20et%20al.%20Adipose-derived%20stem%20cells%20promote%20Glycolysis%20and%20peritoneal%20metastasis%20via%20TGF-%CE%B21/SMAD3/ANGPTL4%20axis%20in%20colorectal%20cancer.%20Cell%20Mol%20Life%20Sci.%202024;81(1):189." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Jing B, Qian R, Jiang D, Gai Y, Liu Z, Guo F, et al. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery. J Nanobiotechnol. 2021;19(1):151.</cite> [<a href="https://doi.org/10.1186/s12951-021-00888-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8141172/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34022897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jing%20B,%20Qian%20R,%20Jiang%20D,%20Gai%20Y,%20Liu%20Z,%20Guo%20F,%20et%20al.%20Extracellular%20vesicles-based%20pre-targeting%20strategy%20enables%20multi-modal%20imaging%20of%20orthotopic%20colon%20cancer%20and%20image-guided%20surgery.%20J%20Nanobiotechnol.%202021;19(1):151." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Pishavar E, Yazdian-Robati R, Abnous K, Hashemi M, Ebrahimian M, Feizpour R, et al. Aptamer-functionalized mesenchymal stem cells-derived exosomes for targeted delivery of SN38 to colon cancer cells. Iran J Basic Med Sci. 2023;26(4):388â€“94.
</cite> [<a href="https://doi.org/10.22038/IJBMS.2023.68039.14873" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10008394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37009014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pishavar%20E,%20Yazdian-Robati%20R,%20Abnous%20K,%20Hashemi%20M,%20Ebrahimian%20M,%20Feizpour%20R,%20et%20al.%20Aptamer-functionalized%20mesenchymal%20stem%20cells-derived%20exosomes%20for%20targeted%20delivery%20of%20SN38%20to%20colon%20cancer%20cells.%20Iran%20J%20Basic%20Med%20Sci.%202023;26(4):388%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Thandar M, Yang X, Zhu Y, Zhang X, Chen Z, Huang S, et al. Dysbiosis of gut microbiota and metabolites is associated with radiation-induced colorectal fibrosis and is restored by adipose-derived mesenchymal stem cell therapy. Life Sci. 2024;341:122502.
</cite> [<a href="https://doi.org/10.1016/j.lfs.2024.122502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38350495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thandar%20M,%20Yang%20X,%20Zhu%20Y,%20Zhang%20X,%20Chen%20Z,%20Huang%20S,%20et%20al.%20Dysbiosis%20of%20gut%20microbiota%20and%20metabolites%20is%20associated%20with%20radiation-induced%20colorectal%20fibrosis%20and%20is%20restored%20by%20adipose-derived%20mesenchymal%20stem%20cell%20therapy.%20Life%20Sci.%202024;341:122502." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Qin L, Liu N, Bao CL, Yang DZ, Ma GX, Yi WH, et al. Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin. Acta Pharmacol Sin. 2023;44(2):268â€“87.
</cite> [<a href="https://doi.org/10.1038/s41401-022-00952-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9326421/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35896695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin%20L,%20Liu%20N,%20Bao%20CL,%20Yang%20DZ,%20Ma%20GX,%20Yi%20WH,%20et%20al.%20Mesenchymal%20stem%20cells%20in%20fibrotic%20diseases-the%20two%20sides%20of%20the%20same%20coin.%20Acta%20Pharmacol%20Sin.%202023;44(2):268%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Didamoony MA, Soubh AA, Atwa AM, Ahmed LA. Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in Gastrointestinal diseases. Inflammopharmacology. 2023;31(6):2973â€“93.
</cite> [<a href="https://doi.org/10.1007/s10787-023-01350-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10692273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37874430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Didamoony%20MA,%20Soubh%20AA,%20Atwa%20AM,%20Ahmed%20LA.%20Innovative%20preconditioning%20strategies%20for%20improving%20the%20therapeutic%20efficacy%20of%20extracellular%20vesicles%20derived%20from%20mesenchymal%20stem%20cells%20in%20Gastrointestinal%20diseases.%20Inflammopharmacology.%202023;31(6):2973%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Kamada Y, Yoshida Y, Saji Y, Fukushima J, Tamura S, Kiso S, et al. Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice. Am J Physiology-Gastrointestinal Liver Physiol. 2009;296(2):G157â€“67.</cite> [<a href="https://doi.org/10.1152/ajpgi.90463.2008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19056764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kamada%20Y,%20Yoshida%20Y,%20Saji%20Y,%20Fukushima%20J,%20Tamura%20S,%20Kiso%20S,%20et%20al.%20Transplantation%20of%20basic%20fibroblast%20growth%20factor-pretreated%20adipose%20tissue-derived%20stromal%20cells%20enhances%20regression%20of%20liver%20fibrosis%20in%20mice.%20Am%20J%20Physiology-Gastrointestinal%20Liver%20Physiol.%202009;296(2):G157%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Harn H-J, Lin S-Z, Hung S-H, Subeq Y-M, Li Y-S, Syu W-S, et al. Adipose-Derived stem cells can abrogate Chemical-Induced liver fibrosis and facilitate recovery of liver function. Cell Transplant. 2012;21(12):2753â€“64.
</cite> [<a href="https://doi.org/10.3727/096368912X652959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22776464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harn%20H-J,%20Lin%20S-Z,%20Hung%20S-H,%20Subeq%20Y-M,%20Li%20Y-S,%20Syu%20W-S,%20et%20al.%20Adipose-Derived%20stem%20cells%20can%20abrogate%20Chemical-Induced%20liver%20fibrosis%20and%20facilitate%20recovery%20of%20liver%20function.%20Cell%20Transplant.%202012;21(12):2753%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Zhao W, Ren G, Zhang L, Zhang Z, Liu J, Kuang P, et al. Efficacy of mesenchymal stem cells derived from human adipose tissue in inhibition of hepatocellular carcinoma cells in vitro. Cancer Biotherapy Radiopharmaceuticals. 2012;27(9):606â€“13.
</cite> [<a href="https://doi.org/10.1089/cbr.2011.1150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22917212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20W,%20Ren%20G,%20Zhang%20L,%20Zhang%20Z,%20Liu%20J,%20Kuang%20P,%20et%20al.%20Efficacy%20of%20mesenchymal%20stem%20cells%20derived%20from%20human%20adipose%20tissue%20in%20inhibition%20of%20hepatocellular%20carcinoma%20cells%20in%20vitro.%20Cancer%20Biotherapy%20Radiopharmaceuticals.%202012;27(9):606%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Serhal R, Saliba N, Hilal G, Moussa M, Hassan GS, El Atat O, et al. Effect of adipose-derived mesenchymal stem cells on hepatocellular carcinoma: in vitro Inhibition of carcinogenesis. World J Gastroenterol. 2019;25(5):567â€“83.
</cite> [<a href="https://doi.org/10.3748/wjg.v25.i5.567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6371009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30774272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Serhal%20R,%20Saliba%20N,%20Hilal%20G,%20Moussa%20M,%20Hassan%20GS,%20El%20Atat%20O,%20et%20al.%20Effect%20of%20adipose-derived%20mesenchymal%20stem%20cells%20on%20hepatocellular%20carcinoma:%20in%20vitro%20Inhibition%20of%20carcinogenesis.%20World%20J%20Gastroenterol.%202019;25(5):567%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Wu L, Tang Q, Yin X, Yan D, Tang M, Xin J, et al. The therapeutic potential of adipose Tissue-Derived mesenchymal stem cells to enhance radiotherapy effects on hepatocellular carcinoma. Front Cell Dev Biol. 2019;7:267.
</cite> [<a href="https://doi.org/10.3389/fcell.2019.00267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6861425/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31781559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20L,%20Tang%20Q,%20Yin%20X,%20Yan%20D,%20Tang%20M,%20Xin%20J,%20et%20al.%20The%20therapeutic%20potential%20of%20adipose%20Tissue-Derived%20mesenchymal%20stem%20cells%20to%20enhance%20radiotherapy%20effects%20on%20hepatocellular%20carcinoma.%20Front%20Cell%20Dev%20Biol.%202019;7:267." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199â€“210.
</cite> [<a href="https://doi.org/10.1002/path.2277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2693329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18161745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wynn%20T.%20Cellular%20and%20molecular%20mechanisms%20of%20fibrosis.%20J%20Pathol.%202008;214(2):199%E2%80%93210." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>GÃ³mez-Ferrer M, Amaro-Prellezo E, Dorronsoro A, SÃ¡nchez-SÃ¡nchez R, Vicente Ã, CosÃ­n-Roger J, et al. HIF-Overexpression and Pro-Inflammatory priming in human mesenchymal stromal cells improves the healing properties of extracellular vesicles in experimental crohnâ€™s disease. Int J Mol Sci. 2021;22(20):11269.
</cite> [<a href="https://doi.org/10.3390/ijms222011269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8540690/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34681929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?G%C3%B3mez-Ferrer%20M,%20Amaro-Prellezo%20E,%20Dorronsoro%20A,%20S%C3%A1nchez-S%C3%A1nchez%20R,%20Vicente%20%C3%81,%20Cos%C3%ADn-Roger%20J,%20et%20al.%20HIF-Overexpression%20and%20Pro-Inflammatory%20priming%20in%20human%20mesenchymal%20stromal%20cells%20improves%20the%20healing%20properties%20of%20extracellular%20vesicles%20in%20experimental%20crohn%E2%80%99s%20disease.%20Int%20J%20Mol%20Sci.%202021;22(20):11269." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Usunier B, Brossard C, Lâ€™Homme B, Linard C, Benderitter M, Milliat F, et al. HGF and TSG-6 released by mesenchymal stem cells attenuate colon Radiation-Induced fibrosis. Int J Mol Sci. 2021;22(4):1790.
</cite> [<a href="https://doi.org/10.3390/ijms22041790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7916908/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33670243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Usunier%20B,%20Brossard%20C,%20L%E2%80%99Homme%20B,%20Linard%20C,%20Benderitter%20M,%20Milliat%20F,%20et%20al.%20HGF%20and%20TSG-6%20released%20by%20mesenchymal%20stem%20cells%20attenuate%20colon%20Radiation-Induced%20fibrosis.%20Int%20J%20Mol%20Sci.%202021;22(4):1790." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Bessout R, Demarquay C, Moussa L, RenÃ© A, Doix B, Benderitter M, et al. TH17 predominant T-cell responses in radiation-induced bowel disease are modulated by treatment with adipose-derived mesenchymal stromal cells. J Pathol. 2015;237(4):435â€“46.
</cite> [<a href="https://doi.org/10.1002/path.4590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26177977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bessout%20R,%20Demarquay%20C,%20Moussa%20L,%20Ren%C3%A9%20A,%20Doix%20B,%20Benderitter%20M,%20et%20al.%20TH17%20predominant%20T-cell%20responses%20in%20radiation-induced%20bowel%20disease%20are%20modulated%20by%20treatment%20with%20adipose-derived%20mesenchymal%20stromal%20cells.%20J%20Pathol.%202015;237(4):435%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int. 2014;2014:340257.
</cite> [<a href="https://doi.org/10.1155/2014/340257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4123563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25132856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Usunier%20B,%20Benderitter%20M,%20Tamarat%20R,%20Chapel%20A.%20Management%20of%20fibrosis:%20the%20mesenchymal%20stromal%20cells%20breakthrough.%20Stem%20Cells%20Int.%202014;2014:340257." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Zhao J, Zhang Z, Cui Q, Zhao L, Hu Y, Zhao S. Human adipose-derived mesenchymal stem cells inhibit proliferation and induce apoptosis of human gastric cancer HGC-27 cells. 3 Biotech. 2020;10(3):129.
</cite> [<a href="https://doi.org/10.1007/s13205-020-2090-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7035394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32154042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20J,%20Zhang%20Z,%20Cui%20Q,%20Zhao%20L,%20Hu%20Y,%20Zhao%20S.%20Human%20adipose-derived%20mesenchymal%20stem%20cells%20inhibit%20proliferation%20and%20induce%20apoptosis%20of%20human%20gastric%20cancer%20HGC-27%20cells.%203%20Biotech.%202020;10(3):129." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Zhao BC, Zhao B, Han JG, Ma HC, Wang ZJ. Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis. Hepatogastroenterology. 2010;57(104):1382â€“9.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/21443090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20BC,%20Zhao%20B,%20Han%20JG,%20Ma%20HC,%20Wang%20ZJ.%20Adipose-derived%20stem%20cells%20promote%20gastric%20cancer%20cell%20growth,%20migration%20and%20invasion%20through%20SDF-1/CXCR4%20axis.%20Hepatogastroenterology.%202010;57(104):1382%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Chapel A, Francois S, Douay L, Benderitter M, Voswinkel J. New insights for pelvic radiation disease treatment: multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy. World J Stem Cells. 2013;5(4):106â€“11.
</cite> [<a href="https://doi.org/10.4252/wjsc.v5.i4.106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3812515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24179599/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chapel%20A,%20Francois%20S,%20Douay%20L,%20Benderitter%20M,%20Voswinkel%20J.%20New%20insights%20for%20pelvic%20radiation%20disease%20treatment:%20multipotent%20stromal%20cell%20is%20a%20promise%20mainstay%20treatment%20for%20the%20restoration%20of%20abdominopelvic%20severe%20chronic%20damages%20induced%20by%20radiotherapy.%20World%20J%20Stem%20Cells.%202013;5(4):106%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Wei J, Wang B, Wang H, Meng L, Zhao Q, Li X, et al. Radiation-Induced normal tissue damage: oxidative stress and epigenetic mechanisms. Oxid Med Cell Longev. 2019;2019:3010342.
</cite> [<a href="https://doi.org/10.1155/2019/3010342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6875293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31781332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20J,%20Wang%20B,%20Wang%20H,%20Meng%20L,%20Zhao%20Q,%20Li%20X,%20et%20al.%20Radiation-Induced%20normal%20tissue%20damage:%20oxidative%20stress%20and%20epigenetic%20mechanisms.%20Oxid%20Med%20Cell%20Longev.%202019;2019:3010342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Helissey C, Cavallero S, Guitard N, ThÃ©ry H, Chargari C. FranÃ§ois S. Revolutionizing radiotoxicity management with mesenchymal stem cells and their derivatives: A focus on Radiation-Induced cystitis. Int J Mol Sci. 2023;24(10):9068.
</cite> [<a href="https://doi.org/10.3390/ijms24109068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10219063/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37240415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Helissey%20C,%20Cavallero%20S,%20Guitard%20N,%20Th%C3%A9ry%20H,%20Chargari%20C.%20Fran%C3%A7ois%20S.%20Revolutionizing%20radiotoxicity%20management%20with%20mesenchymal%20stem%20cells%20and%20their%20derivatives:%20A%20focus%20on%20Radiation-Induced%20cystitis.%20Int%20J%20Mol%20Sci.%202023;24(10):9068." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Zhang J, Liu Y, Chen Y, Yuan L, Liu H, Wang J, et al. Adipose-Derived stem cells: current applications and future directions in the regeneration of multiple tissues. Stem Cells Int. 2020;2020:8810813.
</cite> [<a href="https://doi.org/10.1155/2020/8810813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7787857/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33488736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Liu%20Y,%20Chen%20Y,%20Yuan%20L,%20Liu%20H,%20Wang%20J,%20et%20al.%20Adipose-Derived%20stem%20cells:%20current%20applications%20and%20future%20directions%20in%20the%20regeneration%20of%20multiple%20tissues.%20Stem%20Cells%20Int.%202020;2020:8810813." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>ÄŒesnik AB,Å vajger U. The issue of heterogeneity of MSC-based advanced therapy medicinal products-a review. Front Cell Dev Biol. 2024;12:1400347.
</cite> [<a href="https://doi.org/10.3389/fcell.2024.1400347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11310176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39129786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?%C4%8Cesnik%20AB,%C5%A0vajger%20U.%20The%20issue%20of%20heterogeneity%20of%20MSC-based%20advanced%20therapy%20medicinal%20products-a%20review.%20Front%20Cell%20Dev%20Biol.%202024;12:1400347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Varghese J, Griffin M, Mosahebi A, Butler P. Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther. 2017;8(1):45.
</cite> [<a href="https://doi.org/10.1186/s13287-017-0483-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5329955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28241882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Varghese%20J,%20Griffin%20M,%20Mosahebi%20A,%20Butler%20P.%20Systematic%20review%20of%20patient%20factors%20affecting%20adipose%20stem%20cell%20viability%20and%20function:%20implications%20for%20regenerative%20therapy.%20Stem%20Cell%20Res%20Ther.%202017;8(1):45." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR162">
<span class="label">162.</span><cite>Kawamura T, Yoshioka D, Kawamura A, Misumi Y, Taguchi T, Mori D, et al. Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial. J Translational Med. 2024;22(1):1091.</cite> [<a href="https://doi.org/10.1186/s12967-024-05816-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11610074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39623426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kawamura%20T,%20Yoshioka%20D,%20Kawamura%20A,%20Misumi%20Y,%20Taguchi%20T,%20Mori%20D,%20et%20al.%20Safety%20and%20therapeutic%20potential%20of%20allogeneic%20adipose-derived%20stem%20cell%20spray%20transplantation%20in%20ischemic%20cardiomyopathy:%20a%20phase%20I%20clinical%20trial.%20J%20Translational%20Med.%202024;22(1):1091." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR163">
<span class="label">163.</span><cite>Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE 2, et al. Vision loss after intravitreal injection of autologous stem cells for AMD. N Engl J Med. 2017;376(11):1047â€“53.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1609583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5551890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28296617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuriyan%20AE,%20Albini%20TA,%20Townsend%20JH,%20Rodriguez%20M,%20Pandya%20HK,%20Leonard%20RE%202,%20et%20al.%20Vision%20loss%20after%20intravitreal%20injection%20of%20autologous%20stem%20cells%20for%20AMD.%20N%20Engl%20J%20Med.%202017;376(11):1047%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR164">
<span class="label">164.</span><cite>Bagher L, Hamidreza A, Parisa G, Fereshteh M-J, Abbas N-J, Ahmad Reza D, et al. Clinical grade human adipose Tissue-Derived mesenchymal stem cell banking. Acta Medica Iranica. 2015;53(9):540â€“46.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/26553081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bagher%20L,%20Hamidreza%20A,%20Parisa%20G,%20Fereshteh%20M-J,%20Abbas%20N-J,%20Ahmad%20Reza%20D,%20et%20al.%20Clinical%20grade%20human%20adipose%20Tissue-Derived%20mesenchymal%20stem%20cell%20banking.%20Acta%20Medica%20Iranica.%202015;53(9):540%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR165">
<span class="label">165.</span><cite>Mazini L, Ezzoubi M, Malka G. Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem Cell Res Ther. 2021;12(1):1.
</cite> [<a href="https://doi.org/10.1186/s13287-020-02006-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7781178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33397467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mazini%20L,%20Ezzoubi%20M,%20Malka%20G.%20Overview%20of%20current%20adipose-derived%20stem%20cell%20(ADSCs)%20processing%20involved%20in%20therapeutic%20advancements:%20flow%20chart%20and%20regulation%20updates%20before%20and%20after%20COVID-19.%20Stem%20Cell%20Res%20Ther.%202021;12(1):1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR166">
<span class="label">166.</span><cite>Shimizu Y, Ntege EH, Takahara E, Matsuura N, Matsuura R, Kamizato K, et al. Adipose-derived stem cell therapy for spinal cord injuries: advances, challenges, and future directions. Regen Ther. 2024;26:508â€“19.
</cite> [<a href="https://doi.org/10.1016/j.reth.2024.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11331855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39161365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shimizu%20Y,%20Ntege%20EH,%20Takahara%20E,%20Matsuura%20N,%20Matsuura%20R,%20Kamizato%20K,%20et%20al.%20Adipose-derived%20stem%20cell%20therapy%20for%20spinal%20cord%20injuries:%20advances,%20challenges,%20and%20future%20directions.%20Regen%20Ther.%202024;26:508%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR167">
<span class="label">167.</span><cite>Malhotra A, Thebaud B, Paton MCB, Fleiss B, Papagianis P, Baker E et al. Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022). Pediatr Res. 2023;94(5):1631-38.</cite> [<a href="https://doi.org/10.1038/s41390-023-02707-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10624618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37380752/" class="usa-link">PubMed</a>]</li>
<li id="CR168">
<span class="label">168.</span><cite>Zhao Y, Zhang H. Update on the mechanisms of homing of adipose tissueâ€“derived stem cells. Cytotherapy. 2016;18(7):816â€“27.
</cite> [<a href="https://doi.org/10.1016/j.jcyt.2016.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27260205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Y,%20Zhang%20H.%20Update%20on%20the%20mechanisms%20of%20homing%20of%20adipose%20tissue%E2%80%93derived%20stem%20cells.%20Cytotherapy.%202016;18(7):816%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR169">
<span class="label">169.</span><cite>Welsh JA, Goberdhan DCI, Oâ€™Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.
</cite> [<a href="https://doi.org/10.1002/jev2.12404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10850029/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38326288/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Welsh%20JA,%20Goberdhan%20DCI,%20O%E2%80%99Driscoll%20L,%20Buzas%20EI,%20Blenkiron%20C,%20Bussolati%20B,%20et%20al.%20Minimal%20information%20for%20studies%20of%20extracellular%20vesicles%20(MISEV2023):%20from%20basic%20to%20advanced%20approaches.%20J%20Extracell%20Vesicles.%202024;13(2):e12404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR170">
<span class="label">170.</span><cite>Yang S, Sun Y, Yan C. Recent advances in the use of extracellular vesicles from adipose-derived stem cells for regenerative medical therapeutics. J Nanobiotechnol. 2024;22(1):316.</cite> [<a href="https://doi.org/10.1186/s12951-024-02603-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11157933/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38844939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20S,%20Sun%20Y,%20Yan%20C.%20Recent%20advances%20in%20the%20use%20of%20extracellular%20vesicles%20from%20adipose-derived%20stem%20cells%20for%20regenerative%20medical%20therapeutics.%20J%20Nanobiotechnol.%202024;22(1):316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR171">
<span class="label">171.</span><cite>Clua-FerrÃ© L, Suau R, VaÃ±Ã³-Segarra I, GinÃ©s I, Serena C, ManyÃ© J. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease. Clin Transl Med. 2024;14(11):e70075.
</cite> [<a href="https://doi.org/10.1002/ctm2.70075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11531661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39488745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clua-Ferr%C3%A9%20L,%20Suau%20R,%20Va%C3%B1%C3%B3-Segarra%20I,%20Gin%C3%A9s%20I,%20Serena%20C,%20Many%C3%A9%20J.%20Therapeutic%20potential%20of%20mesenchymal%20stem%20cell-derived%20extracellular%20vesicles:%20A%20focus%20on%20inflammatory%20bowel%20disease.%20Clin%20Transl%20Med.%202024;14(11):e70075." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR172">
<span class="label">172.</span><cite>Papadopoulos KS, Piperi C, Korkolopoulou P. Clinical applications of Adipose-Derived stem cell (ADSC) exosomes in tissue regeneration. Int J Mol Sci. 2024;25(11):5916.
</cite> [<a href="https://doi.org/10.3390/ijms25115916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11172884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38892103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Papadopoulos%20KS,%20Piperi%20C,%20Korkolopoulou%20P.%20Clinical%20applications%20of%20Adipose-Derived%20stem%20cell%20(ADSC)%20exosomes%20in%20tissue%20regeneration.%20Int%20J%20Mol%20Sci.%202024;25(11):5916." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Stem Cell Research &amp; Therapy are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13287-025-04549-2"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13287_2025_Article_4549.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.5Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366020/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366020/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366020%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366020/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366020/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366020/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830985/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366020/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830985/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366020/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366020/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tRnq8kIWQPpya4BkVXJXx9qi3xWoKePWKKHEEQ9i5NEAAjqUjuEuk2dNAvai2z2b">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
